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Ultraviolet irradiation of DNA induces the formation of a
number of mutagenic lesions. The most prolific of these is
the cis-syn thymine dimer (formed maximally at 260 nm) and
this has been implicated in the reaction pathways that lead
to ultraviolet-induced carcinogenesis.
In order that the molecular events underlying these
neoplastic events be understood, it is imperative that the
thymine dimers formed in ultraviolet-irradiated thymine
containing systems be quantitated. In this laboratory,
dimer quantitation is performed using reverse phase high
performance liquid chromatography (HPLC) with ultraviolet
(DV) detection and the data obtained has allowed a kinetic
mechanism for lesion formation to be proposed.
Such studies have used in vitro thymine containing
substrates (aqueous thymine, thymidine, thymidylyl-3',5'-
thymidine, calf thymus DNA and pUC19 plasmid DNA) to
generate the thymine dimer using DV irradiation. with the
planned extension of this research to in vivo cellular
systems (where DNA and hence thymine concentrations are
intrinsically less than those of in vitro systems), a more
sensitive technique for thymine dimer quantitation is
required.
An immunological approach to providing this technique was
chosen. Here, DV-irradiated DNA was injected into rabbits
whose immune system mounted a ' response (i.e. antibody
production) to the DV-DNA antigen. Blood was drawn from the
rabbits at regular intervals to obtain the antibodies. The
technique of immunoblotting was chosen and developed to
allow detection of the thymine dimer antigen. This involved
v
the reaction between the UV-DNA antigen, the primary
antibody (generated by the rabbit) and a secondary antibody
conjugated to an enzyme, all of which were immobilized on
a commercially available membrane system.
Detection and quantitat ion of the immune complex
immobilized on the membrane was performed using the
technique of enhanced chemiluminescence. Upon addition of
a chemiluminescent substrate (luminol) to the immune
complex, the horseradish peroxidase enzyme catalysed the
reaction of luminol, with one of the products being l i t
of 425 nm to 430 nm. This light impinged on a luminescence
film which was developed and printed using standard
photographic techniques. The use of dilutions of the
primary antibody in the immunoblotting protocol with
enhanced chemiluminescent detection, allowed correlations
of antibody dilutions with UV-DNA antigen to be made.
This immunoblotting technique with enhanced
chemiluminescent detection has been used successfully in
detecting thymine dimer lesion formation at levels
currently above the detection limit of the HPLC. It has
also been used successfully in detecting and quantitating
thymine dimers at levels undetectable by the HPLC. To this
end it has proved to be 4000 to 8000 times more sensitive
than the chromatographic technique.
Any immunological technique requires that the antibody of
interest be purified and characterized. Here, purification
of the crude serum was performed using the classical
technique of ammonium sulphate precipitation of proteins.
As an alternative technique, affinity chromatography was
performed on the crude serum using a Memsep 1000 affinity
chromatography cartridge attached to a preparative HPLC
system. Chromatographic data illustrating this purification
are given. Characterization of the DV-DNA antigen was
performed by considering the specificity of the antibody
vi
response in the laboratory animal.
Support for the kinetic mechanisms previously proposed for
pyrimidine dimer formation in DNA is also given in this
work. Calf thymus DNA was irradiated and dimer yields
obtained by immunoblotting. These were used in the computer
programme CAKE together with the previously determined rate
constants to determine simulated dimer yields. A good
agreement between experimental and simulated data indicated
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Where units and symbols used in this thesis are not IUPAC
or SI approved, they are those most commonly used in the
field. This comment is most relevant in those sections
pertaining to DNA sample preparation where mgjml or ~gjml
concentration units are used. Antibody dilutions (e.g. a
one in one thousand dilution) are expressed as 1:1000 where
extensive use has been made of ~l volume units during the
explanation of the antibody dilutions and elsewhere in the
immunoblotting protocol.
Lines drawn through points on a graph are best fit lines,
except in Chapter 6 where simulated data is superimposed on
experimental data points.
CHAPTER 1 INTRODUCTION
This thesis describes an immunological technique for the
detection and quantitation of cyclobutane thymine dimers in
ultraviolet irradiated deoxyribonucleic acid (DNA) ·
Absorption of photons of ultraviolet (UV) irradiation by
cellular DNA leads to thymine dimer formation and this
event is implicated in the reaction pathways that effect
UV-induced carcinogenesis. In these laboratories thymine
dimer quantitation is performed using reverse phase high
performance liquid chromatography with UV detection.
However, this chromatographic technique cannot provide the
sensitivity required for the quantitation of thymine dimer
at cellular levels where dimer concentrations are
inherently less than those of in vitro thymine containing
systems. An immunological technique for thymine dimer
quantitation was thus developed and is presented in this
thesis.
This chapter briefly reviews features of DNA
photochemistry, considering primarily cyclobutane thymine
dimer formation (Section 1.1) , and then considers
immunological aspects of thymine d imer photochemistry
(Section 1.2).
1.1 THE EFFECTS OF ULTRAVIOLET IRRADIATION ON DNA
Deoxyribonucleic acid is the store of genetic information
for all living cells. The DNA macromolecule is thus
responsible for the transmission and expression of genetic
information and thereby controls cellular functioning. Its
structure was, established by Watson and Crick(l) in 1953 as
being two polynucleotide chains plectonemically twisted
about the same central axis to form a double helix(2) (see
Figure 1.1. (3). Each strand of the helix is constructed
from the four nucleic acid bases (adenine, thymine, guanine




~~~ purine and pyrimidine bases
located towards the central axis
Figure 1.1. Space filling model of a portion of the double
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Figure 1.2. A segment of a single polydeoxyribonucleotide
strand illustrating the phosphate-deoxyribose
backbone with attached nitrogenous bases(4).
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phosphodiester linkages in 3'-5' or 5'-3' configurations
(see Figure 1.2. (4». The nucleic acid bases are located
towards the centre of the double helix and are arranged in
such a fashion that a pyrimidine (thymine or cytosine)
moeity of one strand pairs with a purine (adenine or
guanine) base on the other strand. The helix is stabilized
by interstrand hydrogen bonding between the nucleic acid
bases (see Figure 1.3.(2) and intrastrand stacking forces
between adjacent nucleotides. X-ray studies on DNA fibres
of synthetic polymers and natural sequences suggest that
the DNA molecule can adopt one of several conformations (A,
B or C) depending on the nature of its environment.
Conformation B is that found most commonly in aqueous
solutions of low ionic strength (i.e. in living systems).
In vivo DNA exists as free molecules within the cytoplasm
of prokaryotes or as protein associated molecules within
the nucleus of eukaryotes. It is the sequence of nucleic
acid bases within the nuclear material which encodes the
genetic information to be transferred sequentially from the
DNA to form proteins. This flow of information involves
transcription of a single DNA strand to form RNA, and
translation of the RNA to synthesize amino acid chains
which adopt conformational structures as proteins.
Aberrations of the encoded sequence of nucleic acid bases
leads to the eventual synthesis of proteins and enzymes
incapable of functioning within the cellular environment.
At the molecular level, such alterations of the genetic
code -ma y be manifest as an inability by enzymes to control
DNA replication, RNA synthesis or protein synthesis, and
this may lead to tumour development.
Alterations in base sequence may be brought about by a
variety of chemical, viral or physical sources. Chemical
change is occasioned by electrophilic reagents which
covalently interact with DNA components (5) and form DNA





Figure 1.3. Molecular detail of a portion of a double
helical DNA strand, illustrating specifically
the interstrand hydrogen bonding(Zl.
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information. Viral damage is caused by the injection of
viral DNA into the host cell where its incorporation into
DNA also interferes with the fidelity of transcription and
translation. physical damage to DNA may result from
exposure to mechanical forces (e.g. shearing) or radiation.
Radiation damage is associated with exposure to any part of
the electromagnetic spectrum, from gamma to radiowaves(6) ,
with each type of radiation band inducing different types
of damage to the DNA macromolecule. It is this last
mentioned damage mechanism (radiation damage) which is of
concern here, in particular DNA damage formed by
interaction with ultraviolet (UV) radiation.
Exposure of the skin to UV irradiation (100 to 400 nm)
induces both physiological and pathological events. Several
lines of evidence implicate DNA as the target for most of
the biological effects of UV, such as mutation, lethality
and transformation. The action spectrum for cell killing,
mutation and transformation of golden hamster embryo
fibroblasts(7) and human cells(8) are similar to the DNA
absorption spectrum as well as the action spectrum for '
cyclobutane pyrimidine dimer induction (see later). Further
evidence in support of this link between UV radiation and
DNA comes from studies of individuals with the genetic
disorder xeroderma pigmentosum. These individuals are
extremely sensitive to sunlight and frequently develop skin
cancer as a result of UV exposure. Their somatic cells are
hypersensitive to killing by UV radiation(9) and this
extreme sensitivity has been attributed to a defect in the
repair of UV-induced pyrimidine dimers. These studies
suggest DNA to be a target in UV-carcinogenesis, with the
pyrimidine dimer being responsible for at least some of the
abovementioned biological effects.
A number of studies (10-12) have investigated the link
between pyrimidine dimer formation and skin cancer and have
indicated that there is at least a causal relationship
6
between induction of pyrimidine dimers and UV-
carcinogenesis. Further work has also implicated other non-
dimer photoproducts in UV-induced lethality and
mutagenesis. The results obtained are primarily dependant
on the UV wavelengths used for analysis purposes. Each band
(A, B or C) of the UV spectrum exhibits different
biological effects. Ultraviolet A (UVA, 320 nm to 400 nm)
and ultraviolet B (UVB) from 280 nm to 320 nm are
biologically relevant because they penetrate the
stratospheric ozone layer. A filtering effect due to this
protective ozone layer prevents much of the UV wavelengths
of less than 290 nm from reaching the earth's surface.
For experimental reasons (large quantum yields at UVC
wavelengths gave large product yields), the earliest work
on the effects of UV radiation on DNA concentrated on the
UVC range where the formation of pyrimidine adducts and
cyclobutane dimers could be directly implicated in the
reaction pathways that lead to carcinogenesis. As more
powerful UV sources and bet~er analytical techniques were
developed, these investigations were extended to UVA and
UVB regions. In the UVC range, primarily at 260 nm, the
cyclobutane pyrimidine dimer (shown in Figure 1.4.(13») was
found to be induced at significant levels, with the
pyrimidine (6-4) pyrimidone photoproduct being detected at
lower concentrations. Induction of cyclobutane pyrimidine
dimers by 365 nm light on extracted purified DNA is poor in
contrast with the high yield of dimers generated in intact
E. coli bacteria. This suggests that an endogenous
sensitizer (see later) may mediate pyrimidine dimer
production at wavelengths greater than 320 nm(14). In the
UVA range above 365 nm, the most prevalent lesions are
single stranded breaks and DNA-to-protein cross-links(lS),
which may interfere with the fidelity of the genetic code.
UV light can be lethal to cells and was shown to be
cytotoxic in human cells, possibly at wavelengths as long


































Figure 1.4. A segment of a single DNA strand illustrating
the thymine dimer(13).
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As mentioned above, damaging radiation in the UVB and UVC
regions is absorbed by stratospheric ozone but
epidemiological data suggests that radiation can penetrate
the stratospheric ozone layer and impinge on the epidermal
layers of the skin to cause the induction of skin cancerous
tumours(17). Hence UVB radiation has been implicated in the
aetiology of squamous and basal cell carcinoma (associated
with long term sun exposure) and malignant melanoma, the
most feared form of skin cancer which has been linked to
blistering sunburn in early life(18). Although UVA
irradiation is one thousand fold less effective than UVB -in
producing skin redness (erythema) upon irradiation, its
predominance in the solar energy reaching the earth permits
UVA to play an important role in contributing to harmful
effects of UV radiation. Indeed its significance is now
thought to be much greater than previously suspected. UVA
is implicated in dermal tissue alterations (19) and
tumours (20), and has been reported to produce chemical
phototoxic and photoallergic reactions(21) and to be
involved in immune supression due to both inhibition of
Langerhans cells and induction of supressor T-cells. (These
immunological perspectives will be discussed fully in
section 1.2.)
As mentioned earlier, cyclobutane pyrimidine dimers and the
pyrimidine (6-4) pyrimidone photoadduct are implicated as
the most significant lesions formed in UV-irradiated DNA
and a wealth of literature exists to support this. The
initial isolation and identification of the cis-syn
cyclobutane dimer from irradiated frozen aqueous solutions
of thymine in 1960 by Beukers and Berends(22) was followed
by confirmation of its presence in UV-irradiated DNA by
Weinblum(23) and Wacker et al.(24), whilst the 6-4'-
[pyrimidin-2-'one] thymine photoproduct was first described
by Wang and colleagues(25) in the late 1960's after
isolation from UV-irradiated and acid hydrolysed DNA. Early
studies also identified the cis-syn cyclobutane cytosine
9
dimer and the mixed cis-syn thymine-cytosine dimer in uv-
irradiated DNA molecules. The cis-syn isomer is favoured
because it involves a relatively unhindered coupling of
adjacent thymine or cytosine residues along the DNA strand.
(The trans-syn thymine dimer is formed in denatured DNA
where strand separation permits greater flexibility of
adj acent nucleotides.) The 5-thyminyl-5, 6-dihydrothymine
(formed at low relative humidities) and pyrimidine trimers
were also identified in UV-irradiated DNA, and thymine
hydroperoxides and thymine glycols were isolated from
irradiated aqueous thymine reactions. . Despite the
identification of these photoproducts from irradiated
systems, only the cis-syn pyrimidine dimers and the 6-4
photoproducts are generated in SUfficiently high
concentrations to make them amenable to correlations with
biological damage. Figure 1.5. illustrates the structures
of some of the abovementioned photoproducts.
It was primarily because the cyclobutane pyrimidine dimer
was stable and was produced in large amounts that
experimental investigations concerning its correlation with
UV photodamage were made before those of the 6-4
photoproducts. Regan, Carrier and Francis (26) note that
pyrimidine dimers account for approximately 90% of the
damage induced in DNA by UV light. The dimer is produced in
significantly higher yields than the 6-4 photoproduct over
the UV range and from chromatographic analysis of
irradiated and acid hydrolysed DNA, Patrick(27) measured 6-4
photoproduct induction at 5% of the level of cyclobutane
dimers. Later workers focussed attention on both the cis-
syn dimer and the 6-4 photoproduct and it became apparent
that the induction of the 6-4 lesion was sequence
dependant, i. e. the 6-4 photoproducts occur at certain
sites more often than cyclobutane dimers. Evidence
supporting the mutagenicity of the 6-4 photoproduct was
derived from experiments with the lacI gene of E. coli



















Figure 1.5. Structures of selected UV-DNA photoproducts.
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for induction of transition mutations(28). This added weight
to the body of evidence implicating the 6-4 photoproducts
as being coparticipants with the cyclobutane pyrimidine
dimer in mediating the lethal and mutagenic effects of DV
light. Available data also suggests that the photoisomer of
the 6-4 photoproduct (the Dewar pyrimidinone) is produced
in significant amounts upon direct exposure of DNA to
wavelengths between 280 nm and 360 nm and thus may also be
involved in the mechanism of sunlight induced mutagenesis
and skin cancer.
In vitro and in vivo, cyclobutane pyrimidine dimers and the
6-4 photoproduct are formed between two contiguous bases on
the DNA strand under the influence of UV light. In the case
of the cyclobutane dimer, photodimerization occurs via a
[2+2] cycloaddition reaction of the pyrimidine bases across
their C5-C6 double bonds. T~e most abundantly produced of
these dimers is the thymine-thymine pyrimidine dimer,
although reactions between cytosine-cytosine and thymine-
cytosine bases do occur to . smaller extents. As will be
shown later, artificially introduced photosensitizers can
be employed to enhance the production of one kind of dimer
(e. g. thymine-thymine dimer) over the other pyrimidine
dimers.
When free in solution, the pyrimidine bases can give rise
to four isomers of the dimer (as shown in Figure 1.6.) for
thymine. If these bases are held within the DNA helix, then
(as mentioned above) stereochemical constraints imposed by
the helix and the phosphate-deoxyribose backbone permit
only one of the four possible stereoisomers to form and in
native DNA, only the cis-syn isomer has been detected(29).
Photodimerization of adjacent pyrimidine bases along the
DNA strand causes deleterious effects to the secondary and
tertiary conformational structure of the DNA molecule.
Ciarrocchi and Sutherland(30~ showed that an unwinding angle











Figure 1.6. The four stereoisomers of the eyelobutane
thymine dimer formed when an aqueous thymine
solution is irradiated with DV light.
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contributing to the measurable alteration of the tertiary
structure of the DNA as a result of lesion formation. In
support of these observations Pearlman et al. (31) calculated
a bending angle of 27° after thymine dimerization in DNA.
While these structural changes may be responsible in part
for the harmful effects of these lesions in cellular
systems, they may also represent recognition sites for
repair enzymes. As will be discussed in section 1.2.,
alterations to the tertiary structure of DNA as a result of
dimer formation, is implicated as the initiating feature
for antibody production to UV-irradiated DNA.
As a protective function, thickening of the epidermal
layers and increased melanin production of the skin have
developed as mechanisms in reducing the intensity of UV
radiation reaching the basal layers where the carcinogenic
process is thought to start. However , living cells have
also developed a series of repair mechanisms which can
remove UV-induced lesions. Setlow et al. (32) showed that
cyclobutyl pyrimidine dimers in DNA are the substrate for
the photoreactivating enzyme, PRE, and that this lesion
alone is repaired by the enzyme(33). In this light mediated
photoreactivation pathway, the PRE enzyme binds to the
lesion forming a complex which is stable in the absence of
light(34). Upon absorbing a photon of light in the 300 nm to
600 nm range, the enzyme converts the dimer to its two
constituent monomers. In this manner, the fidelity of the
particular DNA sequence is restored. Light independant
repair processes also remove the damaged region of
DNA (17,35,36). The process involves excision of a dimer
containing oligonucleotide and ligation of newly
synthesized material (using the complementary DNA strand as
a template) to . the parental DNA. This rapid repair of
active genes correlates with the resumption of RNA
synthesis after UV irradiation(37) supporting the view that
it is arguably the most Lmport.ant; type of repair(35) of
pyrimidine lesions due to its speed and precision. However,
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post-replication repair is proposed by Zajdela and
Latarjet(38), upholding the view that the excision repair
pathway is inaccurate and that misrepair of the damage is
responsible for the production of some neoplastic tumours.
Several investigations have studied the rejoining of single
stranded breaks in bacterial cells and in human
fibroblasts. In the latter case, UVA induced single
stranded breaks have a half life of 2 to 3 minutes at
37°C(39) which is similar to ' t ha t for the repair of breaks
induced by ionizing radiation(40). Little, however, is known
of the mechanism by which this repair occurs, or the
mechanism by which repair of DNA-to-protein cross-links
occurs.
Efficient removal of DNA lesions by cellular repair
processes appears to be a crucial step in the prevention of
tumour induction. In this regard, a number of human
hereditary diseases such as xeroderma pigmentosum,
Fanconi's anemia and ataxia telangiectasia have been shown
to be unusual in their processing of damaged DNA
components (41,42). Xeroderma pigmentosum patients are unable
to repair pyrimidine dimers and are highly susceptible to
the development of skin cancers. This is due to a defect in
a gene encoding the enzyme{s} that repairs pyrimidine
dimers. People carrying the defect are a thousand times
more likely to develop melanoma than people with functional
copies of the gene(9). However, DNA repair proficient
revertant cells have been isolated from repair deficient
cells, suggesting that a particular patient's condition may
stem from a limited number of enzyme deficiencies. Another
genetic disease concerned with an inability to repair
damaged DNA is basal cell nevus syndrome where patients are
pre-disposed to sunlight induced skin cancers. However,
results indicate that DNA lesions and repair processes
other than pyrimidine dimers are involved in the
pathogenesis of this disease. Recently a human repair gene
was cloned and when transfected into repair deficient
15
rodent cells the gene was able to correct the
deficiency(43). Reports such as this provide evidence of the
mutagenicity of UV-induced lesions. If the lesions are not
removed, then UV - induced mutations are important in
initiating neoplastic events. Brash(44) has suggested that
the frequency of mutation at a given point is more closely
related to the local structure of DNA than to the
photoproduct frequency at that point. This claim is
substantiated by observations that while the presence of
pyrimidine dimers may be a pre-requisite for UV
mutagenesis, the actual mutagenic event can occur at a site
some distance removed from the dimer(45).
since the isolation of the cyclobutane pyrimidine dimer by
Beukers and Berends in 1960 (22) , research on UV
carcinogenesis has focused on a number of themes: attempts
to define the relationship between UV exposure and
induction of skin cancer in man and laboratory animals,
description of the pathogenesis of the disease and
investigations into the mechanism by which UV r-ad i at.Lon
causes cancerous tumours. To gain insight into the last
mentioned line of research, workers have adopted a
reductionist approach by investigating first the kinetics
and mechanisms of dimerization of irradiated free
pyrimidine base in aqueous solution. As mentioned
previously, when free in solution, UV irradiation of
thymine produces four stereoisomers of the cyclobutyl
pyrimidine dimer. When studies were extended to examine
photodimerization of DNA in vitro, only the cis-syn stereo
isomer was detected. (This particular stereoisomer is also
generated in frozen aqueous layers of irradiated thymine.)
Irrespective of the environment of the pyrimidine base
(free in solution or bound within the DNA helix), the
dimerization reaction is photoreversible and a wavelength
dependant photostationary state is achieved (22) • At
wavelengths around 265 nm,. the photoequilibrium favours
dimerization, but at shorter wavelengths around 245 nm, the
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equilibrium shifts to form thymine monomers. It is
interesting to note that the thymine monomer absorbs UV
light maximally at 265 nm, due to the conjugation of the
C5-C6 double bond with the C4 carbonyl group. Since
dimerization involves a [2+2] cycloaddition reaction across
the C5-C6 double bonds of adjacent thymine moeities, it is
logical to expect this characteristic absorbance to
disappear upon dimerization (Figure 1.7.). If photoreversal
is performed (by irradiating the thymine dimer with light
of 245 nm) then the absorption at 265 nm will reappear due
to thymine monomerization being favoured.
Photodimerization of thymine, uracil and cytosine in
solution can be effected by direct irradiation using
wavelengths less than 290 nm, particularly those
wavelengths at 265 nm where the pyrimidine bases have a
maximum UV absorbance, the energy of which is absorbed by
the bases to initiate the dimerization process.
Photodimerization of pyrimidipe bases is generally accepted
to occur via a mechanism involving the triplet state of the
specific pyrimidine base. The process is initiated by the
thymine base interacting with a photon of energy, thereby
converting the thymine base to its excited singlet state.
Kinetic investigations reveal that the majority of the
singlet states decay to the ground state by processes
involving radiationless transitions. A small portion of the
excited singlet states, however, undergo spin inversion
(intersystem crossing) changing to a more stable and longer
lived triplet state. It is this triplet thymine molecule
which collides with a ground state thymine molecule to form
the mutagenic thymine lesion. Bimolecular self-quenching
and radiationless decay have been identified as processes
which occur concomitantly with dimerization. However, this
mechanism applies only to dilute thymine solutions « 1
mM). If the thymine concent~ation exceeds this value, then
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Figure 1.7. Characteristic UV absorption spectra of the
thymine monomer and thymine dimer.
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intermolecular hydrophobic interactions and dipole-induced-
dipole interactions. Seeing that the thymine molecules are
in close proximity (due to their aggregation), diffusion of
isolated thymine molecules is not important and hence the
dimerization process proceeds from population of the
singlet state of the thymine.
This mechanism involving direct irradiation of the thymine
base does not fully explain dimerization at wavelengths
greater than 290 nm. At the UVA and UVB wavelengths (which
do penetrate the stratospheric ozone layer), exogenous
chemical photosensitizers (i.e. those that are added to the
system) can be used to bring about indirect dimerization of
pyrimidine bases in solution(46,47) as well as in DNA(49).
Ketones such as acetophenone, benzophenone and acetone have
been investigated as possible photosensitizers of
pyrimidine formation(46-49). Many other photosensitizers have
been identified, some of which act endogenously, but the
majority are added manually to the cellular system.
Included here are psoralen derivatives, riboflavins and the
abovementioned ketones. Sunscreen constituents, however,
also have photosensitizing properties apart from their
function in absorbing UV radiation to reduce skin reddening
during exposure to the sun. Examples of sunscreen
components which have been shown to enhance thymine dimer
production include para-aminobenzoic acid (50), disodium-
2,2 '-dihydroxy-4,4 '-dimethoxybenzophenonesulphonicacid (51)
and 2 -phenylbenz imidazole-5-sulphonic acid (51). (In contrast
with .t.h e mutational potential of UV induced lesions whose
production is accelerated in the presence of
photosensitizers, it should be noted that selected
exogenous chemical sensitizers find benefit when employed
in photodynamic therapy. During treatment, a sensitizer is
incorporated into an organism and when exposed to light of
the appropriate wavelength for absorption by the
sensitizer, oxygenated pro~ucts harmful to cell function
arise, eventually resulting in the destruction of (tumour)
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tissue (52) . )
In this work, the use of acetophenone was chosen as a
photosensitizer for UV-irradiation of DNA (see later). It
has been demonstrated that irradiation of DNA with 254 nm
light yields several different photoproducts, but the use
of acetophenone and acetone with 313 nm light gives a
product distribution heavily favoured for cyclobutane
pyrimidine dimers(48). Iri particular, acetophenone
photosensitization has been demonstrated to lead to the
almost exclusive production of thymine photodimers in
DNA(49) although thymine-cytosine dimers form to a small
extent (approximately 5% of the reaction product(53)).
An explanation of the selective production of thymine
dimers with acetophenone photosensitization is given as
follows: at the molecular level, several orbitals are
available for population of the nucleic acid bases (Figure
1.8.). The intense absorption band in DNA is primarily due
to n-n* transitions, although n-n* transitions do occur due
to nominally forbidden intersystem crossing mechanisms.
However, photosensitizers are also able to populate the n-n*
states when irradiated with light of 313 nm in the presence
of a pyrimidine base. Irradiation with this wavelength does
not directly excite the DNA since absorption at 313 nm is
negligible. Acetophenone has a lower-lying singlet state
than any of the bases and absorbs extensively at this
wavelength (Figure 1.9.). Due to an intersystem crossing
efficiency of almost unity, every singlet acetophenone
molecule is converted to its triplet state. This triplet
state lies below the triplet level of cytosine, guanine and
adenine, but above the triplet level of thymine. Hence
population of the triplet level of thymine occurs by
collisional processes with the triplet acetophenone. In DNA

















"'"s • • ••




Figure 1.8. Diagram of energy levels available for light
absorption in purines and pyrimidines(S4).












Figure 1.9. Schematic diagram of the main processes
involved in ~cetophenone photosensitized
dimerization of thymine in DNA(9S).
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The use of acetophenone as a sensitizer in this work is
advantageous i~ that irradiation of DNA with acetophenone
requires that only the cis-syn dimer (the main DV
photoproduct) needs to be quantitated. From an
immunological perspective, production of antibodies against
DV-irradiated DNA in the presence of acetophenone implies
that a single antibody population should, in theory, be
generated against a cis-syn thymine dimer antigen, and not
against any other DV photoproducts. This consideration is
important in producing an antibody population of high
specificity.
Previous work in this laboratory proposed a mechanism for
acetophenone photodimerization in DNA(54). Using a computer
simulation of the reaction mechanism, Thomas(54) found good
correlation with experimental data and this supported the
validity of the mechanism. The proposed mechanism describes
in vitro processes, and the work presented in this thesis
provides a stepping stone towards quantitating thymine
dimer production and el~cidating a mechanism of
photosensitized irradiation in vivo. To this end, section
1.2 briefly reviews immunological perspectives of DV
irradiation and in particular discusses aspects of antibody
production against DV-irradiated DNA.
1.2 DNA PHOTOPRODUCT QUANTITATION
RADIOLABELLING AND IMMUNOASSAY
CHROMATOGRAPHY,
The identification of the cis-syn cyclobutane dimer from
frozen aqueous solutions of thymine by Beukers and
Berends(22) in 1960 prompted researchers to investigate not
only the mechanisms by which photoproduct formation occurs
in irradiated systems, but also techniques Whereby
photodamage could be analysed and quantitated both in vitro
and in vivo. Initially quantitation of the most abundantly
produced lesion (the cia-syn thymine dimer) allowed
correlat~ons to be made with the mutagenic and cytotoxic
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potential of this lesion, and thus implicated it in the
reaction pathways that lead to UV-induced carcinogenesis.
In the early stages of investigations into DNA
photochemistry, the most commonly used technique for
analysing and separating photoproducts was descending paper
chromatography. The technique is based on the relative
solubilities of the photolesions in a given solvent system
(e.g. isopropanol: water: ammonium hydroxide). However a 12
to 18 hour migration time was prohibitively time consuming
and coupled with the problems of a lack of resolution of ·
the cis-syn thymine dimer from the 6-4 photoproduct in the
commonly used n-butanol: water: acetic acid solvent
system(55), it was clearly evident that alternative
techniques be employed. Although thin layer chromatography
provided shorter resolution times (3 to 4 hours) (47,56), the
procedure required that the photoproducts be detected by
scintillation counting, the hazards of which will be
highlighted later in this chapter.
Ion-exchange column chromatography was used to overcome the
problems of co-resolution. Using this approach, Varghese
and Patrick(57) resolved the cis-syn thymine dimer from the
6-4 photoproduct, and Weinblum and Johns(58) achieved
resolution of the four thymine dimer stereoisomers from
each other. with the advent of more sophisticated
chromatographic techniques, both gas-liquid chromatography
and high performance liquid chromatography (HPLC) were
employed for photoproduct identification and quantitation.
In spite of the advantages afforded by improved resolution
and scale-up for ion-exchange, gas-liquid chromatography
and HPLC, all of these techniques necessitate the
degradation of DNA to the free base, nucleoside, mono- or
oligonucleotide prior to analysis. Classical degradative
techniques include alkaline hydrolysis, site selective
enzymatic breakdown or hot acid hydrolysis of the UV-
irradiated DNA (also referred to as UV-DNA) to cleave the
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required photoproduct from the DNA strand.
Enzymatic hydrolysis exploits enzymes which sequentially
degrade polydeoxyribonucleotides, yielding photoproducts
which can then be analysed. However, chromatographic
analysis may in some instances be complicated by the
inability of nucleases to cleave the phosphodiester bond
between a photoproduct and its adjacent base, thereby
leaving an additional monomeric unit attached to each
photoproduct. To ensure complete breakdown of the DNA to
carbon, oxygen and carbon dioxide but simultaneously
release stable photoproducts, the technique of hot acid
hydrolysis is employed. Previous research in this
laboratory(54) established a perchloric acid hydrolysis
technique which breaks down the DNA to its constituent free
bases and acid stable photoproducts. Analysis and
quantitation of the relevant photoproduct is then performed
using reverse phase HPLC with DV detection.
Whichever of the a bovementioned techniques is employed for .
analysis and quantitation purposes, a distinct disadvantage
is apparent since subjecting the DNA to harsh hydrolytic
procedures does not allow the recovery of the intact
irradiation substrate after analysis. A compounding problem
is provided by observations that relatively large
irradiation doses are necessary to induce HPLC detectable
changes to the DNA molecule. These drawbacks led to the
development of non-destructive analytical techniques for
photoproduct analysis and quantitation, several of which
allow the quantitation of low levels of photodamage in DNA
without requiring radiolabelling of the relevant
photoproduct. These investigative tools are largely
enzymatic, immunological or molecular biological in nature.
Included here is one of the most sensitive assays for
identifying base damage which involves endonucleolytic
incision at the site of the .dama ge followed by analysis of
the photoproducts produced in the DNA. In this manner
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repair kinetics of pyrimidine dimers have been measured
with an endonuclease isolated from either Micrococcus
luteus or bacteriophage T4-infected cells. In this assay,
measuring the number of chain breaks produced with alkaline
sucrose sedimentation analysis allows base damage to be
assessed(59,60). Apart from identifying pyrimidine base
damage, single stranded breaks at sites of 6-4 photodamage
were induced by endonuclease activity and identified on
gels using gradient sedimentation analysis.
As mentioned above, the sensitivity of these in situ
techniques is greater than that obtained by chromatographic
means and has allowed these biological techniques to be
used for the detection of photodamage at lethal (10 J/m2)
and sub-lethal (0.5 J/m2) UV fluences(162) where the
production of cyclobutyl dimers is too low for quantitation
by chromatographic means. Included in this group of highly
sensitive non-destructive assays is radiolabelling (3 H or
1251 ) of the damage. Lesions are quantified by scintillation
counting of radioactivity but the technique carries with it
all the associated hazards of working with radioactive
species including the observation of base damage induced by
the radiolabel (61,62 ) itself.
with the requirement that cis-syn thymine dimers in this
work should be detectable at concentrations below those
currently detectable by HPLC (i.e. < 10-6 M) an
immunological approach (i.e. the production of antibodies
against DNA photoproducts) appeared to provide the
necessary sensitivity requirements. It must be stressed
that the sensitivity limits which can be achieved using
immunological detection and quantitation are comparable
with those achieved using radiolabelling. Howevar ; the
latter technique requires sophisticated instrumentation and
carries with it the abovementioned disadvantages of working
with radioactive species. Environmental considerations are
also beginning to militate against radioactive material
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usage - chiefly because of the expense and difficulties
associated with waste disposal.
Immunological detection and quantitation of UV-
photoproducts requires that a laboratory animal be injected
with an aliquot of the photoproduct of interest (the
antigen). Because this UV-DNA antigen is recognised as
"foreign" by the animal, a complex series of biochemical
processes are initiated by the immune system, aimed at
ridding the animal of the alien molecules. The end result
of this mobilization process is the production of a '
proteinaceous antibody population with combining sites that
are complementary to unique molecular features of the
antigen stimulus. Through a combination of van der Waals
forces, hydrogen bonding and electrostatic forces, the
antibody population binds the foreign antigen molecules in
reactions of extremely high affinity . In this way the
antigen is neutralized and usually eliminated from the
animal.
It is common for an organism to synthesize a family of
antibodies that respond to multiple features of the antigen
(i.e. phosphate-sugar backbone, short nucleotide sequences,
cis-syn thymine dimer, 6-4 photoproduct). Thus a particular
member of the antibody family will be directed against a
specific structural unit, or epitope (e.g. cis-syn thymine
dimer), of the antigen (Figure 1.10.). Each member of this
family is produced by a single cell type or clone. This
gives rise to the term "polyclonal antibody", where a wide
variety of clones are involved in the production of
antibodies targeted against multiple epitopes of the
antigen. In contrast, monoclonal antibodies are produced in
the laboratory from a single clone. Their great advantage
lies in the fact that all antibodies bind to the antigen in
the same way and with the same affinity. This has important
applications if the antibodies are being used in






Figure 1.10. Antibody molecules binding t o specific











Figure 1.11. Schematic representation of an antibody
molecule . .
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the hybridoma techniques that are essential for monoclonal
antibody production require specialist knowledge and
equipment. Hence in this work, polyclonal antibodies were
produced in laboratory animals against DV-irradiated DNA.
Any antibody population whether generated against single or
multiple antigen features is composed of a number of
classes that differ from one another in chemical and
physical properties. The antibody (or immunoglobulin)
classes which are most commonly identified are
Immunoglobulin G (IgG) , Immunoglobulin ' M (IgM) ,
Immunoglobulin A (IgA) , Immunoglobulin E (IgE) and
Immunoglobulin D (IgD). Of these, the IgG class is the most
abundant in mammalian serum, comprlslng 75 to 80% of the
total antibody complement(63). The basic structural unit of
all antibodies is composed of two light polypeptide chains
and two heavy polypeptide chains joined by disulphide
bridges (see Figure 1.11.). The molecular geometry of this
basic structural unit resembles a "Y". In each arm of the
Y (referred to as the Fa b region), the antibody binds the
epitope of the antigen molecule, while the Fe region
performs specific recognition functions. The antibody
response resulting from exposure to antigenic molecules has
certain well defined characteristics. After presentation of
the antigen, intense protein synthesis occurs in lymphoid
organs prior to assembly of antibody molecules. This
primary immune response produces antibody populations which
are detectable in the blood a week or two after exposure
to, or immunization with, the antigen. This response does
not persist and usually does not result in significant
antigen production as can be seen in Figure 1. 12. The
situation is altered noticeably if a second immunization is
administered. During this secondary response, antibody
production is maintained at a high level, decreasing only
slowly after a few months(63). In the work presented in this
thesis, antibody production . was monitored in rabbits over
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Figure 1.12. Typical antibody response curve, the
antibodies produced after exposure of the
animal to the antigen(63).
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The question of antibody production against DNA or its
constituentnucleotides, nucleosides or nucleic acid bases
is an intriguing one. DNA is integral to every living cell
and superficially it thus appears unlikely that the DNA
molecule is immunogenic (i.e. antibodies can be generated
against it) . However, under specific experimental
conditions (denatured DNA coupled to protein carrier
molecules in the presence of "enhancers") and during the
course of the autoimmune disease systemic LUpus
Erythmatosus, anti-DNA antibodies are elicited. (Aspects of
DNA immunogenicity are discussed in Chapter 4.)
Early studies aimed at producing anti-DNA antibodies(64,6S)
were largely unsuccessful, primarily because the DNA
(purified by 0.5% phenol extraction) contained appreciable
amounts of protein and carbohydrate material against which
antibodies were also produced. Alternative DNA antigenic
substrates (wheat germ, calf thymus, herring roe) and
improved purification techniques facilitated the production
of anti-DNA antibodies with .higher specificity. The most
significant breakthrough, however, came with the
description by Plescia et al. (66) of a technique which
incorporated the protein carrier, methylated bovine serum
albumin, with the DNA antigen prior to immunization (see
section 4. 2 . 1. 4). When the above technique was combined
with the use of enhancers (adjuvants) antibodies were
elicited against both single and double stranded
oligonucleotides(67), synthetic polynucleotides(68) and
RNA(69). These antibodies cross reacted to different degrees
with DNA from other sources and denatured DNA was shown to
be the serologically active species.
The first production of antibodies directed against
modified DNA components was demonstrated in 1966. Van
Vunakis et al. (70) generated antibodies in rabbits to photo-
oxidized DNA, while Levine .et al.(71) pioneered antibody
production against DV-irradiated and denatured DNA. This
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initial demonstration was followed by several other
reports(71-74) of anti-DNA antibody production and in most
cases a detailed examination of the antigenic specificity
of the resultant antibody was undertaken. The epitope or
antigenic determinant against which antibody production is
initiated is the cyclobutane pyrimidine dimer, as suggested
by short wavelength reversal(71), enzymatic
photoreactivation of the photoproducts(72,73) or by a
correlation of the antigenic reactivity with expected
and/or chromatographically measured repair kinetics of
dimers(74). Other studies demonstrated antibodies specific -
for a photoproduct of thymine(71,7S), or a photoproduct of
adjacent thymines(76) suggesting that thymine dimers were
the preferred determinant as opposed to cytosine-thymine
dimers. Furthermore, acetophenone photosensitization was
used to prepare cis-syn thymine dimers in DNA, against
which antibodies were generated in laboratory animals (77,78) .
In this context it should be noted that although antibodies
have also been raised against 6-4 photoproducts (mentioned
previously), references to antibody production against
other non-dimer photoproducts are scant and include only a
reference to antibody production against thymine
glycols (79) .
In the majority of the abovementioned cases, polyclonal
antibodies were produced in laboratory animals (usually
rabbits). However, strickland and Boyle(76) characterized a
monoclonal antibody that was specific for thymine dimers in
polynucleotide or oligonucleotide sequences of at least
four bases long. Monoclonal antibody production has also
been used extensively to characterize 6-4 photoproducts(58) ,
and most recently a group of Japanese scientists produced
monoclonal antibodies which recognized both thymine dimers
and 6-4 photoproducts (80) •
Irrespective of the nature of the antibody produced against
UV-irradiated DNA, consensus is reached among investigators
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that antibody production is initiated by antibody producing
cells responding to conformational changes induced by
dimerization, rather than the pyrimidine dimer itself(81).
There is also fair agreement that the binding sites on the
UV-DNA encompass the backbone of one or both helical chains
of the DNA over a span of about three to six nucleotides or
base pairs (82). These values are similar to the binding
sites of antibodies that bind to undamaged DNA (about 5
nucleotides) and undamaged synthetic polynucleotides (4 to
6 nucleotides). In terms of the antibody combining site,
which is estimated to be 24 to 36 A in length, a segment of
DNA 40 to 50 base pairs in length can allow bivalent high
affinity binding by an IgG molecule(3 ) (Figure 1.13.). For
a single pyrimidine dimer antigenic determinant, the
observation that 3 to 6 nucleotides are necessary for
antibody binding suggests that the presence of one or more
adjacent unaltered bases on one or both sides of the dimer
is necessary to provide stability to the antigen/antibody
complex(74). However, such flanking nucleotides probably do
not function as antigenic determinants, as substition of
different nucleotides into the flanking positions alters
but does not eliminate, antigen binding.
Investigations into the nature of the antibody binding
site, the antigenic determinants and the specificity of an
antibody population have necessitated the development and
establishment of analytical · techniques to examine these
phenomena. Shortly after methods for the production of
anti~UV-DNA sera became widely available, sensitive
immunoassays were reported for the detection of
photoproducts in biological samples. The earliest of these
made use of the immunological technique of complement
fixation to indicate properties of the ~ntibodies generated
against UV-photoproducts. However, this assay was unable to
detect damage caused by low levels of irradiation. Hence
immunofluorescence (labelli~g the photoproduct, or antibody





Figure 1.13. Size considerations allow an IgG antibody to
bind a DNA segment of 40 to 50 base pairs with
high affinity(3).
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was developed and has been used extensively to observe the
repair kinetics of irradiated cells and to detect dimers in
the nuclei of human amnion cells irradiated with a dose of
30 J/m2 (77) Since immunofluorescence is not strictly
quantitative and does not reveal lesions induced by UV
fluences of less than 10 J/m2, an alternative technique of
radioimmunoassay was developed which permits the detection
of photoproducts in intact DNA(74). In this assay, usually
1251 is introduced intti the DNA prior to irradiation and
denaturation. Then the binding between (125 1]-UV-DNA and the
anti-uv-irradiated serum is inhibited by small quantities
of DNA irradiated with low doses of UV light. Scintillation
counting of the resultant antigen/antibody complexes allow
conclusions to be drawn concerning characterization and
quantitation of photoproducts. The limits of sensitivity of
this assay allowed the detection of photoproducts generated
at UV fluences as low as 5 J/m2.
More recently an enzyme linked immunoabsorbent assay
(EL1SA) was reported (82) to measure pyrimidine dimers in .
DNA. Exploiting the interactive and highly specific forces
of immunological components: antigen, antibody and a
secondary antibody specific for the primary antibody are
immobilized in the wells of a microtitre plate. The
secondary antibody is attached to an enzyme, the substrate
of which is added to the immune complex and a colour
reaction (catalysed by the enzyme) proceeds. The intensity
of the reaction product allows quantitation of either the
antigen or antibody to be made. Using the same principle,
the immunoblotting assay has been described(83) which also
immobilizes immune complexes on a support medium (usually
a commercially synthesized membrane) . After immobilization,
the components of the immune complex can quantitated using
radiolabelling(84) or by chemiluminescent techniques where
the enzyme catalyses the production of light. Such an assay
has been reported to detect UV lesions generated at sub-
lethal (0.5 J/m2) UV doses(162) , in comparison with the
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detection limit of 1 to 2 J/m2 for the ELISA.
The brief discussion above has outlined available
techniques used to quantitate antibodies generated against
UV-DNA photoproducts which subsequently allow the
photoproducts themselves to be quantitated. Because the
development of an immunoassay method for the detection of
thymine dimer lesions at low biological UV fluences is the
central feature of the work presented here, more in-depth
discussions concerning immunoassay techniques (and
applications in quantitating thymine dimers), will be found
in section 5.1.
In the work presented here, it was imperative that low
concentrations of thymine dimer be detected. Thus an
immunological approach was adopted and antibodies to the
UV-DNA antigen were raised in rabbits. Excluding the option
of using a radioimmunoassay (because of the associated
problems of dealing with radioactive material), an
immunoblotting protocol was. developed for thymine dimer
detection and quantitation.
Once the methodology was optimized, the experimental
procedures were used to determine thymine dimer yields at
dimer levels undetectable by HPLC. Using the computer
programme CAKE, these results were then used to test the
mechanism proposed by Thomas(S4) for the acetophenone
photosensitized dimerization of thymine in DNA.
This thesis is divided into 6 chapters, the first of which
has dealt with aspects of cyclobutane thymine dimer
production in the context of DNA photochemistry (Section
1), and DNA photoproduct quantitation, examining
specifically the approach of raising antibodies to UV-DNA
photoproducts (Section 2). Chapter 2 deals with irradiation
techniques for the producti9n of the cis-syn thymine dimer
in DNA, while Chapter 3 discusses photoproduct analysis and
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quantitation by the technique of HPLC, currently used in
these laboratories. Then the immunological aspects of DNA
photochemistry will be considered - a discussion of the
experimental aspects of the immunization techniques
employed to raise anti UV-DNA antibodies (Chapter 4), and
immunoassay for the quantitation of thymine dimer
photolesions as used in this work (Chapter 5). In Chapter
6 the results obtained will be presented and discussed.
Included here will be the application of immunoblotting in
supporting the mechanism as proposed by Thomas (54) for




The experiments reported in this thesis fall into four main
categories. These are the experiments relating to the
irradiation and HPLC techniques used in obtaining cis-syn
thymine dimer yields (Sections 2.8.1 to 3.2.3), the
experiments relating to the production of anti DV-DNA
antibodies in rabbits (Sections 4 .2.1 to 4.2.2), the
experiments relating to the purification of the serum
containing thymine dimer antibodies (Section 4. 2 . 3) and
experiments relating to the development and use of an
immunoassay protocol for thymine dimer quantitation
(Section 5.2.2). Listed below are the various chemicals and
equipment used in the experiments carried out.





2.2 CHEMICALS FOR HPLC
Methanol
Perchloric Acid
































































































2.7 EQUIPMENT FOR HPLC, AFFINITY CHROMATOGRAPHY AND
IMMUNOBLOTTING
HBO 500W High Pressure Mercury Lamp (Osram)
Powerpack for HBO Lamp (Schreiber)
Blak-Ray J-221 Longwave UV Intensity Meter
(UVP)






600 Multisolvent Delivery System (Waters)
U6K Variable Injector (Waters)
990 Photodiode Array Detector (Waters)
990 Plotter (Waters)
APCII Personal Computer (NEC)
Microliter Gastight Syringe (10-100 J,£l)
(Hamilton)
4000 Delta Prep: Preparative Chromatography
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System (Waters)
7010 Rheodyne Injector (Waters)
486 Tunable Absorbance Detector (Waters)
745B Data Module (Waters)
sterile syringes (2.5 ml) (Terumo)
DMS 300 DV/Vis Spectrophotometer (Varian)
Suprasil Quartz 50 ~l ultracuvette (Hellma)
Microliter Microcentrifuge (Hettich)
Immobilon-N Transfer Membrane (Millipore)
Fine, non-serated tweezers
Plastic boxes (10 x 10 x 8 cm3 )
clingfilm
Shaking Waterbath (Protea)
Hyperfilm-ECL (18 x 24 cm2 ) (Amersham)
Autoradiography Cassette (18 x 24 cm2 )
UMC 20 Ultrasonic Bath (Ultrasonic
Manufacturing Company)
Number 3 Glass Vials (12 ml) (Polytop)
Sero-wel ELISA Plates (Sterilin)
Memsep 1000 Affini~y Chromatography Cartridge
(Millipore)
Ultracarb 5 aDS 30 HPLC Column (Phenomenex)
Model 25X Steam sterilizer (Wisconsin AIl-
American)
Millex RV 0.45 ~m Filter Unit (Millipore)
Millex GV 0.22 ~m Filter unit (Millipore)
AE 200 Four Place Balance (Mettler)
1.5 ml Eppendorfs
Vacuum Filter Apparatus (Millipore)
Note*: Milli-Q Water refers to water that has
been passed through the Millipore Milli-Q
apparatus which consists of a series of ion-
exchange and organic removal resins.
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2.8 EXPERIMENTAL TECHNIQUES
2.8.1 IRRADIATION TECHNIQUES AND EQUIPMENT
Previous workers in this laboratory (50,54,85) have used a
number of light trains for the irradiation of thymine
(aqueous solution and frozen) and DNA (calf thymus and
plasmid). Light sources used initially were mercury arc
lamps (Hanau ST 40 and ST 75 medium pressure mercury lamps)
which provide an ultraviolet output (line spectrum) in the
240 to 600 nm region. However, for the irradiation of in ·
vitro DNA (aqueous solution of calf thymus DNA and pUC19
plasmid DNA), a high pressure mercury lamp was used by both
Thomas (54) and Aliwell (50). Since this work examines in vi tro
DNA irradiation, it was decided to follow these previous
workers and use this high pressure mercury HBO 500W/2 lamp.
The following section describes the use of this HBO lamp,
its spectral Characteristics, the irradiation cuvettes and
filters used, and the irradiation techniques that were
employed for the study of the photochemistry of DNA-
acetophenone-phosphate buffered saline solutions.
2.8.1.1 Light Source for Quantitative Photolysis
Experiments
Irradiation of in vitro DNA requires an intense light
source. This is because dimerization of pyrimidine
nucleotides is not a very efficient process when
irradiation takes place at wavelengths greater than 290 nm
and consequently quantitation of dimers is difficult. As
mentioned above, a high pressure short arc mercury lamp
(HBO 500W/2 supplied by Osram) was used (Figure 2.1.). The
lamp r consists of a high optical quality quartz glass
discharge vessel containing mercury and a noble gas. The
HBO produces an intense UV source with extensively
broadened emission lines .s up e r i mpos e d on a continuum















Figure 2. 1. Osram RBO 500W/2 high pressure mercury arc lamp
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Figur e 2 .2. The relative spectra l radiation distribution of
the Osram RBO 500W/2 high pressure mercury arc
lamp.
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extremely high luminescence, high arc stability and a good
luminous efficiency. Since that light of wavelength greater
than 290 nm was used for the acetophenone photosensitized
irradiation of .DNA in this work, the HBO lamp in
conjunction with a relevant Pyrex filter (see later), was
a suitable DV light source.
It was important that the lamp be mounted free of
mechanical stress and to allow for thermal expansion during
operation. For best performance and high arc stability, the
HBO lamp was operated in an upright position~ but because
of the dangers of DV radiation, overpressure during
operation and glare, it was installed in a protective
housing. The construction of this housing has been
discussed in detail by previous members of the research
group(54). The lamp was housed in an insulated box
constructed of mild steel through which a Schreiber DC
power supply was attached to the lamp. A fan served to
eliminate any ozone generated by the DV radiation. The DV
radiation emitted from the lamp passed through a square
aperture onto which the filter was attached and impinged on
the cuvette containing the irradiation sUbstrate.
Externally, a bracket supported a shutter gate, filter
holder and cuvette (Figure 2.3.).
Osram recommend a 400 hour lifetime for the HBO lamp and
also that no quantitative radiations are performed until
the lamp. intensity is stabilized (usually after 3 to 5
hours). The lamp intensity was monitored in situ using a
Blak-Ray J-221 Longwave photovoltaic DV intensity meter.
The meter was used to measure the lamp intensity at
intervals during the lamp lifetime, and thus allowed
comparisons to be made between experiments performed at
varying times of the lamp lifetime. Figure 2.4. illustrates
the intensity variation of the HBO lamp that was used as a
function of lamp hours.

















Figure 2.3. Housing used for the HBO lamp, illustrating the
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Figure 2.4. Relative intensity variation of the HBO lamp
with lamp lifetime.
Figure 2.5. Short neck quartz irradiation cuvette.
2.8.1.2
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Irradiation Techniques with the HBO Lamp
Quantitative irradiations were performed using a 1 mm thick
short neck quartz cuvette (shown in Figure 2 . 5 • ). As a
result, only small volumes of solution were irradiated at
a time so that large concentrations of dimer could be
produced within a reasonable ~rradiation period (10 hours
or less).
Because DNA solutions are intrinsically viscous, the short
neck cuvette has the advantage over a long neck cuvette of .
allowing more efficient removal of the irradiated solution
for analysis. It was i mportant to ensure that the cuvette
was clean and dry before use in order that water adhering
to the inner walls of the cuvette would not affect the
concentration of DNA irradiated. To this end , the cuvette
was immersed in a chromic acid solution before use, rinsed
with copious amounts of Milli-Q water and then allowed to
dry thoroughly.
As discussed in section 1.1, a wavelength range of 290 to
320 nm was required for this work. Isolation of a specific
wavelength or range of wavelengths from the DV source can
be accomplished by using a monochromator, chemical filters
or glass filters. Previous members of this research group
have opted for Pyrex and narrow band filters and in this
work, a 10 mm optically flat Pyrex filter was used for
photosensitized irradiations of DNA.
Thomas(54) used a 1 mm optically flat Pyrex glass filter for
photosensitized irradiations. This filter has a 40%
transmittance at wavelengths less than 310 nm which allowed
direct irradiation of the pyrimidine bases of DNA. Direct
« 29 0 nm) irradiation of DNA causes the induction of
thymine dimers as well as other pyrimidine (thymine-
cytosine and cytosine-cytosine) dimers. On the other hand. ,
indirect () 290 nm) DV irradiation of DNA in the presence
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of a photosensitizer induces the production of only the
thymine dimer. In this work it was important that
dimerization of only thymine bases was achieved because
this served to reduce the number of antigenic determinants
(molecules or groups of molecules against which antibodies
are generated) exposed to the rabbit antibody producing
cells. Thus, because only dimerization of thymine (and not
cytosine) occurred, antibodies to thymine dimer alone
should be produced.
However, to totally reduce direct dimerization of DNA, the
transmission characteristics of a 4 mm Pyrex filter was
determined. This was done by taping the filter over one
aperture of the Varian DMS 300 double beam DV/Vis
spectrophotometer and monitoring the percentage
transmission over the 250 to 400 nm range. At 310 nm, the
transmission was reduced from 40% to 35% which still
allowed direct irradiation of the DNA. If the width of the
filter was increased to 10 mm and the transmission
characteristics determined as above, the percentage
transmission at 310 nm was reduced to 6% (Figure 2.6.). In
additi~n, the percentage transmission at 300 nm was
calculated to be 3% and hence irradiation of DNA was
largely eliminated at this wavelength. Thomas(54) however
argues that the quantum yield for DNA dimerization at 310
nm is not significant and that direct dimerization of DNA
causes negligible contributio~s to acetophenone dimer
yields. Despite these observations, a 10 mm Pyrex filter
was .u s e d because this latter filter allowed the
photosensitized irradiation of DNA at wavelengths greater
than 290 nm. This in turn reduced production of cytosine-
cytosine and thymine-cytosine dimers hence ensuring
antibody production against only the thymine dimer antigen.
In order to perform an irradiation, the 10 mm filter was
positioned in the filter holder and all components of the








Figure 2.6. Transmission .characteristics of the 10 mm Pyrex
filter.
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the DNA-acetophenone-PBS (phosphate buffered saline,
section 2.8.2.5) solution was transferred into a cuvette
using a 100-1000 ~l Volac micropipette. The neck of the
cuvette was sealed using clingfilm to prevent evaporation
of volatile acetophenone and PBS during irradiation. After
a lamp warm-up of at least 15 minutes, the cuvette was
positioned in the optical train.
2.8.1.3 Preparation of the Cis-Syn Thymine Dimer
In order to relate integrated thymine dimer peak areas
obtained by HPLC to thymine dimer concentrations, a
calibration curve of known dimer concentrations versus
integrated peak areas was required. This necessitated the
use of large quantities of cis-syn thymine dimer (the
cyclobutane thymine dimer present in DNA). In addition, a
solution of genuine (synthesized) cis-syn thymine dimer
allowed peak identification during HPLC analysis via
spiking or retention time measurements.
The method used in this work for the synthesis of cis-syn
dimer was originally developed by Beukers and Berends(22),
and involves irradiation of frozen solutions of thymine. An
adaptation of the method has been used in this laboratory.
Because of the positions of the thymine molecules relative
to each other in a frozen ice matrix, dimerization of
frozen thymine systems produces only the cis-syn
stereoisomer of the thymine dimer(86). At low thymine
concentrations « 10-3 M), dimerization is thought to occur
via the triplet state, while at high thymine concentrations
(> 10-3 M), aggregates or associated pairs of thymine
molecules are thought to 'iniate dimerization via a singlet
mechanism(87). Although the exact value of the quantum yield
for ice dimerization is debatable, the initial stages of
dimerization are extremely efficient compared with aqueous
solutions. (Values of betwe~n 1 and 2 have been estimated
by Fuchtbauer and Mazur(88) in comparison with 0.65 for
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splitting of thymine dimers in solution.) Thus
significantly higher quantum yields for dimerization from
ice irradiation can be compared with those observed for the
irradiation of aqueous solutions. Hence large quantities of
the cis-syn dimer can be prepared ~rom frozen aqueous
solutions of thymine.
The equipment used for the ice irradiations is shown in
Figure 2.7. A Philips HP-T 400 W medium pressure mercury
vapour lamp with its protective pyrex covering removed
enabled wavelengths of less than 300 nm to impinge on the
frozen thymine/ice system and allowed direct dimerization
of the thymine monomers. An aluminium guard was fitted over
the back of the lamp to provide support and protection if
implosion occurred. The lamp was fitted into a black wooden
box with an aluminium tray fitted to its base. Prior to
irradiation, this tray was filled with finely crushed dry
ice. A 2 x 10-2 M thymine solution (just below the thymine
solubility in water) was prepared and sprayed onto the
crushed ice, using a commerc i.a I insecticide sprayer to
obtain fine and even coverage. A 1 mm thick layer of frozen
thymine was formed. This layer was then irradiated using
the Phillips HP-T lamp for three 5 minute intervals. It was
important to keep a five minute interval between
irradiations to prevent heat generated by the lamp from
thawing the the frozen thymine layer and hence reducing the
cis-syn thymine dimer quantum yield and allowing other
isomers ( eis-anti, trans-syn and trans-anti) to form. The
irradiated thymine film was then removed using a spatula
and allowed to thaw. The above irradiation procedure was
repeated until approximately 500 ml of 2 x 10-2 M thymine
solution had been irradiated.
Once irradiation was complete, the solution was heated to
dissolve the precipitate and filtered hot in order that any
particulate matter be .r emov e d . The filtrate was
concentrated to 150 ml by evaporation on a hot plate after
50











Figure 2.7. Apparatus used to generate cis-syn thymine
dimer by UV-irradiation of frozen aqueous
solutions of thymine.
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which the solution was cooled and filtered to remove the
dimer which had precipitated. since small amounts of
thymine monomer co-precipitate with the dimer, a
purification stage is required. Purification involved
washing the filtered solid with absolute ethanol in which
thymine monomer is significantly more soluble than dimer.
After a further washing stage using water, the dimer was
then twice recrystallized from water at 80°C.
The purity of the cis-syn dimer produced was determined by
DV spectroscopy and HPLC and found to be greater than 98%.
The DV spectrum of a diluted dimer sample is shown in
Figure 2.8.
The following section describes the preparation of DNA
solutions for irradiation. First, the choice of calf thymus
DNA as an irradiation substrate will be discussed together
with the parameters of its purity and concentration which
can be measured. Then, the use of acetophenone as a
photosensitizer of only thymine dimerization will be
discussed and this will be followed by a description of the
manner in which DNA-acetophenone-PBS solutions were
prepared.
2.8.2 PREPARATION OF DNA SOLUTIONS FOR IRRADIATION
A reductionist approach has been used by members of this
research group in developing a kinetic model for the
photosensitized irradiation of thymine. Starting with the
irradiation of aqueous solutions of free thymine base, work
was extended through studies of thymidine(110) to the
irradiation of the more complex thymidylyl-3' ,5'-
thymine (110,111) (TpT) system. This study was extended by
examining the kinetics of irradiated calf thymus DNA and,
then, finally to plasmid DNA(SO). Seeing that mechanisms
have been proposed and s LmuLat.ed for all these thymine
containing systems, it was logical to develop an
Absorbance / AU
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Figure 2.8. Characteristic absorption spectrum of the
cis-syn thymine dimer.
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immunoblotting routine using a DNA system, as opposed to an
irradiated aqueous thymine system as the antigen in this
immunoassay.
2.8.2.1 Use of Calf Thymus DNA
Calf thymus DNA was used by a previous member(54) of this
research group and to facilitate mechanistic studies that
were performed in this work (Section 6.7.1), irradiated
calf thymus DNA was used as the antigen. Sigma Type 1
highly polymerized calf thymus (double stranded)
deoxyribonucleic acid sodium salt was thus injected into






As can be seen, Chargaff I s Rules (90) of % Adenine = %
Thymine and % Guanine = % cytosine are obeyed. As will be .
discussed in section 4.1.1, native DNA is not irnmunogenic,
but if DNA is denatured (by heating or chemical means),
large quantities of antibodies are generated against it.
DNA is always associated with histone proteins within the
nucleus of the cell. In the Sigma DNA preparation, this
protein had been removed to give a white fibrous
preparation containing less than 3% protein. The Sigma
analysis was performed using a standard biochemical assay
for protein determination. It was important that the
protein concentration be low, so that the number of
antibodies generated against protein be minimized.
In addition to considering the protein content of the DNA,
the examination of other parameters can also be
investigated to characteriz~ the DNA. These include:
a. The absorbance maximum (Ama x = 260 nm) and UV spectrum in
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the 220 nm to 320 nm range.
b. Melting temperature at which 50% hyperchromism (see
section 4.2.1.3.) is reached.
c. Purity, as defined by A260 / A280 = 2.
d. Concentration (usually measured in mg/ml) .
All of these parameters have been investigated in this
work, or by Thomas(54) , using a varian DMS 300 double beam
UV/Vis spectrophotometer. DNA samples were prepared in PBS
(without the addition of acetophenone) as outlined in
section 2.8.2.5 and a dilution of this solution (0.1 mg/ml
in PBS) was scanned over the 220 nm to 320 nm range against
a PBS blank. A 0.1 mg/ml concentration was chosen for UV
absorbance measurements, since at this DNA concentration
the absorbance was within the optimum efficiency range of
0.5 to 1.5. In all cases, the resulting absorbance maximum
was in the range 258.5 nm to 259.1 nm and had an absorbance
of approximately 1.2. The absorption spectrum of a o. 1
mg/ml buffered DNA sample is shown in Figure 2.9. (Ama x =
259.1 nm).
The melting temperature (indicative of the source of the
specific DNA) of a DNA solution was previously measured in
this laboratory. Although the procedure is experimentally
demanding, Thomas(54) determined the melting temperature of
calf thymus DNA to be 87°C (in good agreement with reported
values for DNA sodium salt from calf thymus DNA of the same
ionic strength and pH(89».
The purity of the DNA used in this work, as well as the
measurements of the concentrations of the solutions used,
will be discussed in section 2.8.2.2 and section 2.8.2.3
respectively.
2.8.2.2 Purity of DNA Samples
Although the DNA as suppl i.ed by Sigma had less than 3%








Figure 2.9. Absorption spectrum of a 0.1 mg/ml DNA sample.
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interfere with photochemical experiments. The purity of a
dilution of the stock DNA solution was determined by
measuring the absorbance of an aliquot of this solution at
260 nm and 280 nm. The ratio A2 60 / A2 8 0 for pure DNA should
be 2(91). These measurements examine the absorbance of those
protein impurities in the DNA which absorb at 280 nm. The
absorbance is chiefly associated with the aromatic rings of
the amino acids tryptophan and tyrosine (Section 4.2.3.1).
In all cases, the ratio A2 60 / A2 8 0 for the calf thymus DNA
yielded an answer of 1.85 or greater, thus indicating the
absence of protein contaminant in the stock DNA solution.
2.8.2.3 Determination of DNA Concentrations
Thomas(54) determined the concentration of a DNA solution by
weighing and UV absorbance measurements. The latter
technique relied on determining the absorbance at 260 nm of
an alkaline (pH 12) DNA preparation. Using the Beer-Lambert
Law, A = ec l, and knowing the relevant extinction co-
efficient, €, which was specific for the system being used,
the DNA concentration could be calculated. However, such
investigations are fraught with error: primarily because
quoted extinction co-efficients (or molar extinction co-
efficients for proteins and nucleic acids) are strongly
dependant on the bUffer, pH and ionic strength of the
solution under investigation. In addition these conditions
are not always specified in the literature.
Taking into account the problems associated with the
spectrophotometric determination of DNA concentrations, it
seemed plausible to use weighing as a means of calculating
DNA concentrations. The water content of nucleic acids is
usually not known, so that measurement of concentration by
weighing out a known amount of DNA, dissolving it in PBS
and making up to volume could be in error. Sigma does,
however, provide water and sodium percentages for each
sample of DNA,dispatched, and for the calf thymus DNA used
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in this work, the DNA contained 9% sodium and 13.3% water.
25.55 mg of DNA was weighed out on a four place Mettler AE
200 balance. After correcting for the sodium and water
present and making up to 25 ml in a volumetric flask the
DNA concentration (by mass) was effectively reduced from
1.022 mg/ml to 0.7941 mg/ml. If a molar mass of 2 x 106 is
used(54), the DNA solution is 3.970 x 10-10 M.
2.8.2.4 Use of Acetophenone as a Sensitizer
Irradiation of DNA with UV light less than 290 nm induces
the formation of pyrimidine dimers via direct interaction
between the light quanta and the target DNA. If light of
greater than 290 nm is used for irradiation purposes, then
a sensitizer must be added to promote dimer formation. (As
was mentioned in section 1.1, wavelengths greater than 290
nm do impinge on the earth's surface, whereas those less
than 290 nm are filtered out due to the protective ozone
layer. )
The photosensitizer of choice in this work is acetophenone
(Figure 2.10.). The mode of action of acetophenone
sensitization was explained in section 1.1 and other
members of this research group have investigated the
kinetics of acetophenone photosensitized irradiation of
aqueous thymine(92) and calf thymus DNA(54) in detail. Lamola
and Yamane(93) first showed conclusively that irradiation of
DNA at 313 nm in the presence of acetophenone results in
the nearly exclusive production of thymine dimers in DNA.
The addition of acetophenone to irradiated DNA systems
simplifies the photochemical studies of this system because
only the cis-syn thymine dimer (Which is the main UV
photoproduct in irradiated DNA) is formed. This, in turn,
aids chromatographic quant~tation of photoproduct yields.
Thus to facilitate antibody production against the main uv-
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Figure 2.10. Structure of Acetophenone.
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photoproduct (cis-syn thymine dimer), and minimize antibody
production against any other pyrimidine dimers (cytosine-
thymine or cytosine-cytosine dimers), acetophenone was
chosen as the sensitizer.
Saarchem LAB grade acetophenone (l-phenylethanonej 120.15
g/mol) was used in this work. The DV spectrum of an aliquot
of 4 x 10-2 M acetophenone in PBS is illustrated in Figure
2.11. The acetophenone does absorb at wavelengths greater
than 290 nm and it can transfer its energy in a diffusion
controlled reaction to the thymine bases. Rahn(94) has
calculated the €313 of acetophenone to be 105. In aqueous
solution, the triplet lifetime of acetophenone is
approximately 125 J1.s(94). This is sUfficiently long for
diffusion controlled reaction with the thymine bases to
occur.
The solubility of 2 x 10-2 M to 8 X 10-2 M acetophenone in
PBS was determined by Thomas (54). Results indicated that
sensitizer concentrations gre~ter than 4 x 10-2 M should not
be exceeded because of extended time periods required for
the sensitizer to dissolve. In addition, it is noted that
thymine dimer yields for the same DNA sample irradiated for
the same period, were significantly lower for a 4 x 10-2 M
acetophenone solution as opposed to a 2 x 10-2 M
acetophenone solution(95). Although these observations were
not observed by Thomas, they can possibly be explained in
terms of acetophenone quenching of dimer yields. Hence, 2
x 10-2 M acetophenone was used for all photosensitized
irradiations of DNA.
It is usual for DNA-photosensitizer solutions to be pre-
bubbled with nitrogen for 15 minutes prior to irradiation.
This serves to reduce dissolved oxygen to less than 10-6 M
and hence excludes oxygen (and free radical) interference
in kinetic modelling. Ho~ever, Thomas(S4) showed that













Figure 2.11. Absorption spectrum of acetophenone.
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affect dimer yields under the experimental conditions
employed. Thus in this work it was also excluded in DNA
sample preparation prior to irradiation.
2.8.2.5 Preparation of DNA Solutions
As far as possible, sterile conditions were employed for
sample preparation. sterilization ensured that the
immunogens injected into the laboratory animals were free
of bacterial contamination and thus eliminated the animal
mounting an immune response to them. In addition,
sterilization prevented microbial degradation of the DNA as
well as inhibiting destruction due to nucleases present on
glassware.
sterilization was routinely performed by autoclaving the
glassware in a Model 25X Wisconsin All-American steam
sterilizer for 20 minutes once a temperature of 250°C had
been achieved within the sterilizer.
In order to reproduce physiological conditions, phosphate
buffered saline (PBS) at a concentration of 0.15 M and pH
7.4 was used to dissolve the DNA. Solutions of PBS were
prepared by weighing 8 g of NaCl, 0.12 g of KH2P04 , 0.20 g
of KCI and 0.91 g of NaHP04 • Analytical grade reagents were
used in all cases. The salts were dissolved in a small
volume (100 ml) of Milli-Q water and made up to 1 litre in
a volumetric flask. The pH of the PBS buffer was tested
using, a Jenko portable pH meter calibrated against UniVAR
pH 7.0 and 4.0 buffer solutions. The pH of the PBS buffer
was between 7.3 and 7.4 in all cases. The PBS was filtered
through Durapore 0.45 ~m filters and sterilized as outlined
above.
As mentioned in section 2.8.2.4, acetophenone was used as
the photosensitizer at a concentration of 2 x 10-2 M. The
best mean~ o f dissolving the acetophenone was by sonication
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for approximately 2 hours. Thus, the relevant volume of
acetophenone (58 ~l for 25.00 ml PBS) was transferred to a
sterile beaker using a 20 to 200 ~l Volac micropipette and
25 ml PBS added. The beaker was transferred to the
sonicator and when acetophenone globules were no longer
observed in solution, sonication was complete. Because
acetophenone is volatile, the beaker was sealed with
clingfilm or tinfoil during sonication.
The DNA was weighed on a four place analytical Mettler AE
200 balance. Because the DNA was particularly fibrous,
tweezers were used for transferral of DNA during weighing.
The DNA was then transferred to the PBS-acetophenone
solution and allowed to dissolve by stirring on a magnetic
stirrer in the coldroom (approximately -5°C) for about 2
days. The solution was transferred to a sterile "A" grade
vOlumetric flask and made up to the mark with 0.15 M PBS-
2 x 10-2 M acetophenone solution. Aliquots of this stock
solution were transferred to sterile 1.5 ml plastic
Eppendorf vials which were then frozen to inhibit microbial
and nuclease activity . When required, the Eppendorf was
brought to room temperature and the DNA solution (usually)
irradiated as described in section 2.8.1.2.
The following Chapter discusses the techniques whereby
irradiated DNA samples are treated prior to analysis; in
particular, the method of perchloric acid hydrolysis of DNA




3.1 PHOTOPRODUCT ANALYSIS IN IRRADIATED DNA
The determination of the nature and concentration of
photoproducts in a DV-irradiated DNA sample has been
approached in two ways. The first technique relies on
hydrolytic procedures which break down the DNA into its
constituent free bases, nucleosides, mono- or
oligonucleotides prior to analysis. This classical
degradative technique involves hot acid hydrolysis,
alkaline hydrolysis or site selective enzymatic breakdown
of the DNA and is the means by which a photoproduct can be
cleaved from DNA. Subsequent to degradation, photoproduct
analysis has been performed via a number of chromatographic
means. Initially, paper chromatography(96) and thin layer
chromatography(97) were used, but these have been superseded
by ion exchange chromatography(98) and gas liquid
chromatography(99). More recently HPLC techniques have been ·
employed for photoproduct analysis and quantitation.
The second investigative tool for DNA photoproduct analysis
involves non-destructive detection in situ. The techniques
used are largely biological in nature and make use of
enzymatic, immunological or molecular biological (e.g. use
of restriction endonucleases) methodologies. Applications
of these non-destructive techniques are found in section
1.2. As was discussed in that section, the aim of the work
presented here is the development of an immunoassay
technique for the quantitation of thymine dimer. Although
more sensitive than HPLC analysis, it utilizes
methodologies applicable more to the realms of
immunochemistry and biochemistry. Because the work reported
here was performed in a .physical chemistry laboratory,
initially it seemed appropriate that a degradative
technique should be chosen for analysis of DNA components
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and hot acid hydrolysis had been used by Thomas (S4) and
Aliwell(SO) as the mode of degradation of DNA. This
technique will be described in the following section, and
the HPLC routine which was adopted for quantitation of the
photoproducts subsequent to degradation will be discussed
in section 3.2.
3.1.1 ACID HYDROLYSIS PROCEDURE
Hot acid hydrolysis using 9.2 M perchloric acid was used to
degrade the UV-irradiated DNA. This was followed by reverse
phase HPLC analysis of the hydrolysate in order that cis-
syn thymine dimer yields be determined. The N1 glycosyl
bond, joining the nitrogenous base to the deoxyribose sugar
moeity, and the phosphodiester bond linking the sugar to
the phosphate are broken during the hot acid hydrolysis.
The deoxyribose sugar is completely degraded to carbon,
carbon dioxide and oxygen. (The carbon is seen as a black
deposit during hydrolysis.) Under the conditions employed
(9.2 M perchloric acid; 100~C), the cyclobutyl dimer is
stable and can subsequently be separated from other purine
and pyrimidine bases by reverse phase HPLC.
The protocol which was adopted for DNA degradation and
dimer analysis in irradiated DNA solutions was optimized in
terms of per'chLorLc acid concentration, temperature,
duration of hydrolysis and perchloric acid:DNA ratios by
Thomas(S4). The details of the final protocol are as
follows:
a. The irradiated DNA sample was transferred to a Durham
tube by inverting the quartz irradiation cuvette over
the Durham tUbe until the contents were transferred.
b. The cuvette was rinsed with Milli-Q water and the
washings added to the contents of the Durham tube.
c. The solution was evaporated to dryness under a gentle
stream of nitrogen.
d. A 100 ~l aliquot of 9.2 M perchloric acid was added to
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the Durham tube and the tube sealed with clingfilm.
e. The tube was immersed in a polyethylene glycol bath
thermostatted at 100°C for 1 hour and then cooled in ice
for 15 minutes to halt hydrolysis.
f. The hydrolysed sample was transferred to a 1.5 ml
Eppendorf vial, together with two 100 ~l washings from
the Durham tube.
g. The hydrolysate was neutralized with 10 M KOH. The final
volume was 400 ~l, the same as the volume originally
irradiated. Because of the exothermic nature of the
neutralization reaction, this was performed on ice.
h. The solution was centrifuged on a Hettich
microcentrifuge (12 500 rpm) for 15 minutes.
i. A 30 ~l aliquot of the supernatant was injected onto the
HPLC using an Ultracarb 5 ODS 30 column with Milli-Q
water eluant (pH 6) at a 0.7 ml/min flow rate.
3.2 PHOTOPRODUCT ANALYSIS BY HPLC
The chromatographic separation of nucleic acids and nucleic
acid components (nucleotides, nucleosides and nitrogenous
bases) was developed as a result of clinical investigations
into defects of purine and pyrimidine metabolism (100)
(causing such conditions as mental retardation, renal
failure and toxemia). Separation of these nucleotides was
originally performed using open column ion-exchange
techniques, but the advent of High Performance Liquid
Chromatography facilitated the isolation and quantitation
of the nucleic acid constituents in biological fluids and
tissues. separations which originally took several hours
using ion-exchange were dramatically shortened using HPLC.
On-line detection systems meant that accurate
characterization and quantitation of the solutes was
achieved. In particular, octadecyl silica (aDS) C1 8 reverse
columns were employed for the separation of nucleic acid
constituents (101-106) , whi Le C18 columns have found
application for the separation of photoproducts of
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pyrimidines, nucleotides and nucleosides(107-109).
Reverse phase chromatography employs mobile phases which
are more polar than the stationary phase (CI S ODS in this
case). Hence, the more non-polar compounds, interact more
efficiently with the relatively non-polar column packing
and thus elute later than the polar sample components.
Separation of these components is thus based on slight,
though distinguishing, differences in polarity of the
components themselves. The reverse phase packings which are
used are faster to equilibrate than their normal phase
counterparts, use less organic solvents (mobile phase) and
'h a v e more versatile surface chemistries than bare
(uncoated) silica used in the normal phase. In the work
presented here, reverse phase chromatography has been used
for the analytical separation of the components
(nitrogenous bases and photoproducts) of UV-irradiated DNA.
3.2.1 HPLC EQUIPMENT AND OPERATION
A Waters 600 Multisolvent delivery system was used for this
work. The system consisted of two 225 ~l pumpheads, a U6K
injector, a Waters 990 photodiode array detector, a NEC APC
II personal computer and a Waters 990 plotter. Seeing that
the operation of this equipment has been dicsussed in
detail by other members of this research group (110,111), only
a brief resume will be given here.
The multisolvent delivery system consisting of the fluid
related unit and the electronics system, generates
gradients using an interactive, microprocessor-based liquid
chromatography system. This allows complex gradient
programmes and clean up procedures to be run. The pump
heads have a 225 ~l volume, making this instrument suitable
for semi-preparative and analytical work. The photodiode
array detector consists of 5~2 photodiodes which provide a
continuous UV/Vis monitoring of the sample from 190 to 800
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nm. In this way, a full spectrum of the sample is provided
with recall features allowing similarities and differences
between chromatograms to be made. This computerized storage
of data allows spectral and chromatographic overlays,
contour plots and 3-D displays (absorbance versus
wavelength versus time) to be generated. This latter
feature is illustrated in Figure 3.1. Sample analysis and
peak identification is thus greatly aided.
To increase column lifetime, the Ultracarb 5 ODS 30 column
which was used in this work was washed and stored in HPLC
grade methanol. To reduce contamination of the column by
particulate matter or bacterial sources, all glassware was
washed using chromic acid and the Milli-Q water used as the
eluant in this work was collected just prior to use. A
disposable Waters Guard-Pak ~-Bondapak CIa precolumn insert
was included between the solvent delivery system and the
column. The solvents were filtered through 0.45 ~m Durapore
filters. Removal of particulate matter protects sensitive
equipment (optical cell, pumps, column etc.) within the
HPLC. Filtration of the solvents also served to degas them.
It was only necessary to filter the solvents prior to use.
The solvents were subsequently stored in sealed bottles
while the HPLC was operational. If the multisolvent
delivery system was being used to generate gradients, then
degassing was performed by purging the solvents with helium
prior to and during use. Injections of samples onto the
HPLC were made with a Hamilton airtight 100 ~l syringe. The
precision of injection was 1.0% as determined by mUltiple
injections of a standard solution.
3.2.2 OPTIMUM CONDITIONS FOR CIS-SYN THYMINE DIMER
ANALYSIS
An Ultracarb 5 ODS 30 analytical column has been used by
members of this research gJ;ouP (50,54) for the separation,










Figure 3.1. 3-D spectral and chromatographic data which is
generated by the Waters 990 multiple photodiode
array detector.
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by the irradiation of DNA with selected photosensitizers
and sunscreen constituents. This column was chosen over a
range of similar C18 octadecyl silane columns for separation
and identification purposes because of its superior
resolution abilities in separat i ng DNA components.
In addition, Aliwell(SO) performed a series of column tests
on conventional aDS as well as the newer Ultracarb columns.
The chromatographic parameters of resolution (R) ,
selectivity (a), capacity factor (K) and efficiency (N) for
the optimum separation of a 1 x 10-2 M thymine solution from
a 2 x 10-2 M cis-syn thymine dimer solution were determined.
Results indicated that Ultracarb columns outperformed the
aDS columns, and that the semi-preparative columns were
superior to analytical columns. This latter feature was not
important for the work presented here as only analytical
separations were employed, but these results illustrate the
use of Ultracarb columns for the separation of nucleic acid
nitrogenous bases and photoproducts.
Ultracarb 5 aDS columns are 250 mm in length with an
internal diameter of 4.6 mm. A stainless steel casing
houses the C18 packing material on silica gel. Particle size
is 5 J.l.m on average and all residual silanols are end
capped. The Ultracarb 5 aDS 30 has 31% carbon loading,
while its counterpart, the 5 aDS 20 has a loading of only
22% • The former column with its higher non-polar carbon
component provides slightly enhanced separation for reverse
phase chromatography.
As a starting point, the Ultracarb 5 aDS 30 was employed
using Milli-Q water (pH 3) as the eluant at a flow rate of
0.7 ml/min. A 30 J.l.l aliquot of the hydrolysed DNA sample
was injected int? the HPLC. The resulting chromatogram is
illustrated in Figure 3.2. Identification of the various
pyrimidine and ,pur i ne bases. and photoproducts present was
performed by spiking the hydrolysate with an aliquot (5 J.l.1)
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Figure 3.2. HPLC chromatogram showing separation of UV-
irradiated DNA hydrolysate with a Milli-Q water
(pH 3) mobile phase.
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of the relevant compound, as well as by injecting an
aliquot of a solution of the pure compound onto the HPLC
and noting the retention time. It was imperative that the
eluant and flow rate parameters used for the column be kept
constant during the identification stages. In this manner,
the cis-syn thymine dimer was identified as that component
which eluted at 28.5 minutes, while the thymine monomer was
identified by its retention time and UV spectrum to elute
slightly later than the dimer at 32.4 minutes (monomer is
more polar than dimer) .
The guanine moeity eluted at 12.05 minutes when a partially
soluble guanine solution was injected into the HPLC.
Adenine was found to elute at 12.03 minutes. Comparison of
the UV spectra with those obtained by Voet et al. (112)
confirmed that these two components co-elute. Figure 3.3.
illustrates the retention times of the pure guanine and
adenine bases, together with their respective UV spectra.
The cytosine base itself cannot be identified on the
chromatogram because this base deaminates to uracil during
hot acid hydrolysis. Spiking with a uracil solution and
noting . the retention time confirmed that this component
eluted at 3.70 minutes with the salt peaks under the
abovementioned conditions of eluant and flow rate.
Nucleosides as nitrogenous bases are relatively weak bases.
Below pH 4. 15 and 3. 2 respectively, guanine and adenine
will be protonated, while extremely low pH values (less
than . -3) (113) are needed to induce protonation of both
thymine and uracil. Thus at pH 7, none of these bases
should be protonated. Hence, to simplify solvent
preparation and improve chromatographic separation of the
purine and pyrimidine bases and photoproducts, Mi 11i-Q
water (pH 6) at a o. 7 ml/min flow rate was used as the
eluant. The resulting chromatogram is seen in Figure 3.4.
Improved resolution of the thymine monomer from the dimer
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Figure 3.3. HPLC chromatogram showinq retention times and
UV spectra of spiked quanine and adenine
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Figure 3 .4. HPLC chromatogram showing
irradiated DNA hydrolysate




appeared superior. This fact was substantiated by using 3%
methanol in Milli-Q water (pH 3) which gave a resolution of
the thymine monomer and dimer similar to that achieved for
the Milli-Q water (pH 3) alone. Hence, Milli-Q water (pH 6)
was used at a flow rate of 0.7 ml/min on an Ultracarb 50DS
30 column for the separation and quantitation of cis-syn
thymine dimer from the thymine monomer in this work.
3.2.3 CONSTRUCTION OF A
CALIBRATION GRAPH
CIS-SYN THYMINE DIMER
A standard cis-syn thymine dimer calibration graph was
required in order that dimer concentration (of prepared
cis-syn thymine dimer) be related to dimer peak areas from
HPLC analysis of irradiated DNA samples. The integrated
dimer peak area of a particular component separated by HPLC
is directly proportional to the concentration of that
component present in the sample. Hence,
peak area = K .x concentration
where K is the constant of proportionality which is
obtained from the gradient of the graph relating dimer peak
area to dimer concentration. To construct such a graph, a
series of cis-syn dimer solutions are required which fall
into the expected range of dimer yields obtained by HPLC.
A stock solution of approximately 3 x 10-5 M cis-syn dimer
was prepared by weighing out 0.00189 g of the prepared cis-
syn thymine dimer and dissolving it in 250 ml of Milli-Q
water, with heating to approximately 70°C. Successive
dilutions of this stock solution were prepared and an
aliquot of 30 ~l of each solution was injected into the
HPLC using the conditions outlined in the previous section.
Three injections were performed for each solution and the
peak areas integrated at 2.20 nm were averaged for each
solution. The extinction coefficient of the dimer at 220 nm
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was determined by Clemmett(114) to be 4 x 103 M-l cm-l. A
calibration graph of dimer peak areas versus dimer
concentration was constructed and linear regression of this
calibration graph (shown in Figure 3.5.), yielded the
following equation which was used to determine cis-syn
dimer yields by HPLC anlysis in this work:
[TT] = PA + 19.9477
1.22692 x 108
where [TT] refers to the cis-syn thymine dimer
concentration as a molarity and PA refers to the integrated
peak area at 220 nm.
sections 2.8.1. to 3.2.3 have discussed irradiation
techniques, DNA solution preparation and photoproduct
analysis in irradiated DNA. These techniques were ones
commonly used by members of this research group for
analysis of irradiated systems.
Attention is now turned to the immunological aspects of
this work. In Chapter 4, an introduction concerning the
immunogenicity of DNA will be followed by a detailed
discussion of the preparation of DV-DNA samples for
immunization of rabbits. Thereafter, the immunization of
rabbits will be discussed, followed by a discussion of the
purification techniques of the serum (containing thymine
dimer antibodies) produced by rabbits in this work.
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Figure 3.5. Cis-syn thymine dimer calibration graph used in






Investigations into the production of anti-DNA antibodies
in humans was initiated by Seligmann in 1957 who noted
anti-DNA antibodies in the . serum of pati.ents with the
disease Systemic Lupus Erythmatosus (SLE). This common
auto-immune disease is characterized by inflammatory
destructive changes in many organ systems, as well as the
production of antinuclear antibodies. A rash of fixed
erythema forming a butterfly pattern on the face is common
with SLE patients, and this condition is worsened by
exposure to sunlight. SLE may also be induced by drugs
(e.g. Hydralazine) where the serum of these patients
contain antibodies to histone protein{l15).
For both idiopathic and drug related lupus, the basic
question can be asked as to whether antibody production
arises from an unusual presentation of the antigen or from
an abnormality or alteration of the immune system itself(3).
Whichever option proves to be the correct one, the
discovery of anti-DNA antibodies has opened up avenues of
research which will eventually elicit information about
therapeutic agents which will act by selectively modifying
nuclear macromolecules, making them more immunogenic to the
immune sy'stem.
Are nucleic acids immunogenic? In normal animals, both
nucleic acids and histone proteins are poor immunogens when
used as pure materials. If DNA and synthetic
polynucleotides (double stranded RNA or DNA-RNA hybrids)
are denatured, then the addition of protein carriers (see
Section 4.2.1.4) renders the nuclear material immunogenic.
If these same carriers are used in conjunction with native
DNA, then no antibody production in response to the DNA is
78
noted. Chemically modified DNA, with an appropriate carrier
molecule is strongly immunogenic, and it has been shown
that modified structures are the major antigenic
determinants in inducing antibody production. When histones
are presented as histone-RNA complexes, they too, exhibit
immunogenicity. It appears likely that antibody production
in response to nuclear material, is strongly dependant on
the physico-chemical state of the DNA and that antibodies
may well be produced against modified conformations of the
secondary, or higher, structure of the DNA rather than the
DNA itself.
In helical double stranded DNA, all pyrimidine/purine bases
are directed towards the central axis of the helix and are
thus unavailable as antigenic determinants. Thus the
deoxyribose-phosphate backbone is the major antigenic site
when the molecule comes into contact with antibody
producing cells. A single site could include a short
segment of one or both backbones over a distance of about
3 base pairs (116). Denaturation of DNA (achieved by rapid.
heating and cooling, or chemically induced - see section
4.2.1.3) gives rise to a collapsed single stranded coil
which may be presented to the antibody producing cells as
loops or helices of deoxyribose-phosphate backbone. This is
illustrated in Figure 4.1. In addition, many purine and
pyrimidine bases are now exposed to solvent and available
to act as determinants for those antibodies that react only
with denatured DNA(117). However, only the determinants for
a few sera have been examined in detail. Included here is
the thymine dimer which has been shown to be the antigenic
determinant in UV-irradiated and denatured DNA(71) and which
was injected into rabbits as UV-irradiated DNA in the work
presented here. Wakizaka and Okuhara(81) have concluded that
UV irradiation of DNA induces at least two different
antigenic sites which are responsible for the production of
two distinct antibodies. ~oreover, their work indicated




Figure 4.1. Diagram of DNA strands illustrating the purine
and pyrimidine bases exposed to antibody
molecules when DNA is denatured.
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especially partial strand-separation of the double helical
structure, greatly contributes to antigenicity. Considering
the abovementioned aspects of the immunogenicity of DNA,
the following section (4.2.1) describes the preparation of
the irradiated DNA samples for immunization of rabbits in
this work. First, the choice of DNA concentrations will be
discussed. Thereafter, the use of acetophenone as a
photosensitizer will be discussed briefly. optimum
denaturing conditions will also be evaluated, as well as
the addition of methylated bovine serum albumin and Freunds
Incomplete Adjuvant to the samples with which rabbits were
immunized.
4.2 EXPERIMENTAL TECHNIQUES
4.2.1 PREPARATION OF DV-DNA SAMPLES FOR IMMUNIZATION OF
RABBITS
4.2.1.1 Choice of DNA Concentrations
Although the DNA concentration used as the antigen for the
immunization of laboratory animals is not crucial, it was
important that the dimer concentration injected into the
rabits be known, in order that antibody production be
related to dimer yields. The DNA solutions of chosen
concentrations would thus be DV-irradiated and the dimer
yields analysed by HPLC. The hot acid hydrolysis technique
as explained in section 3.1.1 was optimized by Thomas(54)
for the hydrolysis of 0.1 to 1.0 mg/ml DNA, and hence a
range of DNA concentrations within these limits was chosen.
It was also favourable not to create an "overload"
situation of antigen in the rabbit tissue, although such a
condition would have been difficult to detect during the
immunizations themselves.
In order to determine irrad.iation times so that maximum
thymine dimer yields could be produced, a series of time
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runs involving 0.5 mgjml and 1.0 mgjml DNA with 2 x 10-2 M
acetophenone were performed. Using the HBO 500Wj2 short arc
mercury lamp and the 10 mm Pyrex filter, 400 ~l aliquots of
DNA were irradiated for varying lengths of time. The
samples were acid hydrolysed and analysed by HPLC using the
Ultracarb 5 ODS 30 column and Milli-Q water (pH 6) at a 0.7
mljmin flow rate. Results are illustrated graphically in
Figures 4.2. and 4.3. Maximum dimer yield of approximately
3.2 x 10-5 M was obtained for the 1.0 mgjml DNA sample as
evidenced by the plateau in Figure 4.2 after 10 hours.
irradiation. Maximum dimer production of 9.0 x 10-6 M was
achieved for the 0.5 mgjml DNA sample after 6 hours
irradiation. Thus for injection of the 1.0 mgjml DNA into
the rabbits, the immunogen was irradiated for 10 hours,
while for injection of 0.5 mgjml DV-irradiated DNA a few
months later, the DNA aliquots were irradiated for 6 hours.
Initially a 1.0 mgjml DNA and 2 x 10-2 M acetophenone
solution in PBS was prepared as a stock solution. A 400 ~l
aliquot was irradiated and denatured before being complexed
to methylated bovine serum albumin and Freunds Incomplete
Adjuvant. The addition of these other constituents thus
effectively reduced the concentration of DNA injected to
0.72 mgjml although dilution did not affect the number of
thymine dimers presented to the rabbit immunocompetent
cells. A solution of 0.5 mgjml DNA was similarly prepared.
The immunization schedules that were employed in this work,
as well as the problems that were dealt with, are discussed
in section 4.2.2.3.
4.2.1.2 Use of Acetophenone
As was explained in section 2.8.2.4, acetophenone was added
to all DNA preparations that were irradiated either for
HPLC analysis, or prior .t o immunization of rabbits.
Addition of this triplet photosensitizer ensured that the
82
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Figure 4.2. Cis-syn thymine dimer yields as a function of
irradiation time with [DNA] = 1 mg/ml and
[Acp] = 2 x 10-2 M.
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Figure 4.3. Cis-syn thymine dimer yield as a function of
irradiation time with [DNA] = 0.5 mg/ml and
[Acp] 2 x 10-2 M.
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major DV photoproduct was the cis-syn thymine dimer,
generated via indirect photosensitized irradiations of the
DNA. Thus antibody production was directed against this
photoproduct.
DNA-acetophenone-PBS solutions were prepared as outlined in
section 2.8.2.5 using a stock solution containing 0.15 M
PBS buffer and 2 x 10-2 M acetophenone. A 400 ~l aliquot of
the prepared DNA solution was transferred to a quartz
irradiation cuvette and irradiated for the chosen
irradiation period using the HBO 500W/2 mercury arc lamp.
At the end of the irradiation period, the sample was
transferred to a Durham tube and denatured as oulinedin
the following section.
4.2.1.3 Determination of Optimum Denaturation Conditions
Denaturation may be described as the reversible or
irreversible change in the properties of proteins or
nucleic acids. This process is most commonly effected by .
the addition of heat or chemicals to a protein or DNA
preparation, which brings about changes to the secondary,
and maybe tertiary and quaternary structure, of the
compound.
To understand how denaturation affects the DNA
macromolecule, it is imperative that the stabilizing forces
within the molecule be explained. The stability of the
Watson-Crick double helix structure depends primarily on
the associative hydrogen bonds between purine and
pyrimidine bases, as well as hydrophobic interactions
between the bases themselves due to stacking. In addition,
a further stabilizing influence is provided by cavitation
energy; that is energy supplied by the hydrogen bonding of
the deoxyribose-phosphate backbone to a shell of water
molecules. From an ionic p~int of view, counter ions such
as Na+ and Ca2+ neutralize the negative charges on the
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backbone of the polynucleotide.
If sufficient energy is provided to the DNA to overcome its
melting temperature, or if a chemical preparation is added
(1 M NaOH, 0.01% to 1.0% formaldehyde(118) to the DNA, then
loss of these stabilizing factors brings about loss of the
secondary structure of the DNA and denaturation is brought
about.
Spectroscopic analysis has been used to monitor the
denaturation process(118). DNA absorbs strongly at 260 nm
due to absorption of this radiation by the conjugated
double bond systems of the constituent purines and
pyrimidines. If destacking of these bases occurs (i.e. if
the DNA is denatured), an increase in UV absorption is
noted at 260 nm proportional to the extent of denaturation.
This phenomenon is call1ed the hyperchromic effect(119).
In this work, denaturation was effected by heating the DNA.
Alternative denaturation routines such as the addition of
formaldehyde, glycols, alcohols or sulphoxides(120) to the
DNA preparation, could have complicated the nature of the
antibody binding sites of the antibodies, hence reducing
specificity.
Doty et al.(121) first noted that slowly heated DNA
undergoes a co-operative melting out of the helical
structure yielding disorganized and coiled polynucleotide
chains. At a 0.02 M concentration of Na+ ions, the midpoint
of this transition (melting temperature) lies in the 80 to
100°C range depending on the guanine-cytosine content of
the DNA (guanine-cytosine bonds are stronger than thymine-
adenine bonds). These researchers also noted that two
different molecular states of the DNA are obtained
depending on the rate of cooling of the DNA, the DNA
concentration and the ionic strength of the solvent. If the
DNA is heated and then fast cooled, the DNA consists of
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single strands having approximately half the molecular
weight of the original preparation (118). If the DNA is
heated and cooled slowly, then it consists of recombined
strands united by complementary base pairing over most of
its length. These two states of the DNA are illustrated in
Figure 4.4., together with other hypothetical conformations
which may also exist. The heated and slowly cooled DNA is
called renatured DNA, while the former ' denatured state is
essentially inactive. These forms can clearly be
distinguished by differences in absorbance temperature
curves (see Figure 4.5.), density, appearance in electron
micrographs and hydrodynamic properties.
Several researchers have noted that the dimerization
process brings about concomitant changes to the higher
structure of DNA. Ciarrocchi and Sutherland(30) postulate
that photodimerization of thymines in DNA induces an
unwinding of the helical structure of DNA. Using X-ray
diffraction studies, the unwinding angle was calculated to
be 8°. The use of sensitizers during irradiation has also
been implicated in altering secondary DNA structure.
Charlier and Helene(122) proposed that the hydroxy radical
formed during photolysis in the presence of the
photosensitizer benzophenone is responsible for observed
chain breakage. The use of acetophenone and acetone has
been shown to induce fewer strand breaks than
benzophenone (123). Thus localized denaturation of DNA is
induced during irradiation, yet these features are
insufficient in maximally exposing the thymine dimers to
immunocompetent cells.
It is advantageous for the DNA presented to the rabbit
immune system to be in the single strand form. This
facilitates exposure of the thymine dimers (located towards
the central axis of the DNA) to the antibody producing
cells. Seeing that calf thymus is double stranded, it was
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Figure 4.5. Thermal transitions of native, slowly cooled
and quickly cooled DNA(121).
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consideration, complexation of methylated bovine serum
albumin (MBSA, section 4.2.1.4) with native DNA results in
a compact fibrous clot that is impossible to inject. If the
DNA is denatured, then the precipitate formed between the
carrier protein and DNA is granular and dispersed and is
injected without difficulty.
Leipold et al. (82) performed denaturation of a 0.5 mgfml DNA
sample by boiling the double stranded nucleic acid for 10
minutes and then rapidly chilling the sample on ice. This
technique was also performed by Wani et al.(124), Plescia,
Braun and Palczuk(66), as well as Doty et al.(121). It was
important in this work that the denaturation technique
yield a fully denatured (as opposed to a partially
denatured) preparation. For highly purified DNA, increases
in A260 (absorbance at 260 nm) of as much as 40% are
indicative of a fully denatured sample(119). Hence a series
of denaturing conditions were tested, in order that fully
denatured samples be prepared. A 0.1 mgfml DNA solution in
PBS was prepared and 400 J.l.l aliquots were heated on a .
polyethylene glycol (PEG) bath at 100°C for varying lengths
of time (10, 20 and 30 minutes). After heating, the samples
were rapidly transferred to crushed ice for 10 minutes.
A 10 minute heating period gave a 41% increase in
absorbance at 260 nm, while the 30 minute period conferred
a 72% increase in absorbance at 260 nm. Erratic results for
the increase in absorbance after 20 minutes were obtained
and hence this heating period was excluded. The increases
in absorbance after 10 and 30 minut~s are illustrated in
Figure 4.6. Seeing that full denaturation was achieved by
heating the DNA sample for 10 minutes at 100°C, this
heating period was chosen to denature the UV-DNA immunogen
in accordance with the denaturation as performed by Wani et
al. (124), Plescia et al. (66) and Leipold et al. (82). During
denaturation in the PEG bat~, an aluminium foil seal which







Figure 4.6. Absorption spectra of 0.1 mg/ml DNA
illustrating an increase in absorption at
260 nm following selected heating denaturation
periods.
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tube containing the DNA sample. This allowed evaporation of
the acetophenone during denaturation. Heating was followed
by rapid transferral of the Durham tube (using tweezers) to
a beaker of crushed ice for 10 minutes. When the tube and
contents had come to room temperature, the sample was
transferred using a micropipette into a sterile 12 ml
Polytop glass vial (vial number 3). Thus the DNA strands
were separated during heating and the rapid c oo l i ng
maintained this separation and hence ensured maximum
exposure of the thymine dimer to the rabbit immunocompetent
cells.
A total volume of 2.2 ml was injected into laboratory
rabbits by Leipold et al.(82), with the DNA-MBSA being in a
1:1 ratio with the Adjuvant. Following this protocol, 660
~l of sterile Milli-Q water was added to the contents of
the Polytop vial to yield 1.10 ml of diluted DNA complex
after addition of MBSA. The water was added in 3 aliquots,
which were first added to the Durham tUbe and the washings
then added to the contents of the sterile glass vial. The
vial was sealed and stored in the refrigerator if this
solution was not to be used immediately.
The following section descibes how the irradiated and
denatured DNA samples were conjugated to the protein
carrier molecule methylated bovine serum albumin in order
to facilitate antigen transfer across cell membranes after
immunization.
4.2.1.4 Complexation to Methylated Bovine Serum Albumin
Carrier molecules enable the antigen to be taken up by
immunologically competent cells and thus participate in the
induction of antibodies specific for the antigen. This
requirement of absorption of the carrier-antibody complex
can be performed by any .he t e r o l og ou s protein, however
consideration must be given to the fact that conjugation to
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a non-immunogenic polymer may render the polymer
immunogenic and thus induce antibodies against it. A second
consideration in the choice of a carrier is the feasibility
of forming a conjugate between the antibody and the
carrier.
In the case of proteins, conjugation is easily achieved
through reaction of the antigen with free -NH2 and -OH
groups of amino acids to produce covalent linkages to the
nucleic acid. However, several other linkages have also
been employed for this purpose. Halloran and Parker (125)
described the use of water soluble carbodimide reagents to
conjugate nucleotides (e.g. thymidylic acid) to proteins,
potentially through a phosphoramide linkage. In this and
other cases, antibodies were generated against both the
antigen and the heterologous carrier proteins, but there
are problems associated with achieving covalent complexes
between nucleic acids and the carrier proteins.
This problem of aChieving covalency led Plescia et al.(66)
in 1964 to postulate the formation of electrostatic
comp Lexes between DNA and carrier molecules: DNA is an
acidic polymer which interacts readily with basic proteins
under physiological conditions to form stable complexes.
Bovine serum albumin was used exclusively as a carrier
protein and it seemed plausible that methylated bovi.ne
serum albumin (MBSA) could be used as a carrier for DNA.
Results showed conclusively that antibodies would be
produced against antigens (e.g. DNA) linked to the MBSA
through non-covalent, but nevertheless stable bonds. This
general methodology of producing complexes through
electrostatic interactions has sUbsequently proved to be
effective not only for nucleic acids, but also for the
production of antibodies against certain polypeptides and
polysaccharides that are ordinarily not inununogenic in
chemically pure form(126). Seaman et al. (68) showed that MBSA
is also an effective carrier for synthetic polynucleotides
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including Poly (A), Poly (I) and Poly (C). Levine et al.(71)
have shown MBSA to be an effective carrier for UV-
irradiated DNA and Seaman et al. (127) have shown it to
effective for photo-oxidized DNA.
If this technique of forming electrostatic interactions is
employed, the nature of the interaction as well as the
groups involved appears to be critical. DNA-MBSA elicits a
specific antibody against DNA(66), while conjugates of DNA-
BSA (formed by hydrogen bonds) fail to do so(68).
Apart from facilitating uptake of the antigen by antigen
presenting cells, complexes of polynucleotides and MBSA are
apparently resistant to nuclease attack (66) . It is
postulated that this resistance to enzyme attack may be
important for the efficacy of MBSA as a carrier for
polynucleotides. Sela(128) has proposed that this carrier
moeity, while not contributing to the specificity of
antibody production, plays an important role in defining
the biosynthesis and structure of the antibodies formed.
Plescia et al.(66) mixed solutions of native DNA and MBSA,
to find that a compact fibrous precipitate resulted. If
heat denatured single stranded DNA and MBSA were mixed,
fine particles formed which did not dissociate under
physiological conditions and were highly resistant to the
action of DNAse. Seeing that irradiated and denatured DNA
was being used as the antigen in this work, it was apparent
that MBSA would act as an efficent carrier of t.he DNA
antigen.
The stability of this DNA-MBSA complex depends primarily on
the concentration (and hence pH) and nature of the buffer
used as a diluent. Dissociation of the DNA-MBSA complex
. occurs at high and low pH and at salt concentrations
greater than 0.15 M. Thus the PBS buffer (pH 7.35) in which
the DNA was dissolved, provided a suitable diluent for the
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DNA-MBSA complex. Because MBSA dissolves more easily in
water than in 0.15 M NaCl, the MBSA was added to irradiated
and denatured DNA samples as an aqueous solution.
The MBSA was supplied by sigma and was prepared according
to the method of Sueoka and cheng(129). This involved
methylating BSA with absolute ethanol in a n HCl
environment. The resulting feathery compound was stored in
a dessicator in a refrigerator. A 1% solution was prepared
by Plescia et al.(66) and this concentration has been used
in all subsequent work on the immunization of laboratory
animals with DNA components. In this work, the solution was
prepared using sterile glassware and sterile Milli-Q water.
Here, 0.2507 g of MBSA was weighed out and transferred to
a beaker containing approximately 20 ml sterile water.
Despite the fact that the MBSA was light and feathery, it
dissolved easily with swirling. The contents of the beaker
were then transferred to a sterile 25 ml vOlumetric flask
and made up to the mark using sterile Milli-Q water. The
solution was stored in a refrigerator. Seven months later,
more 1% MBSA solution was prepared because of visual
bacterial comtamination of the original MBSA solution.
When the MBSA solution was required, it was brought to room
temperature. Plescia et al.(66) suggested a 1:1 weight ratio
of DNA:MBSA to be used. For a 400 ~l aliquot of 1 mg/ml
irradiated and denatured DNA, the corresponding mass of
MBSA was present in a 40 ~l aliquot of 1% MBSA. This volume
of MBSA was transferred to the DNA solution contained in
the sterile 12 ml Polytop glass vial using a 20 to 200 ~l
micropipette. The solution became cloudy as the ionic
conjugate was formed.
Although the DNA-MBSA conjugate could have been
into the rabbits at this stage, enhanced
production has been achieve~ if the conjugate is






Freunds Complete or Incomplete Adjuvant). The following
section describes the usage and advantages of adjuvants in
immunization schedules and discusses the use of the
adjuvant employed in this research.
4.2.1.5 Use of Freunds Incomplete Adjuvant
When dealing with limited amounts of protein or nucleic
acid as antigen or when the "i mmunoge n is a weak one (e.g.
nucleic acids), it is advantageous to employ techniques
that enhance the immune response. By facilitating transport
of antigen to immunocompetent cells (see previous section),
the use of MBSA has the function of enhancing antibody
production. However, greater enhancement of antibody
production is commonly effected by the proper use of
adjuvants.
From an immunological perspective, the use of adjuvants
potentiates the humoral antibody response to the injected
antigen. Among the most common adjuvants are inorganic
adsorbents such as mineral oils, aluminium hydroxide gels
and bacterial cell wall components. Because of the
diversity of materials having adjuvant properties, the
specific mode of action of the adjuvant is not well
understood. Three major effects are, however, involved
albeit to different degrees for each adjuvant type. The
most important effect concerns a slowing of the release of
the immunogen from the site of injection. This is thought
to occur by either adsorption onto solid particles (as in
the case of aluminium hydroxide) or by incorporation into
an oily emulsion. Thus by adsorption onto the adjuvant, the
emulsion forms a "depot" of antigen in the host tissue from
which"small quantities of antigen are continually released,
sometimes for a year or more (Figure 4.7.). This allows
more antibody forming cells to be exposed to the limited
amount of antigen and because the antigen is contained






Figure 4.7. Diagram illustrating the mode of action of
Freunds Adjuvant.
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the antigen by proteolytic enzymes is retarded.
A second function of adjuvants is thought to involve a
stimulatory effect on reticuloendothelial cells. The
addition of the adjuvant attracts a local infiltration of
the injection area by mononuclear cells and thus stimulates
phagocytosis (endocapsulatory destruction) of the antigen
by the macrophages. It has also been shown that adjuvants
induce an increased circulation of lymphocytes (involved in
antibody production) through lymphoid tissues in the
drainage area, macrophages being important for the
initiation of the changes of lymphocyte traffic.
In 1942, Freund and co-workers (130) developed a series of
adjuvants containing mycobacteria, mineral oil and
emulsifier, which today remain the most potent adjuvants
known. The most widely used mixture contains 9 parts light
mineral oil (e.g. Bayol) to 1 part detergent (e.g. Arlacel
A). The detergent usually contains a high level of both
lipophilic and hydrophobic. groups facilitating the
formation of a stable emulsion. These simple oil-detergents
are known as Freunds Incomplete Adjuvants. The addition of
heat killed mycobacteria (Mycobacterium butyricum or M.
tUberculosis) at a 0.5 mg/ml concentration to the oily
mixture is referred to as Freunds Complete Adjuvant and is
far more effective in eliciting an immune response,
presumably by increasing local inflammatory responses due
to the mycobacteria. Despite these much touted advantages
of enhancing antibody production over a period of time, it
is also possible that the emulsion might destroy some of
the antigenic determinants of antigens(131).
The Freunds Adjuvant employed in this work was supplied by
Sigma as 11Freunds Incomplete Adjuvant". An incomplete
adjuvant was chosen because this compound would enhance,
but not artificially elevate~ antibody titres in the rabbit
serum.
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The Incomplete Adjuvant, containing 15% mannide monoleate
in 85% paraffin oil, was supplied as a series of 10 ml
ampoules. These were stored in a refrigerator. When
required, the adjuvant was brought to room temperature and
a sterile 2.50 ml hypodermic needle was used to withdraw a
1.10 ml aliquot of the oily suspension. This was then
transferred to the DNA-MBSA solution in individual Polytop
glass vials. The addition of the 1.10 ml aliquot of
adjuvant ensured that a 1: 1 volume ratio of DNA-MBSA to
Adjuvant was achieved. The system immediately formed two
immiscible layers which were difficult to inject into the
rabbit ear vein. However, this problem was overcome by the
staff of the Biomedical Resources Centre (University of
Durban-Westville) who aspirated the oily emulsion prior to
immunization using two syringes.
As will be explained in section 4.2.2.3, 8 individual UV-
irradiated DNA immunogens (containing both MBSA and Freunds
Incomplete Adjuvant) were administered over a 4 week period
to each of 2 rabbits. All 8 samples were transported to the
Biomedical Resources Centre at the University of Durban
westville where they were stored in a refrigerator before
being administered at the appropriate time.
This section (4.2.1) has elucidated the means by which a
UV-DNA antigen was prepared for immunization into
laboratory animals. This involved denaturation of the DNA
(allowing maximum exposure of the thymine dimer antigenic
determinants), complexing to MBSA (facilitating transfer of
the antigen to immunocompetent cells) and adding Freunds
Incomplete Adjuvant (enhancing antibody production of the
poor DNA antigen).
The following section (4.2.2) describes · the choice of
laboratory animal used for immunization of the UV-
irradiated DNA antigen, the immunization schedule that was
followed in this work, as well as the means of bleeding the
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rabbits in order to obtain the serum containing the thymine
dimer antibodies.
4.2.2 IMMUNIZATION OF RABBITS
This section describes the immunization and bleeding of the
laboratory animals used in this work. First, the choice of
animal to which the UV-irradiated DNA antigen was
administered will be discussed. Then the housing of the
laboratory animals will be discussed, followed by the
injection routes and immunization schedules that were
chosen. Finally, the bleeding of the animals (to obtain the
antibodies generated against the UV-irradiated DNA) will be
discussed.
4.2.2.1 Choice of Animal for Immunization
There are few instances in the literature where one species
of laboratory animal gives consistently better responses
than another to a particular immunogen(132). In most cases
where a choice of laboratory animal must be made, the
decision usually depends on the animal availability and the
volume of serum required. Usually the larger the animal the
higher the yield of serum. It is also sensible to immunize
a species of animal that has never been exposed to the
antigen in question.
with these considerations in mind, rabbits are usually the
first -choice for immunizations unless very large volumes of
sera are required. From a practical point of view, rabbits
are cheap to house and feed, easy to care for and bleed,
and are particularly robust when immunized repeatedly. An
alternative species is the chicken, which is also easy to
handle, but the antibodies that it produces behave
differently from those of mammalian species and are thus
best avoided.
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To date, complexes of DNA and MBSA have been tested in two
species, the rabbit and the mouse. Antibodies were produced
by the rabbit to both DNA and MBSA, whereas the mouse
proved unable to produce antibodies against either (134) •
This lack of response was noted in several strains of mice,
so appears to be general for this species. It was thus
sensible to use rabbits as the host animal for
immunization.
New Zealand white male rabbits were supplied by the
Biomedical Resources Centre at the University of Durban-
westville and all immunizations and bleeds were performed
by their staff. New Zealand white rabbits were used by Wani
et al. (124), Natali and Tan (75) and Plescia et al. (66) while
Levine et al. (71) and Leipold et al. (82) made mention of
using between one and nine rabbits for the production of
anti-DNA antibodies in rabbits. In this research, three
rabbits were used for immunization purposes over the period
of a year.
4.2.2.2 Housing of Rabbits
Each of the three rabbits used was housed in a fibreglass
rabbit cage suspended over a stainless steel tray
containing dust free woodshavings as bedding material. The
animals were housed in purpose built animal rooms at the
Biomedical Resources Centre. The room temperature was
maintained at 21°C while the relative humidity was
controlled at 50%. Air ventilation was maintained at 15 to
20 air changes per hour by means of an airconditioner. A 12
. hour light cycle followed by a 12 hour dark cycle was
maintained using electrical light switches. The animals'
daily diet of compressed food pellets was supplemented with
hay twice weekly and they had access to fresh water
whenever it was required.
4.2.2.3
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Injection Routes and Immunization Schedules
Injections (subcutaneous, intravenous and intramuscular)
were administered to the rabbits by the staff of the
Biomedical Resources Centre. They were performed using 25
gram one inch needles attached to 25 ml disposable plastic
syringes. Subcutaneous delivery of the antigen was
performed under a loose fold of skin behind the neck of the
rabbit. Intravenous injections were performed using a
marginal ear vein, while intramuscular injections were
performed using the hind leg musculature of the rabbit.
Initially two rabbits received the UV-irradiated DNA
antigen, one via a subcutaneous and the other by an
intravenous injection route. The 1 mg/ml antigen was
administered to both rabbits once a week over a four week
period using the abovementioned injection routes. However,
it soon became obvious that intravenous injection of the
antigen (containing UV-irradiated DNA, MBSA and Freunds
Incomplete Adjuvant) was not successful, primarily because -
the viscous antigen was difficult to inject into the ear
vein of the rabbit; the vein kept closing up and had to be
rubbed repeatedly during injection . Hurn and Chantler(131)
also note that administration of Freunds Adjuvant via an
intravenous route can induce the condition of fatal fat
embolism. Cardiac puncture was thus performed on this
rabbit and the large volume of serum that was obtained was
used in the serum purification protocol using affinity
chromatography (see section 4.2.3.4 to 4.2.3.10) as well as
the developmental stages of the immunoblotting protocol
(Section 5.2.1).
Four months after the final subcutaneous injection of the
1 mg/ml antigen, the same rabbit received a further series
of subcutaneous injections (1 mg/ml) .In order to compare
antibody production via injection routes, a third New
Zealand white male rabbit received a series of
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intramuscular injections of the 1 mgjml DV-irradiated DNA
(complexed to MBSA and Freunds Incomplete Adjuvant). As
previously, 4 injections were administered to each animal
over a four week period.
In order to keep a high antibody titre in the rabbit serum,
a further series of .s ubc ut a ne ou s and intramuscular
injections were performed on the same rabbits using a 0.5
mgjml DV-DNA antigen. The first injection was performed
approximately 50 days after conclusion of the previous
injection schedule.
4.2.2.4 Bleeding of Rabbits
In order to obtain the antibodies generated against thymine
dimer, blood collections were performed using the marginal
ear veins of the rabbits. Bleeds were performed prior to
each injection (thus 4 bleeds gave 4 serum samples during
the injection schedule) as well as 10 and 20 days after
completion of the fourth injection. The very first of the
bleeds was a control bleed, while the fifth and sixth
bleeds monitored antibody production once antigen
injections had ceased.
When bleeds were performed, the animal was restrained in a
purpose built rabbit restraining box and did not require
the use of anaesthetics. The blood sample (usually 2 to 5
ml) was stored in a 5 ml test tube in a refrigerator
overnight in order to clot the blood. The following morning
the clotted blood sample was centrifuged at 3500 rpm for 15
minutes, after which the serum (containing the thymine
dimer antibodies) was pipetted into 1.50 ml Eppendorf
vials. The vials were labelled and frozen in the freezer
compartment of a refrigerator until immunoblotting analysis
or serum purification was performed.
The following section (4.2.3) describes the purification
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regimes that were employed in this work. First, the
precipitation of protein from crude serum using saturated
ammonium sulphate solutions will be discussed. Then, the
theoretical aspects of affinity chromatography, employing
a commercial Memsep cartridge, will be explained and
following that the developmental work for antibody
purification using this cartridge will be discussed.
4.2.3 PURIFICATION OF CRUDE SERUM
This section describes techniques for the purification of '
the serum containing antibodies to thymine dimer. First,
ammonium sulphate precipitation of immunoglobulins will be
discussed and evaluated as a purification technique. Then,
the technique of affinity chromatography will be discussed
in terms of a protocol chosen to provide reproducible
purification of the antibody containing serum.
4.2.3.1 Characterization of the Crude Serum by UV
Spectroscopy
A Varian DMS 300 UV/Vis double beam spectrophotometer
together with Hellma 50 ~l ultracuvettes (shown in Figure
4.8.) was used to obtain UV spectra of the crude rabbit
sera. The serum components of vertebrates are not
restricted to antibodies, serum proteins (transferrin,
albumin and cytochrome) are also present and serve
important functions such as iron transport within
vertebrate tissues. All of the serum components (antibodies
and serum proteins) are obviously proteinaceous or
glycoproteinaceous in nature. Hence, a UV spectrum of a
serum sample will not distinguish between the antibodies or
serum components. However, UV spectra were run and compared
against the spectra obtained from commercial rabbit IgG
(the most prolific antibody comprising 80% of the total
antibody production). This served to confirm whether
antibodies were generated during and after the immunization
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exterior interior











Figure 4.9. Absorption spectra of serum samples (1:200
dilution) taken from 6 successive bleeds of the
rabbit.
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schedules and the results are discussed below.
Figure" 4.9. shows six UV spectra (1:200 dilutions of each
serum sample), one from each of 6 successive bleeds during
and after the immunization of the rabbit with the UV-
irradiated DNA antigen (see section 4.2.2). All spectra
have the characteristic UV absorption maxima at 278.3 nm to
279.1 nm and 216.9 nm to 219.7 nm. The abso~ption at 278.3
nm to · 279.1 nm is associated with the tyrosine and
tryptophan amino acid content of the antibody and serum
proteins. More specifically, it is the conjugated double
bond systems of tryptophan (Figure 4.10.) and tyrosine
(Figure 4.11.) which provide the absorption. Tryptophan has
Amax at 278 nm(133) which is not affected by changes in pH,
while tyrosine has Amax at 274.5 nm(133) which is affected
by ionization of the -OH group in alkaline solution. Thus
the PBS diluent used here (pH 7.35) has marginally affected
the Amax due to the tyrosine absorption. The absorption in
the far UV at 216.9 nm to 219.7 nm has been assigned to the
peptide bond (134) .
In order to compare UV spectra of diluted serum samples
against known antibody samples, commercial rabbit IgG was
obtained from Sigma. The antibody was developed in rabbits
using highly purified proteins as immunogens, and the IgG
fractions of the antisera were prepared by fractionation
and ion-exchange chromatography. The product was delivered
in lyophilized (freeze dried) form and had been evaluated
by the producers for purity, specificity and potency using
immunoelectrophoresis and quantitative precipitin analysis.
(The latter is a general immunological technique which
relies on precipitation of immune complexes as specific
concentrations of antigen or antibody.) The product was
stored in a refrigerator at 2 to Soc.
The rabbit IgG was weighed out using a Mettler AE 200 four












Figure 4.10. Structure of tryptophan.
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Figure 4.11. Structure of tyrosine.
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antibody. A mass of 0.008 g of IgG was weighed out and
transferred to a 1 ml aliquot of PBS contained in an
Eppendorf vial. The antibody dissolved instantaneously when
the vial was shaken by hand. Because of the small mass
involved, the antibody was difficult to weigh out and it
would thus have been logical to weigh out a larger mass of
IgG and dilute the sample using PBS. Ho ev e r , at these
higher concentrations, the antibody reached its solubility
limit in PBS.
A UV absorbance spectrum of 0.8 mg/ml commercial rabbit IgG
is seen in Figure 4. 12 . The accuracy in weighing out a
small mass of IgG was tested by calculating the extinction
coefficent· of the IgG using the Beer-Lambert Law. A series
of UV spectra were determined for a 0.4 mg/ml IgG
concentration and 1 cm pathlength. The average extinction
coefficient for these runs was found to be 1.43 (mg/ml)-l
cm-1. This value compares favourably with the value of 1.50
(mg/ml)-l cm- 1 determined by Phillips and Kalthoff(135) and
others (136). Because the serum contains transferrins and
albumins (serum proteins) as well as antibodies, antibody
concentrations in the serum were not determined using the
abovementioned Beer-Lambert Law and calculated extinction
coeff icient. As will be shown in section 6.3, absolute
values of antibody concentrations were not used in
constructing a calibration graph relating antibody
dilutions (determined by immunoblotting) to thymine dimer
concentrations.
The following sections (4.2.3.2 and 4.2.3.3) outline the
initial purification technique (ammonium sUlphate
precipitation) of the crude serum that was employed in this
research. First, the rationale of salt prec.ipitation of
proteins will be discussed. Then, the protocol which was












Ammonium Sulphate Precipitation of Proteins:
Explanation of the Technique
The purification of proteins is usually a formidable task;
their fragile nature requires that careful control be
exercised over factors such as pH and temperature because
exposure to even moderate temperature and pH changes
elicits slow denaturation. In addition, if the protein of
interest is to be separated from other proteinaceous
systems, very slight changes in iso-electric point (that pH
or concentration where a protein is electrically neutral)
or any other relevant criteria, must be invoked in order to
effect separation and purification.
Because of the size and instability of proteins, the usual
methods of purification of organic materials (distillation
and solvent extraction) cannot be exploited. To complicate
purification techniques even further, an evaluation of the
degree of purification and overall yield must be performed
for any particular purification regime. As an example, a
procedure that results in a lOO-fold purification of the
protein, but yields only 1% of the product of interest is
of little use.
Taking cognisance of the abovementioned factors, a number
of fractionation techniques for protein purification are
available. These include ion-exchange chromatography (where
DEAE (diethyl-aminoethyl) cellulose anion-exchange columns
or CM (carboxymethyl) cellulose cation-exchange columns
yield sustantial purification of proteins(137»),
electrophoresis (which gives excellent separations and
permits near quantitative recovery of the protein of
interest), molecular sieves, crystallization and affinity
chromatography. This last mentioned technique will be
discussed in detail in sections 4.2.3.4 to 4.2.3.10.
Because of its ease of use, salt precipitation of proteins
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was chosen as the initial purification technique in this
work. First described in 1937, it is still the simplest and
one of the most efficient techniques for protein
purification, provided it is not necessary for the
immunoglobulin classes to be separated from one another.
The technique gives a preparation which contains all the
immunoglobulins, other non-immune serum globulins and a low
percentage of albumin (140) . Its advantages are the
utilization of standard laboratory equipment at room
temperature.
Proteins vary remarkably in their solubilities in
concentrated salt solutions. Consequently, purification may
be achieved by addition of sufficient salt to precipitate
the protein of interest. This protein may then be collected
by centrifugation. To this end, the salts most commonly
used are ammononium sulphate and sodium sulphate. (Ammonium
sulphate is usually preferred.) However, besides salts
ethanol, dioxane and polyethylene glycol are also employed
for this purpose (139) .
Fractional separation by salt precipitation is thought to
occur because the salt reduces the amount of free water
surrounding the protein molecule as a hydration shell
(Figure 4.13.). The solubility of the protein at any salt
concentration is thus dependant on its own inherent ability
to attract water molecules. with most proteins and
biologic~l materials, this is determined by electrostatic
charge and the pH of the medium. The ,greater the difference
between the pH and the pI (iso-electric point) of the
protein, the greater the ability to form a water shell and
hence, the less likely it is to precipitate.
Mahler and Cordes(138) quote ammonium sulphate precipitation
as providing a 80% yield of the protein of interest with a
4-fold purification. As will be outlined in Section 6.1.1,





:......~---~'olecule at separating agent
Figure 4.13. Proposed mode of action of salt precipitation
of proteins.
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IgG using affinity chromatography.
The following section describes the technique of ammonium
sulphate precipitation of proteins, as employed for the
purification of antibodies in this work.
4.2.3.3 Use of a Protocol for Ammonium Sulphate
Precipitation of Antibodies
Although individual procedures for ammonium sulphate
precipitation of proteins do vary, all procedures utilize
saturated ammonium sulphate solutions and buffers. In this
work, the procedure for ammonium sUlphate precipitation of
antibodies was supplied by G. Contrafatto of the Department
of Biology at the University of Natal and used a saturated
ammonium sulphate solution buffered at pH 6.5 for the
precipitation of specific protein antibodies.
Merck analytical grade ammonium sulphate (132.14 g/mol) was
used to prepare a saturated solution of ammonium sulphate
according to the procedures of Dawson et al.(141) At 25°C,
saturation is effected by the addition of 766.8 g of
ammonium sulphate to sufficient water to make 1 dm3 of
solution. This mass was weighed out and transferred to a 1
litre "A" grade vOlumetric flask. Milli-Q water was added
to bring the solution to the correct volume. This yielded
a 4.06 M solution with a density of 1.2450 g/cm3 as
determined by Dawson et al (141) .
A 0.5 M NaOH solution was prepared by weighing out 2.00 g
of NaOH pellets (BDH, LAB grade, 40.00 g/mol), dissolving
them in approximately 50 ml of Milli-Q water, transferring
to a 100 ml vOlumetric flask and making up to the mark with
Milli-Q water. Ammonia solution (BDH, LAB grade, 35%, 58.0
g/mol) was used to bring the saturated ammonium sUlphate
solution to pH 6. 5. This was performed by adding 3. 5%
ammonia solution dropwise to 100 ml of the saturated
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solution stirred on a magnetic stirrer. A portable Jenko pH
meter calibrated against pH 7.0 and pH 4.0 UniVAR buffer
solutions was used to determine the resulting pH which was
between 6.45 and 6.5.
Because the volumes of serum which were obtained after
centrifuging the rabbit blood were small (500 to 1000 ~l),
an even smaller aliquot of serum was used (200 to 500 ~l)
to purify the antibodies in the serum. A specific volume of
serum was added to a 5 ml beaker and the serum was stirred
using a magnetic stirrer. For a 500 ~l aliquot of serum,
250 ~l of saturated ammonium sulphate solution (pH 6.5) was
added dropwise to the stirred solution using a 100 to 1000
~l Volac micropipette. Addition of the saturated solution
turned the serum a milky colour. At this stage, the pH was
carefully adjusted to 7.8 by the dropwise addition 0.5 M
NaOH. A portable Jenko pH meter was used to determine the
pH of the solution. Thereafter the solution continued to be
stirred for 2 to 3 hours during which it turned to the
clear colour it was prior to ammonium sulphate addition.
The solution was decanted into a 1.5 ml Eppendorf vial and
spun for 2 x 15 minute sessions using the Hettich (12 000
rpm) Ultracentrifuge. A small white precipitate (protein)
was noted at the base of the vial. The supernatant was
decanted from the protein and this protein resuspended in
the original volume (500 ~l) of PBS. However, this was a
tricky procedure which required the use a thin pointed
capilliary tUbe to dislodge the white precipitate from the
base of the vial and resuspend it - in the buffer. The
solution was transferred to a 5 ml glass beaker and the
entire procedure of precipitation with ammonium sulphate
repeated. Thereafter the solution continued to be stirred
for a further 2 to 3 hours, was centrifuged in an Eppendorf
vial and less protein was noted at the base of the vial in
comparison to the amount . noted the first time the
precipitation was performed. The supernatant was decanted
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and an attempt was made to dissolve the precipitate in 500
~l of PBS. Despite several attempts to dissolve the
protein, it did not dissolve satisfactorily. Although this
technique had apparently partly purified the serum
components (by precipitation of the antibodies and some
globulins(140»), the protein could still contain an
extensive amount of ammonium sulphate which was then
removed by the auxiliary procedure of dialysis against a 50
mM phosphate buffer (pH 6.8).
Preparation of the phosphate buffer involved the individual
preparation of 50 mM Na2HP04 (UniVAR) and 50 mM NaH2P04.2H20
(BDH) by weighing out 7.0988 g of Na2HP04 and 7.8009 g of
NaH2P04.2H20 respectively and making up to 1 litre in
individual volumetric flasks. After filtering to remove
particulate matter, 500 ml of each solution was mixed in a
1 litre volumetric flask, and the pH checked to be 6.8
using a portable Jenko pH meter.
Dialysis tubing (2.5 cm diameter) was prepared for use by
boiling 10 to 15 cm strips in 1% Na2C03 for 20 minutes,
soaking in 10 mM EDTA for 20 minutes at room temperature,
washing twice in Milli-Q water for 20 minutes each at room
temperature and finally autoclaving in Milli-Q water.
The sample to be dialysed (500 ~l) was transferred from the
Eppendorf vial to the dialysis tubing (which was knotted at
one end) with a micropipette. The other end of the tUbing
was knotted and the tUbing immersed in approximately 50 ml
of the phosphate buffer. The buffer solution was changed
twice daily and the solutions dialysed for 4 days.
Thereafter the dialysed and purified antibody solution was
transferred with a micropipette to an Eppendorf vial.
Dialysis of this small volume of solution using standard
dialysis tUbing was Lnconqruous as it led to numerous
changes in concentration of the antibody during transferral
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to and from the tubing. Such alterations would have been
important if the purified serum was used in the
immunoblotting protocol (Section 5.2. 1.8 ) with enhanced
chemiluminescence detection (Section 5.2.2.4). The
situation was not improved when a smaller diameter tUbing
(0.60 cm) was employed, as the volumes being used were
still too small. Despite the fact that ammonium sulphate
precipitation can be used very successfully for the
purification of large volumes of serum, and was used
successfully for antibody purification in this work, the
small volumes (500 ~l) used dictated the" use of an
alternative purification technique.
This laboratory had just recently acquired a waters Delta
Prep 4000 HPLC system with a tunable absorbance 486 DV
detector. It was decided to use this HPLC with a Memsep
affinity chromatography cartridge to purify the crude
serum.
sections 4.2.3.4 to 4.2.3.10 describe the technique of
affinity chromatography as well as the development and use
of a working protocol for serum purification using this
chromatographic technique.
4.2.3.4 Explanation of the Affinity Chromatography
Technique
The separation of antibodies by chromatography has
superseded ammonium sUlphate precipitation of proteins as
a separation technique. This has become necessary because
of the requirement for pure antibody preparations in
analytical, clinical and preparative biochemistry in which
antibodies find application as components of immunological
assay kits, as stationary phases in affinity chromatography
and as carriers of therapeutic agents in cancer therapy. In
turn, the need for advanced techniques to purify and
analyse antibodies has been accelerated.
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The chromatographic separation of antibodies relies on
differences in four properties of the. immunoglobulins: size
and shape, charge, hydrophobic character and ligand
specificity. These are all exploited in chromatographic
separation regimes. Historically, purification of IgG has
been achieved through a mUltistep process involving
ammonium sulphate precipitation and anion-exchange
chromatography on a DEAE cellulose column. IgG obtained
from this two step process contains less than 10% of other
proteins by mass(142). A variation of this process is to use
a chromatographic step in place of the salt precipitation.
Here hydrophobic interaction chromatography coupled with
anion-exchange chromatography has been shown to produce 95%
pure IgG(143). It has also been possible to couple
chromatographic steps: a mixed-bed anion/ cation-exchange
column operated at low ionic strength near the pI of bovine
IgG1 has been used to produce IgG1 of more than 95% purity
from bovine serum (144). IgG isolated by the procedures
mentioned above is generally composed of one or more
subclasses. Fractionation into sub-classes is most commonly ·
achieved using ion-exchange chromatography and this
separation technique was used for the resolution of mouse
IgG3 and IgG2b from IgG1 and IgG2a which co-elute (145) .
Hydroxylapatite absorbs biomolecules (nucleic acids and
proteins) as a function of the extent and difference of
their surface charge. This chromatographic technique
(hydroxylapatite chromatography) has been used in the
fractionation of both polyclonal and monoclonal
antibodies(142). A comparative study of different types of
high performance chromatography indicates that
hydroxylapatite chromatography is slightly superior to ion-
exchange chromatography and hydrophobic interaction
chromatography for the resolution of ascites monoclonal
antibodies(146). Hydroxylapatite columns are widely used in
the purification of antibodies(147) giving more than 75%
recovery. In addition, Juarez-Salinas et al.(148) have used
high performance hydroxylapatite chromatography for the
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separation of IgG molecules on the basis of idiotypes,
(antigenic determinants characteristic of a particular
variable domain of an immunoglobulin) even when the IgG
molecules belonged to the same sub-group. Along the same
lines, ion-exchange mediated separation is a specific
regime relying on the immunoglobulin molecule having a pI
more basic than any contaminating serum proteins(147). In
this way, the immunoglobulins subclasses (IgM, IgA, IgE,
etc.) are separated from one another and can be collected
in semi-preparative applications. However, as such
specialized separations were not required, hydroxylapatite
chromatography and ion-exchange chromatography were
rejected as a purification technique in this work.
Separation of the immunoglobulins from contaminating serum
proteins is more easily achieved using affinity
chromatography, and to date, this has had limited
application in antibody purification. with the advent of
commercial affinity chromatography columns, the use of this
technique is increasing and. was chosen as the mode of
separation in this work. The technique relies on the
specific interaction of proteins (or other biomolecules)
with ligands immobilized by covalent binding to an
insoluble matrix. For example, an enzyme may interact with
an immobilized substrate or an immobilized lectin may
interact with the carbohydrate moeity of a glycoprotein.
Elution of the adsorbed protein is carried out using
specific eluants of pre-determined concentrations and pH's.
Affinity chromatography absorbents usually consist of three
covalently linked components; the insoluble matrix, a
spacer and the specific ligand. The insoluble matrix is
normally composed of beaded 4% or 6% agarose which is
stabilized by cross-linking with epichlorohydrin or
bisoxirane. A cellulose matrix was used as the support
medium for the Memsep 1000 affinity chromatography
cartridge used in this work. Spacers are used as affinity
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chromatography absorbents when a low molecular weight
ligand is attached directly to the matrix. A hydrocarbon
chain of 6 to 8 carbon atoms long is positioned between the
matrix and the ligand and serves the function of reducing
steric effects. When the ligand is a macromolecule (as in
this work), the ligand is attached directly to the solid
matrix and no spacer is used. Any molecule which interacts
specifically with the protein, antibody or nucleic acid
that is to be purified is potentially useful as a ligand in
affinity chromatography. Enzyme substrates, lectins or
~ntigens which interact with only a single type of protein .
are of this type. others such as co-enzymes (NADH),
nucleotides (ATP, AMP) and immobilized dyes interact
specifically with a wider range of macromolecules.
An example of affinity chromatography related to UV-
irradiation of DNA is given by Kronvall, Grey and
Williams(149) who raised antibodies to UV-irradiated DNA and
precipitated these antibodies using ammonium sulphate. The
partly purified serum was applied to a 5 ml column of
single stranded DNA-Sepharose for affinity adsorption of
anti-single stranded DNA antibodies. After elution, the
non-adsorbed material was applied to a 5 ml column of UV-
irradiated single stranded DNA-Sepharose. Antibodies
againstUV-irradiated single stranded DNA bound strongly
and eluted with a 4 M urea, 0.5 M NaCI and 0.2 M acetic
acid pH 3.1 buffer. These purified antibodies were used in
UV repair studies of UV-irradiated human skin.
Returning to the theoretical aspects of affinity
chromatography, most ligands (usually proteins) can be
LmmobLl.Lz ed on an insoluble matrix by reaction under mild
conditions with agarose activated cyanogen bromide (150) .
Included here is the Protein A molecule which has been
shown to interact specifically with . only the IgG
immunoglobulin of selected ~ammals. Protein A is that cell
wall protein (42 000 d) expressed by the bacterial species
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staphylococcus aureus which precipitates normal human gamma
globulin as well as mouse, rabbit and guinea pig globulins.
It has been stated that all humans have so called natural
antibodies to this cell wall protein and it has been shown
that the ability of normal human sera to agglutinate s.
aureus is based on a reaction with this antigen which was
subsequently named Protein A. Detailed studies on
precipitin reactions have revealed that Protein A reacts
with the mouse gamma 2a , gamma 2b and gamma 3 globulins as
well as human IgG-1, -2 and -4 subgroups (151) , while human
IgD and IgE showed no reaction. Sub-group precipitation
with rabbit sera has, to date, not been performed. However,
for the abovementioned species, it is proposed that the
last 19 amino acids of the heavy chain of gamma G globulins
from horse, rabbit and humans are the same, which could
partly explain the selectivity of reaction of Protein
A(151) .
The reaction between Protein A and IgG is a rather specific
one. The distinct sub-group pattern as well as the
reactivity of immunoglobulin sub-fragments indicate that
the very specific structures of immunoglobulin chains are
involved. Kinetic studies on the interaction between
Protein A and human gamma globulins yielded values for this
equilibrium constant of approximately 4 x 107
litres/mol (152). This value far exceeds that of hapten-
antibody reactions and is indicative of the high
specificity of the reaction.
This Protein A-IgG reaction is postulated to be mediated by
the Fe fragment of antibody molecules, unlike normal
antigen/ antibody reactions which involve the Fab fragment of
the antibody (see section 1.2). For this reason, Protein A
reactions with IgG are referred to as "pseudo-immune"
reactions. Langone(153) has shown that the binding of the
Protein A molecule to the Fe .region of the antibody molecule
does not affect the antibody ability to bind antigen. In
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addition, Langone et al.(154) have postulated that 4
tyrosine residues of a Protein A molecule are responsible
for its ability to bind the Fe domain of IgG. Mota, Ghetie
and Sjoquist(155) have proposed that complex formation
between IgG and Protein A in rabbits involves two rgG
molecules binding to a single Protein A molecule. This
hypothetical model is illustrated in Figure 4.14.
Apart from purifying sera in biochemical .and analytical
applications, formalinized Protein A containing
staphylococci have been used as particulate adsorbents.
Lind and Mansa(156) adsorbed 93% of rabbit IgG from a serum
sample using this technique. The adsorption efficiency
correlates well with the 90% recovery of commercial rabbit
IgG using the Memsep cartridge in this work (see section
6.1.1) .
other applications of Pro ein A include labelling Protein
A with 1251 , followed by immobilizing an antigen to a solid
bead support and incubating the antigen with the Protein A-
125r complex. Scintillation counting of the resultant
radioactivity allows the antigen to be quantitated. Under
optimal conditions, research of this nature allowed
picomole levels of the antigen to be determined. In this
manner, Langone et al.(154) determined the fluid phase IgG
concentrations in human and rabbit sera to be 9.5 and 13.6
mgjml respectively.
If only the antibodies generated against thymine dimers
were required, an affinity column could have been packed
with commercially synthesized oligo-dT. The relevant
antibodies would bind to the oligo-dT, while the non-
thymine dimer antibodies would elute from the column.
However, such a purification step was prohibitively
expensive considering both the cost of the oligo-dT and the
specialized knowledge and expertise required to pack an




~ Protein A molecule
Figure 4.14. Hypothetical model of Protein A-rabbit IgG
binding.
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to cellular systems in this laboratory might well require
oligo-dT affinity purified antibodies for accurate
quantitation, and in this instance an oligo-dT packed
affinity column would be required.
Affinity chromatography thus separates immunoglobulins from
other serum proteins and hence effects separation. However,
Protein A only binds to the sub-classes of the IgG
molecule, allowing the IgM, IgA and IgE antibodies to pass
straight through. Because IgG comprises between 75 and 80%
of all immunoglobulins and because antibody purification
was not used in any quantitative work in this research, it
was adequate for this percentage of the antibody population
to be purified. If quantitation of antibodies themselves
was important, then affinity chromatography is limited as
it is unable to separate immunglobulin sub-classes from
each other.
The following sections (4.2.3.5 and 4.2.3.6) describe the
equipment (Memsep Chro~atography 1000 affinity
chromatography cartridge attached to a Delta Prep 4000
Preparative HPLC system with DV detection) that was used in
this work for the purification of rabbit IgG from other
rabbit immunoglobulins and serum proteins.
4.2.3.5 Affinity Chromatography Cartridge Operation
In this work the Protein A ligand was housed in a Memsep
Chromatography 1000 affinity chromatography cartridge
supplied by Millipore. The cartridge has been designed for
the rapid extraction, concentration and purification of
immunoglobulins from complex feed streams such as tissue
culture media, ascites fluid or serum. Other applications
include the separation of plasma proteins, extracellular
proteins, inositol phosphates and the separation of nucleic
acids from proteins and nuc l.eotLdes . To this end, the
matrix and ligand are housed within a polypropylene capsule
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containing mesh distributors (Figure 4.15.). The matrix
consists of 1.2 J.Lm regenerated cellulose disc membranes
positioned on top of one another (Figure 4.15.). Diffusion
problems are eliminated by the pore size used which allows
even the largest of biomolecules easy access to all
available active sites. Thin diffusion channels at each end
of the membrane stack ensure efficient flow distribution
while minimizing the dead volume of the unit. In addition,
the regenerated cellulose network excludes problems such as
bed shrinkage at high saline concentrations or bed
movement. Air bubbles trapped in the unit are easily
removed by increasing the flow rate of the mobile phase.
Memsep cartridges are supplied with a variety of active
groups depending on the specific application of the
cartridge. DEAE, carboxymethyl, quaternary methylamine or
Protein A are incorporated into Memsep cartridges. The
Memsep 1000 has a 1.4 ml bed volume, while its larger
counterpart (Memsep 1010) has a 4.9 ml bed volume. The
smaller cartridge was chosen in this work because of the
cost factor involved.
These cartridges have a pH operation range of 2 to 11 which
makes them suitable for the purification of the wide
variety of biological fluids mentioned above. Temperatures
of 50°C were not exceeded in this work, and it was
imperative that an operating pressure of 100 psi (6.87 x 10 5
Pa) or less be used for fear of the cartridge exploding.
This consideration implied that mobile phase flow rates had
to be maintained between 1.5 ml/min to 8.0 ml/min. However,
in this work, flow rates greater than 1.5 ml/min did cause
backpressure build up, presumably due to buffer
precipitation in the solvent lines. Hence, flow rates
greater than 1.5 ml/min were not used in this work.
The advantages of using Memsep cartridges for purification
are manifold. The pure cell~lose matrix exhibits very low










Figure 4.15. Schematic representations of the Memsep 1000
Affinity Chromatography Cartridge.
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recovery is maximized. Control of functional group
incorporation in the manufacture of the cartridge ensures
that reproducible per~ormance is obtained. Memsep
cartridges can be re-equilibrated and regenerated up to 100
times for use. Finally, the cartridge is compatible with
syringes and peristaltic pumps and can easily be attached
to conventional HPLC equipment.
This attachment to an HPLC system is effected by a series
of threaded connections and ferrules (Figure 4.16.)
attaching the inlet of the cartridge to the injector valve
and the outlet to a detector or fraction collector.
Seeing that the operation of the Delta Prep 4000
Preparative HPLC has not been discussed by any members of
this research group, the following section (4.2.3.6)
discusses the workings and operation of this HPLC.
4.2.3.6 Preparative HPLC Equipment and Operation
The HPLC system used in this study is a Waters Delta Prep
4000 HPLC solvent delivery system that can be used for
qualitative, analytical and preparative scale
chromatography. It was attached to a Waters Tunable 486
Absorbance UV detector and Waters 745 Data Module with
integration functions. The HPLC system accommodates large
scale and small scale operation without replumbing the
system, .c onve n i e nt l y allowing direct scale-up of samples.
Figure 4.17. illustrates the Delta Prep system. The
controller (1) houses the electronics of the system,
thereby controlling solvent gradients, flow rates and
sparging -dur i ng analysis. The fluid handling unit (2)
consists of the pump heads with two 500 J..I.l volume pump
heads, the solvent sparge valve assembly and solvent
proportioning valve assembly. The column rack (3) contains
the rheodyne injector, pump . purge valve, column switching
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Figure 4.16. Connections for the attachment of the Memsep





Figure 4.17. Schematic representation of the Waters Delta
Prep 4000 HPLC system.
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analytical or preparative columns. The Rheodyne 7010
injector (4) contains fixed sample loops allowing a
constant volume of sample to be injected each time. In this
work, a 100 J.£l fixed volume loop was attached to the
injector replacing the 5.1 ml loops the system was supplied
wit h (see section 4.2.3.8.3). The purge valve (5) allows a
choice of solvent flow; either from the pump to waste, or
through the injector, columns and rest of the system. The
column switching valve (6) allows either the small scale or
large scale tubing arrangements to be chosen, while the
inlet and outlet ports (7) accept the outlet from the pump
for either the small scale or large scale arrangements. The
purge outlet port (9) directs solvent flow from the inlet
port to this outlet port when the purge valve selects the
purge mode.
The Waters tunable 486 absorbance detector is a single
channel tunable UV/Vis detector designed for HPLC
applications. The detector can operate as a stand alone
unit (when attached to a chart recorder) or with other
system modules such as the Waters 4000 delivery system and
integrator. It provides a usable light intensity over the
190 to 600 nm range, although it is usual for only the UV
range (190 to 400 nm) to be used.
The optical design of the 486 detector includes a deuterium
source lamp, illumination lens, aperture slit, diffraction
grating, beam splitter, flow cell (sample and reference
sides) as well as a dual photodiode. Figure 4.18.
illustrates the optics showing the path of a light beam as
it passes through the components in the optics assembly.
The dual light beams pass through the sample and reference
sides of the flow cell to dual photodiodes where they are
converted to analogue currents. A pre-amp board serves to
convert this current to digital signals for processing by














Figure 4.18. Schematic representation of the path of a
light beam through the optical configuration
of the Waters 486 detector.
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The flowcell contains the Taper-cell designed to eliminate
common absorbance detection problems. These include
refractive index changes due to change~ in solvent. In this
case stray light bends within the flow cell causing
absorbance errors. Gradient changes may cause refraction as
well as reflection at the junction of the window and cell.
The patented Taper-cell corrects these unwanted phenomena
permitting true absorbance detection to occur. The
analytical cell has a 10 mm path length while in the
preparative cell the path length is reduced to 3 mm.
During a 1 hour lamp warm up, wavelength calibration of the
instrument occurs automatically. The detector locates and
identifies the 656 nm peak in the deuterium lamp emmision
spectrum to ensure that the calibration is correct.
On the electronics side, the 486 detector design i s
digitally based and includes hardware such as the front
panel keyboard, printed circuit boards and their
interconnections. The detector software includes features
such as sensitivity and filter settings, wavelength
selection, chart polarity and lamp on/off control.
The Waters 745 data module uses a three function keyboard
to receive, process and store digital information from the
detector. Function keys allow operations such as peak
width, peak threshold, attenuation and chart speed to be
altered for specific requirements during operation. Sample
tables can be set up in memory allowing reports to be
generated of component name and concentration, retention
time, peak area and detector response factor. In this
manner, a comprehensive list of relevant data is obtained
after an injection.
The following section describes the solvent and sample
preparation procedures that were employed in this work for
serum purification using the Memsep 1000 affinity
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chromatography cartridge.
4.2.3.7 Preparations Required Before Use of the Memsep
cartridge
This section describes the preparation of the buffer
solutions (0.05 M Tris/HCI, 0.1 M NaCI, pH 8 and o. 1 M
glycine/HCI pH 2.5 and 0.02% sodium azide in 0.1 M Tris/HCI
pH 8) and samples. The attachment of the Memsep 1000
cartridge to the Waters 4000 Delta Prep HPLC is also
discussed. The development of a working protocol for serum
purification using the Memsep cartridge will be discussed
in section 4.2.3.8.
4.2.3.7.1 Preparation of Buffer Solutions
The buffer solutions used in this work were those
recommended by Millipore. A 0.05 M Tris/HCI, 0.1 M NaCI, pH
8 (Tris/HCI buffer) was used for sample loading and
equilibration. It was prepared by weighing out 6.0575 g of
Tris (Tris[hydroxymethyl] aminomethane; Saarchem analytical
grade, 121.14 g/mol) and 5.8442 g NaCI (Saarchem analytical
grade, 58.44 g/mol). The salts were dissolved in a beaker
containing approximately 500 ml Milli-Q water and stirred
magnetically. At 25°C, a pH of 8.0 was established by the
addition of 292 ml 0.1 M HCI(141) to the salt solution. Acid
addition was performed using a 100 ml burette. The solution
was transferred to a 1 litre volumetric flask and made up
to the mark using Milli-Q water. The pH of the solution was
checked using a Jenko portable pH meter and in all cases,
the pH was between 7.95 and 8.05. As mentioned in section
4.2.3.3, proteins are particularly susceptible to pH
changes. Hence buffer preparation was routinely carried out
with great care.
A 0.1 M glycine/HCI, pH 2.5 solution (glycine/HCI bUffer)
was used as the IgG elution buffer in this work. A mass of
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7.507 g of analytical grade glycine (BDH, 75.07 g/mol) was
added to a 1 litre vOlumetric flask and Milli-Q water was
added to dissolve the glycine and make the solution made up
to 1 litre. Then, 250 ml of this solution was added to 142
ml of 0.1 M HCI(141) in a 1 litre vOlumetric flask. Milli-Q
water was used to bring the solution to the correct volume.
The pH was checked to be between 2.45 and 2.50 in all cases
using a Jenko portable pH meter. Because the glycine was an
easily available source of -f ood , this solution was
particularly susceptible to microbial attack. To inhibit
degradation of this solution, it was stored in a
refrigerator when not in use.
The 0.02% sodium azide in 0.1 M Tris/HCI, pH 8 was used as
the storage buffer for the Memsep cartridge when the
cartridge was not in use. Sodium azide has recognized anti-
bacterial properties, but care was taken in solution
preparation because of its potentially explosive
properties. A 0.1 M Tris solution was prepared and 0.1 M
HCI added to establish a pH of 8. Then, 0.02 g of sodium
azide was carefully weighed out and transferred to a 100 ml
aliquot of this Tris/HCI solution.
All buffers were filtered through 0.45 ~m Durapore filters
to remove insoluble material. Apart from blocking the
solvent lines, optically dirty buffers and solvents cause
baseline noise and drift, and columns become blocked.
Filtration also degassed the buffers. Degassing served the
important function of eliminating oxygen from solution,
thereby preventing oxidation of the buffers themselves. In
HPLC applications, oxygen is known to increase noise
because less light reaches the detector thus causing
baseline drift. At pH 8, a 0.2 M Tris/HCI solution has a UV
cut-off of 212 nm. At pH 8, a UV spectrum of the 0.05 M
Tris/HCI, 0.1 M NaCI showed a 214 nm cut-off which did not
affect the 280 nm detection wavelength used in this work.
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4.2.3.7.2 Preparation of Serum Samples
Millipore suggested dilution of serum samples prior to
filtration of these samples. In this work, 1:10 or 1:50
dilutions were performed which minimized clogging of the
filtration apparatus. Filtration was performed because
biological samples are often contaminated with particulate
and bacteriological matter which, if not removed, leads to
premature clogging of the Memsep cartridge itself.
Sample preparation by means of filtration was performed
using Millex RV filtration units which contained 0.45 ~m
Durapore polyvinylidene as the filters. These filters are
hydrophobic and have low protein binding characteristics.
They are contained in a PVC housing (Figure 4.19.). A
single unit was attached to a 2.5 ml hypodermic syringe
(without a needle) containing the diluted serum sample. By
depressing the plunger, the sample was filtered through the
unit. The filter was used until the f i l t r a t i on membrane was
clogged with particulate matter. Once filtered through 0.45
Mm filters, the serum samples were filtered through Millex
GV filtration units which contained 0.22 Mm Durapore
polyvinylidene filter units. This product removed all
micro-organisms and particulate matter and precipitated
dissolved powders greater than 0.22 Mm in size. The Millex
GV units were supplied sterile and were only t o be used
once. However, sterile conditions were not important during
HPLC analysis and hence the filter was re-used until it
became clogged. For both the Millex HV and GV filters, a
pressure greater than 75 psi was avoided for fear of the
Durapore membrane disintegrating.
4.2.3.7.3 Attachment of the Memsep Cartridge to the
Preparative HPLC
As mentioned in Section 4.2.3.5, the Memsep cartridge can
be attached to a peristaltic pump system as well as an
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Figure 4.19. Schematic diagram of the Durapore
polyvinylidene filtration unit.
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HPLC. In this work, using the small-scale set up, it was
easy to insert the cartridge between the injector and
detector using the threaded connections and tubing
mentioned in section 4.2.3.5. Initially 9" stainless steel
tubing (actually 1/9000 of an inch tubing, but referred to
as 9" tUbing by the manufacturer) was used at the inlet and
outlet of the rheodyne injector. When backpressure problems
were experienced, this tubing was replaced with 20" tubing
which meant the samples were easier to inject. However, a
larger diameter tubing caused turbulent flow of the sample
within the tubing , resulting in broadening of the IgG
fraction on the chromatogram. Once the back pressure
problems were solved (by setting the mobile phase flow rate
at 1.5 ml/min), the tUbing was replaced with 9" tUbing.
The serum sample was injected manually into the rheodyne
injector; it passed directly to the Memsep cartridge before
moving to the analytical flow cell of the DV detector.
Because only 100 ~l of sample was accommodated on the loop,
the remainder went to waste where it could be re-injected
if requ ired.
4.2.3.8 Development and Use of a Working Protocol for
Serum Purification Using Affinity Chromatography
Solvent and sample preparation as well as the attachment of
the Memsep cartridge to the HPLC was descr i be d in the
previous section. Now, the development and use of a working
protocol for serum purification will be discussed in
detail.
4.2.3.8.1 Development of a Working Protocol
Once attached to the HPLC, the Memsep cartridge was
equilibrated using Tris/HCl buffer before use. Freshly
filtered buffers were prepared, and the Memsep cartridge
was equilibrated by passing more than 20 column volumes of
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Tris/HCI through the device. A PT EVAL (peak threshold
evaluation) of between 12 and 200 delivered by the
attached data module indicated that the instrument was
sufficiently stable to use.
When a run was performed, a lamp warm-up of 1 hour was
necessary. As outlined in section 4.2.3.6, wavelength
calibration took place automatically during this time. The
detection wavelength was set at 280 nm for maximum protein
absorbance. First, a blank injection was made to ensure a
flat baseline. The latter demonstrated that the buffers
were not contaminated so a s to cause a measurable
absorbance to be registered by the detector. The diluted
serum sample was then loaded onto the syringe and manually
injected through the rheodyne injector onto the Memsep
cartridge. The Memsep cartridge was rinsed with the
Tris/HCI buffer until the absorbance of the eluant at 280
nm returned to zero. As mentioned previously, the Tris/HCI
buffer was used to load the serum sample and as will be
outlined in section 4.2.3.10, it eluted the serum proteins
as well as other immunoglobulins whilst simultaneously
adsorbing the IgG onto the cartridge. Desorption of the
antibody was performed by passing the glycine/HCI buffer
through the cartridge and monitoring the absorbance at 280
nm until it returned to baseline. The eluate was collected
as fractions containing the IgG for further analysis. If
the cartridge was not to be re-used immediately, more than
20 column volumes of 0.02% sodium azide in 0.1 M Tris/HCI
was passed through it. The cartridge was detached from the
HPLC, re-capped and stored in a refrigerator until
required. If the cartridge was to be re-used immedi~tely,
the Tris/HCI buffer was used to re-equilibrate it.
The step-by-step workings of the Memsep cartridge were
described above. However, the entire protocol was optimized
in terms of the gradients and flow rates used, as well as
optimizing the integrator functions and sensitivity. The
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following sections describe this optimization process.
4.2.3.8.2 optimization of Flow Rates and Gradients
As mentioned in section 4.2.3.4, the upper threshold
pressure limit of the Delta Prep 4000 was set at 100 psi
for fear of the Memsep cartridge exploding at backpressures
higher than this. This implied that flow rates greater than
8 ml/min were not to be exceeded in this work. However,
despite extensive rinsing of the solvent lines using
filtered Milli-Q water, crystallization of buffers was
still occuring to a small extent in the lines, and did
cause excess backpressures to develop. Hence, flow rates
less than 8 ml/min were used in this work.
From a chromatographic point of view, the effect of flow
rate on sample resolution was investigated . with other
parameters (gradients, sample dilution, attenuation) held
constant, a 1:50 dilution of a serum sample was injected
onto the Memsep cartridge using 1.0, 1.5 and 2.0 ml/min ·
buffer (Tris/HCI and Glycine/HCI) flow rates. Figures
4.20., 4.21. and 4.22. illustrate the resulting
chromatograms. Although much noise is noted on the 1.5 and
2.0 ml/min chromatograms, these flow rates do allow the IgG
component to elute earlier (18.3 to 21.7 minutes for the
2.0 ml/min, as opposed to 34.6 to 39.7 minutes for the 1.0
ml/min sample). This consideration is important if mUltiple
samples need to be run within a short space of time.
Because of the backpressure and crystallization problems
mentioned earlier, a flow rate of 1.5 ml/min was chosen for
this work.
However, to reduce the elution time of the component of
interest (and hence speed up analysis), another parameter
can be varied. Figures 4.23. and 4.24. illustrate
separation using step gradients pre-programmed into the
Delta Prep 4000 solvent delivery system. In Figures 4.20 to
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Figure 4.20. HPLC chromatogram illustrating separation of
the IgG fraction from the serum proteins and
other immunoglobulins using a 1.0 ml/min flow
rate of the Tris/HCl and Glycine/HCl buffers.
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Figure 4~21. HPLC chromatogram illustrating separation of
the IgG fraction from the serum proteins and
other immunoglobulins using a 1.5 ml/min flow
rate of Tris/HCl and Glycine/HCl buffers.
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Figure 4.22. HPLC chromatogram illustrating separation of
the IgG fraction from the serum proteins and
other immunoglobulins using a 2.0 ml/min flow
rate of Tris/HCl and Glycine/HCl buffers.
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Figure 4.23. HPLC chromatogram illustrating separation of
the IgG fraction from the serum proteins and
other immunoglobulins with the Tris/HCl buffer
loading the serum sample for 0 to 15 minutes.
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Serum proteins and IgM, IgA and IgE
IgG
Figure 4.24. HPLC chromatogram illustrating separation of
the IgG fraction from the serum proteins and
other immunoglobulins with the Tris/HCl buffer
loading the serum sample for 0 to 12 minutes.
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Figure 4.25. HPLC chromatogram i llustrating separation of
the IgG fraction from t he serum proteins and
other immunoglobulins us i ng a 1.5 ml /min flow
rate of buffers, with Tr i s / HCl l oadi ng the
serum sample for 0 t o 2 minutes and
Glycine/HCl desorbing the IgG fraction for 2
to 20 minutes.
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4.22., separation was effected by the delivery of Tris/HCI
for 0 to 20 minutes, followed by the desorption of the IgG
component using the glycine/HCI buffer for the subsequent
20 to 35 minutes. Reducing the loading time of the Tris/HCI
buffer gradually from 20 to 15 (Figure 4.23.) to 12 (Figure
4.24) to 2 minutes in a series of experimental runs,
greatly reduced analysis time. In both these examples, the
glycine/HCI buffer eluted the IgG componen~ for a further
20 minutes. Figure 4.25. illustrates this shorter run time
and the resulting improved chromatogram as well as an
improved injection technique. (The sample 'wa s filtered
through the Millex GV filter first, as opposed to filtering
through the Millex GV filter while the sample was being
injected onto the Memsep cartridge.) The baseline
perturbation at 19 to 20 minutes is due to column re-
equilibration and refractive index effects as the new
solvent passed through the analytical flow cell.
Gradients and flow rates can thus be optimized as follows:
Tris/HCI buffer - 1.5 ml/min - 0 to 2 minutes
glycine/HCI buffer - 1.5 ml/min - 2 to 20 minutes
4.2.3.8.3 Choice of Rheodyne Injector Loop Volume
The Waters Delta Prep 4000 system was supplied with a
series of rheodyne loops aimed at delivering a fixed volume
of sample to a column or cartridge. In this manner,
inaccuracies due to manual volume selection by a syringe
are avoided. The HPLC Rheodyne 7010 injector was supplied
with two 2.5 ml loops as well as one 100 ~l loop. These
three loops could be configured in any combination to
change the injection volume.
When using diluted samples for analysis, a single 2.5 ml
loop was too large for the volumes of serum available.
Hence, this loop was replaced with a 500 ~l loop and the
majority of the developmental work regarding antibody
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purification was performed using this loop size. However,
the chromatograms yielding the best resolved serum protein
and IgG peaks are obtained from the use of a 100 ~l loop
(Figures 4.26.,4.27. and 4.28.). Whichever loop was used,
ten times the volume of the loop was drawn into the syringe
to ensure the loop was completely filled prior to the
sample moving to the Memsep cartridge. Excess sample went
to waste and was re-injected if required. Accuracy of
injection was calculated to be 0.5% by mUltiple injection
of a standard sample.
Millipore suggested that while a run was in operation (and
the rheodyne injector in the "inject" position), the loop
be rinsed with a volume of mobile phase (Tris/HCl, in this
work). The mobile phase went directly to waste and thus did
not affect the chromatography, while the loop was cleared
of any adhering sample which might affect subsequent
analysis.
4.2.3.8.4 Optimization of Integrator Parameters
with the fundamental chromatographic settings of the HPLC
optimized as discussed in sections 4.2.3.8.1 to 4.2.3.8.3,
this section discusses ways in which the digital signal
from the detector can be altered to display differently.
This is brought about by altering some of the pre-set
parameters of the Waters 745 data module. A chart speed of
0.5 cm/min was set and maintained throughout this work. A
peak threshold (PT) of 500 was set initially. This value
indicated to the integrator function that any integrated
peak areas greater than 500 must be responded to and
represented on the chromatogram. Setting the PT value to
3000 meant that a large portion of the noise on the IgG
fraction was eliminated. This is clearly illustrated in
Figure 4.29. where a significant reduction in signal-to-
noise ratio can be seen in . comparison with Figure 4.24.




































Figure 4.26. HPLC chromatogram illustrating optimum
separation of the IgG fraction from the serum
proteins and other immunoglobulins using a
































Figure 4.27. HPLC chromatogram illustrating optimum
separation of the IgG fraction from the serum
proteins and other immunoglobulins using a
100 ~l loop volume (Attentuation set at 64).
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Figure 4.28. HPLC chromatogram illustrating optimum
separation of the IgG fraction from the serum
proteins and other immunoglobulins using a

































Figure 4.29. HPLC chromatogram illustrating optimum
separation of the IgG fraction from the serum
proteins and other immunoglobulins with loop
volume = 100 ~l, attenuation = 32 and peak
threshold = 3000.
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However, no one chromatographic parameter will adequately
effect resolution of a chromatogram. In this regard, the
peak width (PW) and attenuation (Atten) which are pre-
programmed into the data module radically affect the manner
in which the chromatogram is displayed. Peak width values
alter the breadth of the serum protein and IgG peak. The
default PW setting of 6 was used in the developmental
stages of this work, but when resolution of the serum
protein from the IgG fraction was important, PW values of
30 and 40 were experimented with, and a value of PW = 30
was finally settled on. Figure 4.30. illustrates a PW = 40,
all other parameters except flow rate of 2.0 ml/min being
held constant.
The attenuation setting affected the full scale deflection
of the pen across the width of the chromatographic paper.
Values of 1 (default), 2, 4, 8, 16, etc. were programmed
into the data module and the attenuation value altered
according to the individual serum sample. In this work,
attenuation values less than 16 caused extensive baseline·
noise and were not used. In the developmental stages of the
antibody purification, attenuations of 32 and 64 were used,
with a setting of 128 allowing all the serum protein signal
to be displayed. Figures 4.26., 4.27. and 4.28. illustrate
attenuation settings of 32, 64 and 128, respectively for
the same serum sample with the Tris/HCI buffer loading for
2 minutes and the glycine/Hel desorbing the IgG fraction
for a sUbsequent 18 minutes. In these figures PT = 3000 and
PW = 30 were used, as well as a loop volume of 100 ~l.
It must be stressed, however, that the parameters used in
this work are specific for the serum sample under
investigation. They do give an indication, though, of the
nature of the parameters which are applicable to
purification work of this type, and the way in which they





























Figure 4.30. HPLC chromatogram illustrating optimum
separation of the IgG fraction from the serum
proteins and other immunoglobulins with loop
.."., .
volume = 100 )..1.1, 'attenuation = 32, peak
threshold = 3000 and peak width = 40.
4.2.3.9
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Collection of IgG Fractions
Despite the fact that only two peaks are evident on the
c hr oma t og r ams , a series of runs with commercial rabbit IgG
were performed to confirm the retention time and presence
of the IgG fraction. As outlined in section 4.2.3.1, rabbit
IgG was weighed out and dissolved in PBS buffer.
Confirmation was performed by injecting the commercial IgG
fraction in PBS onto the Memsep c~rtridge and noting the
rete'ntion time. This IgG sample was collected and re-
injected under identical operating conditions and the -
retention time noted. A serum sample was also spiked with
commercial IgG and the increase in absorbance of the IgG
peak at the relevant retention time noted.
However, fraction collection was only performed when the
waste line, originally 1 metre long, was replaced with a 3
to 4 cm length of 40" tUbing connected to the outlet of the
analytical detection cell. Thus, as the increase in
absorption at 280 nm was registered on the detector, the
sample was simultaneously collected until the absorbance of
the detector dropped back to zero.
For a 0.96 mg/ml rabbit IgG sample injected using a 100 ~l
loop and attenuation of 32, a serum component at 1.12
minutes is evident in Figure 4.31. This 7% contamination
can be attributed to the serum protein present in the
prepared sample, or contamination of the rheodyne loop
itself. The sample was collected between 14.2 minutes and
25.2 minutes. At a 1.5 ml/min flow rate, 17.5 ml of sample
was collected, effectively diluting the IgG to 0.00547
mg/ml. This concentration of IgG was not detectable on the
HPLC even at low attenuation values of the data module.
Hence, a more concentrated IgG solution of 2.42.mg/ml was
prepared, injected onto the Memsep and the fraction between
11.90 minutes and 21.90 .mi nut e s was collected. The
concentration of the IgG was effectively reduced to 0.016
151
Figure 4.31. HPLC chromatogram illustrating a
0.96 mg/ml commercial rabbit IgG sample passed
through the Memsep cartridge under optimum
operating conditions.
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mg/ml. This sample was re-injected at a series of
attenuation settings (16, 32 and 64). Because the sample
was diluted, spreading of the peak was evident on the
chromatogram, but the retention time remained constant in
all cases that were tested (Figure 4.32.). This suggested
that the second peak was indeed IgG . This was corroborated
by spiking a serum sample with commercial IgG and noting
the increase in peak area at the same retention time. An
additional confirmatory test was attempted. The UV
absorbance of the diluted IgG against a Tris/HCI blank was
measured. However, because of the extremely dilute IgG
sample, no UV absorbance was noted.
The final section provides some comments
interpretation of the chromatogram.
4.2.3.10 Interpretation of HPLC Chromatogram
on the
using anion-exchange chromatography and carefully
controlled gradients, Gemski et al. (157) identified
transferrin and albumin as those serum proteins present in
a sample of tissue culture fluid. It is likely that these
same contaminants are present in mammalian serum samples.
Seeing that a single peak (or shoulder and a peak) is
evident in the chromatograms in this work, and because the
Tris/HCI buffer was used without a concentration gradient,
it is likely that the serum components plus any IgE, IgA,
or IgM immunoglobulins co-elute. This postulate could have
been tested by spiking a serum sample with the relevant
serum protein ·-,,. or immunoglobulin. However, these
biochemicals are prohibitively expensive and confirmation
of their presence served no purpose in this work. However,
Ey, Prowse and Jenkin(158) do confirm that IgM, IgA and IgE
antibodies do not show significant binding to a Protein A
column and can be collected ,with other serum proteins in
the effluent.
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Figure 4.32. HPLC chromatogram confirming the retention
time of rabbit IgG at 17 minutes.
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Chapter 5 now discusses the immunoassay protocol that was
chosen in this work to detect and quantitate thymine dimers






This chapter describes the choice and development of an
immunoblotting protocol for the detection and quantitation
of thymine dimer in UV-irradiated DNA. This section (5.1)
provides a brief introduction to the immunoblotting
protocol chosen in this work for the detection of UV-DNA
antigen and antibodies generated against it. First t.he
discussion will focus on a description of the technique,
then a review of thymine dimer detection techniques using
immunoblotting will be given.
5.1.1 DESCRIPTION OF THE IMMUNOBLOTTING DETECTION
PROTOCOL
Immunoblotting is a general term used to describe a
powerful molecular technique for the identification of
specif ic antigens. Use is made of affinity interactions
between an antigen and an antibody generated in response to
the antigen. These interactions take place when the
antigen, which has been immobilized on a membrane, is
exposed to the antibody. Measurement of the subsequent
binding of the antibody to the antigen allows quantitation
of the membrane bound antigen to be made. The aim of the
immunoblotting protocol developed in this work was the
quantitation of thymine dimer lesions in ·u l t r a v i o l e t -
irradiated DNA. After being transferred to the membrane by
"dot blotting", the UV-irradiated DNA was immobilized
there. Antibodies generated against the UV-DNA antigen were
then added. The antibodies bound to the antigen located on
the membrane surface and the degree of binding (and hence
antigen concentration) were quantified. A more detailed
description follows.
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Immunoblotting was first described by E.M. Southern (83) in
1975 for the detection of particular sequences of single
stranded DNA in a mixture of DNA fragments and has become
known as "Southern Blotting". When used in molecular
biology applications, Southern Blotting involves the
following protocol. Restriction enzymes are used to
recognise a specific nucleotide sequence within the DNA and
then to cleave both strands of the DNA at the location of
that sequence. The restriction-enzyme digested DNA is then
fractionated by electrophoresis within an agarose gel
medium. The next step is the transferral of the separated
fragments to a suitable support membrane by means of a
"blotting" procedure. Once transferred, the DNA must be
fixed on the suppport medium. In the original Southern
Blotting protocol, this is accomplished by baking the
membrane for several hours in a warm oven, after which a
protocol may be followed to allow for the addition of
antibody specific for the sequence of interest, and for the
assessment of the degree of antibody binding. This
subsequently allows the concentration of the DNA sequence
to be measured.
An obvious extension of this idea has been the development
of a technique for the identification of specific RNA
sequences within a population of RNA molecules. This
technique has been named "Northern Blotting". Similarly, a
technique for the identification of proteins and other
biomolecules (e. g. DNA components) has become known as
"Western Blotting".
An immunoassay can be described as a technique or protocol
allowing for the identification or quantitation of
antibodies. For the development of an immunoassay to detect
thymine dimers in UV-irradiated DNA, the specific
immunoassay technique called "Western Blotting" or simply
"Immunoblotting" was adapted. to allow the spotting of the
antigen directly onto a membrane (using a micropipette)
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rather than to transfer it electrophoretically from a gel.
Once the antigen was spotted on the membrane, all remaining
sites on the membrane (i.e. those which have not been
covered with the antigen) are blocked using a suitable
reagent (~.g. 2% dried milk powder). The membrane is then
incubated or immersed in the crude serum containing the
antibodies and after washing with a detergent (e.g. 0.1%
Tween-20), the membrane (which now holds bound
antigen/antibody complexes) is incubated with a secondary
antibody conjugated to an enzyme system. The secondary
antibody/enzyme complex binds to the antigen/antibody
complex.
As will be discussed later in this work (Section 5.2.2),
the enzyme is chosen to catalyse a light reaction. The
intensity of the light emitted is then used to quantitate
the antibody and antigen systems used in this work. The
immobilization of all components on the membrane surface is
illustrated in Figure 5.1.
For the purpose of this work, the manufacturer's protocol
as supplied by Amersham, was used for the development of an
immunoblotting technique (Section 5.2.1.7). The procedure
used by Amersham is a very general one, and had to be
tailored to the specific requirements of quantitating
thymine dimers in UV-irradiated DNA.
The following section is
techniques which have been
develop an immunoassay
quantitation.
a review of immunoblotting
used by previous workers to
method for thymine dimer
5.1.2 REVIEW OF THYMINE DIMER DETECTION TECHNIQUES
USING IMMUNOBLOTTING
This section seeks to survey ,pr e v i ous work which quantified
pyrimidine dimers by means of immunoassay. As was outlined
.
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Figure Sol. Schematic representation of the immobilization
of antigen, antibody and secondary antibody on
















above, immunoassay is the general term for any technique
which quantitates antibody by the detection techniques of
radioimmunoassay, fluorescence detection
(immunofluorescence) or ELISA. Because an immuno technique
can be used for detection and quantitation, detection only
(as in this work) or quantitation only, some of the
discussion which is to .t o l l.ow serves to strengthen and .
extend the comments and observations made in section 1.2.
In this section (5.1.2), the discussion will first centre
around a review of the immuno techniques that were used to
quantitate thymine dimers generated in UV-irradiated DNA
systems. Then the discussion will extend to previous work
performed to quantitate thymine dimer specifically by means
of immunoblotting; that is, blotting of the UV-DNA antigen
onto a membrane surface followed by incubation of the blot
with antibody. Subsequent detection and quantitation using
one of several techniques (scintillation counting or
fluorescence tagging) is then performed.
The development of immunoassays for the detection of
modified nucleic acid components began more than 20 years
ago with the demonstration that these compounds are
antigenic under certain conditions(66,67,68,78,132). since
that time, a wide variety of antibodies have been produced
that are specific for DNA components modified by many
different carcinogens, both chemical and physical in
nature(70) .
Several immunoassay methodologies have been used for the
detection of modified nucleic acid components including
pyrimidine dimers generated in irradiated cellular DNA. For
instance, Tan and Stoughton (159) demonstrated the existence
of UV-induced lesions in DNA in cell nuclei of irradiated
' t i s s u e sections (and human skin) by using light microscopy
to observe antibodies labelled with a fluorescent tag.
These immunofluorescent techniques are not SUfficiently
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sensitive to easily reveal lesions induced by low fluences
of radiation (less than 10 J/m2) and, in addition, require
some fairly sophisticated fluorescence measurement
instrumentation. As an alternative, radiolabelling of the
antibodies (3H or 125I) can be used (radioimmunoassay).
Seaman et al. (74) sucesssfully used this technique as a
means of detection of thymine dimer removal in bacterial
and mammalian cells. Cornelis et al.(72) used 1251 labelled
antibody directed against UV-irradiated DNA to measure
pyrimidine dimers in situ.
One technique which does not rely on radiolabelled DNA or
fluorescence tagging of the antigen is the Enzyme Linked
Immunosorbent Assay (ELISA). This technique has been used
for detection of pyrimidine dimers in DNA and is similar to
immunoblotting in that the antigen, antibody and secondary
antibody conjugated to an enzyme are immobilized on a
support medium. The support medium is a 96 well plastic
EL1SA plate, and it is the well which provides the surface
of attachment for the immune complex. When a substrate
(e.g. 5-amino-2-hydroxybenzoic acid) is added to the
complex, the enzyme catalyses the conversion of the
substrate to a chromogenic reaction product. Quantitating
the colour intensity produced during the course of the
reaction allows the bound antibody, and hence the bound
antigen, to be quantitated.
A "mi c r oEL1SA technique was successfully implemented by
Leipold and co-workers (82) for the quantitation of
photolesions using UV-irradiated DNA coupled to the wells
of an EL1SA plate. Lesions induced by UV irradiation doses
as low as 2.5 J/m2 were detected using 8 ~g of sample.
Work has been performed in this laboratory on the
quantitation of thymine dimers in aqueous thymine and in in
vitro DNA systems. The de~elopment of an immunoassay
technique in these laboratories is designed to extend this
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work to quantitation of thymine dimers in cellular systems
of DV-irradiated DNA. Here, the cells are to be irradiated,
the DNA extracted and the thymine dimers quantitated using
an immunoassay. (The HPLC techniques used for the in vitro
studies are too insensitive for the quantities of DNA
involved.) Because of the hazards of using radioactive
material in the laboratory, and because of the longer
shelf-life of non-isotopic labels, the radioimmunoassay
technique for thymine dimer quantitation was not chosen.
Fluorescence tagging is not strictly a quantitative
technique (160) , and would not yield the levels of
sensitivity required in this work.
However, immunoblotting, does offer an appropriate method.
Recently, an immunoblotting technique was described by
Nehls et al. (84) for the quantitation of carcinogen-modified
nucleosides in DNA. Femtomole to picomole amounts of these
nucleosides were detected using a radioimmunoassay method
of quantitation. Nehls et al.(84) propose that this method
yields significantly lower detection limits than the
radioimmunoassay (used for detection) which was also
performed on these modified nucleosides. Comparable
sensitivity to immunoblotting can be achieved using an
ELISA, but reproducibility is often a problem, partly due
to variations in absorption of the antigen onto the wells
of the plastic ELISA plate. The membrane system used by
Nehls et al.(84) appeared to provide a reliable support for
immobilization of DNA.
Plaza and co-workers(~61) in 1991 used an immunoblotting
protocol to demonstrate repair kinetics of DV-DNA damage
using an antigen specific for pyrimidine dimers as well as
the other photolesion, the 6-4 photoproduct. Wani et
al.(162) used an immunoblotting technique for detection of
pyrimidine dimers in non-labelled skin fibroblasts and calf
thymus DNA irradiated at sU~-lethal (0.5 Jjm2) doses of DV.
The observation that this technique could detect thymine
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dimers generated at sub-lethal DV fluences, added weight in
support of choosing immunoblotting as the technique for
quantitation of thymine dimers in DV-irradiated DNA.
The following section describes the development of a
"tailored" protocol for this work, from the choice of
reagents and equipment to the development of a technique
which delivered reproducible results. Firs~, the choice of
immobilizing membrane will be discussed, followed by the
choice of diluent buffer. Thereafter will follow a
discussion concerning the choice of detergent 'wash solution
that was chosen for use, as well as the choice of blocking
reagent. The choice of secondary antibody will also be
discussed, together with the equipment that was chosen for
use in this work. Once the choice of reagents and equipment
have been discussed, this chapter will extend to the
development of the immunoassay protocol for thymine dimer




A PROTOCOL FOR ANTIBODY
This section seeks to discuss the choice of reagents
(Section 5.2.1.1 to section 5.2.1.5) and equipment (Section
5.2.1.6) used in this work. Thereafter the development of
a protocol for antibody detection will be discussed in
terms of the chosen reagents and equipment.
5.2.1.1 Choice of Membrane
Immunoblotting protocols require a support medium upon
which all antibody/antigen interactions take place. A
membrane system is most commonly adopted, although
absorption onto polystyrene can also be used. The
advantages of using a membrane system include accessibility
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of the antigen to the appropriate antibody, shorter
reaction times for reagent immobilization and economy of
reagents. These advantages led to the use of a membrane
system being favoured as the immunoblotting matrix.
Numerous membranes are commercially available, with
nitrocellulose being the most widely used material(163).
originally nitrocellulose membranes were used for the
microfiltration of bacteria but they are now also used for
immunoblotting. In this latter application the antigen and
antibody are adsorbed throughout the matrix predominantly
by chemical interaction. Binding by chemical interaction is
important in enhancing the attachment of the immune complex
to the membrane and facilitating its detection on the
luminescence film once the chemiluminescence detection
protocol has been followed (Section 5.2.2.3). During the
development of the immunoblotting technique in the 1980's,
many of the antigens which were used for blotting purposes
were proteins. It was found that proteins, and especially
those of low molecular weight, bound to nitrocellulose with
low affinities and were lost during subsequent .
processing(163). This had the obvious disadvantage of not
allowing the immune complex to be visualized on the
luminescence film during detection.
Because of this problem of low affinity binding of the
proteinaceous antigen to the nitrocellulose membrane,
alternative matrices for protein blotting were developed.
Diazobenzyloxymethyl-modified cellulose paper has been
used (164), but had the problem of loss of antigen sample
when the antigen is transferred from the agarose gel to a
modified cellulose support medium. To overcome this
problem, other membraneS have been developed and include
diazophenylether paper(16S) as well as nylon based
membranes. These latter two membranes contain positively
charged diazonium or tertiary amino groups introduced
during the manufacturing proqess. This ensures less antigen
loss because of an enhanced binding capacity of the antigen
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to the membrane. This, in turn, increases the sensitivity
capacity of the immunoblotting technique because of
electrostatic interactions between the membrane and
polyanions in the antigen. This observation is supported by
Gershoni and Palade (163) who determined the binding capacity
of the commercially available charge modified membrane,
Zetabind. Their work indicated that this membrane has a
binding capacity for proteins of 480 ~g/cm2, in comparison
with unmodified membranes which have binding capacities of
approximately 80 ~g/cm2.
In this work, in order to ensure all thymine dimer
containing DNA antigen was bound to the membrane, a charge
modified membrane was chosen for immunoassay development.
The membrane chosen (polyvinylidene difluoride, PVDF) has
specific applications to binding nucleic acids or nucleic
acid components and is commercially available as Immobilon-
N, a high strength and durable charge modified membrane.
The membrane exhibits high DNA binding which may be
attributed to the combination of the charge modified
surface and the chemical nature of the PVDF. Ionic
interactions (and hence binding) between the membrane and
the polyanions of the phosphate backbone of DNA are
enhanced by means of the charge modified membrane surface,
while the fluorocarbon backbone of the PVDF membrane
contributes to hydrophobic interactions between the
membrane and the nucleotide bases. These characteristics
also help retain blocking agents added at a later stage of
the protocol. This last-mentioned aspect ensures that
binding of a non-specific macromolecule to the membrane
itself does not occur, thereby facilitating detection of
the immune complex against a clear background. Other
advantageous features of the PVDF membrane include its
hydrophobic nature, implying that it is compatible with
acids and is highly resistant to organic solvents. This
allows vigorous washing routines which also remove non-.
specific protein molecules that may bind to the membrane
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itself.
According to Millipore, Immobilon-N was also compared to
three other commmercially available membranes in a Southern
Blotting test protocol. A nitrocellulose membrane (BA-a5),
a nylon membrane (Hybond), a charge-modified nylon membrane
(Genescreen) and Immobilon-N were sUbject to blotting of
three dilutions of Lambda DNA. The Immobilon-N charge
modified PVDF membrane showed the highest sensitivity of
all membranes for detecting low concentrations of DNA (0.01
J.Lg DNA). At the highest loading of 0.20 J.Lg DNA, the '
Immobilon-N showed a more intense signal when detected by
radioimmunoassay. Thus the Immobilon-N was shown to be the
most effective of the membranes tested for nucleic acid
binding.
5.2.1.2 Choice of Diluent
An immunoblotting protocol requires extensive washing of
the membranes at each stage of the protocol, in order to
remove extraneous solution that might enhance, instead of
reduce, non-specific binding of biomolecules to the
membrane. Usually a detergent that is dissolved i n a
diluent buffer is used to achieve this. The crude ser um
samples and secondary antibody are also diluted using this
same buffer. As discussed in section 2. a. 2 .5, all DNA
samples were prepared in 0.15 M phosphate buffered saline,
pH 7.4 (PBS) in order to reproduce physiological
conditions. As a diluent in the immunoblotting protocol,
the manufacturer (Amersham) suggested the use of tris
buffered saline, pH 7.6 or phosphate buffered saline, pH
7.4. Because PBS was already being used as a buffer in the
DNA work, it was decided to simplify solution preparation
by using PBS for immunoblotting as well.
Solutions of PBS were prepared by weighing a g of NaCI,
0.12 g of KH2P04 , 0.20 g of KCI and 0.91 g of Na2HP04 •
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Analytical grade reagents were used in all cases. This gave
a 0.15 M PBS solution. The salts were dissolved in a small
volume (100 ml) of Milli-Q water in a beaker and then made
up to 1 litre in a vOlumetric flask. The pH of the buffer
was measured using a Jenko portable pH meter calibrated
against UniVAR pH 7.0 and pH 4.0 buffer solutions. The pH
of the buffer solution was between 7.3 and 7.4 in all
cases. The PBS was stored in the refrigerator and was
vacuum filtered prior to 'u s e in order to remove any
particulate matter.
5.2.1.3 Choice of Detergent Wash Solution
In order to wash the membranes, the manufacturer (Amersham)
suggested the use of 3% Tween-20. (As discussed above, the
Tween-20 was dissolved in PBS.) Fonong et al.(166) also used
this solution when detecting autoantibodies in human serum.
Leipold et al.(82) suggested the use of 0.05% Tween-20 in
PBS, and Thomas et al.(167) used 0.1% Tween-20 in PBS. A
0.05% Tween-20 in PBS was also used by Mizuno et al.(168) in
an ELISA protocol that established a monoclonal antibody
which recognized cyclobutane-type thymine dimers in DNA.
Another detergent which has been used on a regular basis
for washing membranes is 0.1% Triton X-lOO (a
polyoxyethylene ether non-ionic detergent) in PBS(84).
The protocol as used by Leipold and co-workers (82) was used
as a sta~ting point in developing an immunoassay, and thus
it was decided to adopt the use of Tween-20. Once a few
minor problems concerning the use of Tween-20 had been
identified (see below), this reagent was used throughout
the developmental and data collection stages.
Analytical Grade Riedel-de-Haen Tween-20
(Polyoxyethylenesorbitan monolaurate, density 1.10 g/cm3 )
was used. Initially a 3% .s o l u t i on in PBS (PBS-T) was
prepared. This was used in a few initial runs, but the
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concentration was excessively high (even though specified
by the manufacturer) and resulted in the antigen/antibody
complex being washed from the membrane before detection.
Amersham did, however, note that high concentrations of
Tween-20 may reduce the binding of antibodies, particularly
low affinity antibodies. A literature search was undertaken
and it was found that far lower concentrations than the 3%
solution of Tween-20 were generally used(82,167).
Concentrations were usually in the 0.05% to 0.1% range.
When a 0.1% PBS-T was used and an immunoblotting protocol
performed, antigen/antibody complexes were not washed from
the membrane and were sucessfully detected on the
luminescence film (Section 5.2.2.3). Hence a 0.1% Tween-20
solution in PBS was used in all washing steps.
Tween-20 is a lumpy, . yellow liquid which could not be
weighed or transferred easily. It was decided to use a
syringe or micropipette to deliver a reproducible volume of
detergent to the PBS buffer. It was usual to prepare 1
litre of solution at a time since this volume was
sufficient for two entire protocols. In order to prepare a
0.1% solution of Tween-20 in PBS (density of Tween-20 =
1.10 g/cm3 , it was necessary to deliver 0.909 ml of Tween-20
to 1 litre of filtered PBS. Initially a micropipette was
used to deliver the 0.909 ml, but because the detergent was
too viscous, it could not be drawn into the narrow pipette
tip. Hence a 2.50 ml graduated plastic syringe was used to
draw up 0.90 ml of Tween-20. By eliminating all air bubbles
in the detergent when drawing up, this was an easy task to
perform. This volume (0.90 ml) was then transferred to a
vOlumetric flask which was then made up to 1 litre with
filtered PBS.
Being viscous, the Tween-20 did not dissolve
instantaneously in the PBS and in order to ensure complete
solvation, the solution was ~onicated for approximately 30
minutes with occasional shaking of the flask by hand.
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The detergent was stored at room temperature and because
only 0.90 ml was required to prepare 1 litre of solution,
an aliquot (50 ml) of the reagent was transferred to a
vial. It was important that a glass vial as opposed to a
plastic vial was used for storage to prevent compounds from
diffusing into the Tween-20 from the plastic and affecting
its detergent functions.
5.2.1.4 Choice of Blocking Reagent
Several reagents have been used by researchers in order to
block sites on the membrane not occupied by
antibody/antigen interactions. Such a step is crucial in
immunoblotting protocols as it serves to reduce non-
specific protein binding (e.g. binding of secondary
antibody directly to the membrane) and hence simplifies
identification of the immune complex against a clear, as
opposed to a darkened background on the luminescence film.
Blocking is most commonly achieved by incubating the blot
in a high concentration of bovine serum albumin, horse
serum albumin , fetal calf serum, haemoglobin, ovalbumin or
gelatin. Hawkes et al. (169) suggests the use of 3% (w/v)
bovine serum albumin and 1% (v/v) normal goat serum in tris
buffered saline. More common is the use of a dried milk
solution dissolved in the PBS-Tween wash solution. Such a
reagent has been used by Nehls (84) , Fonong (166) and
Thomas(167) as well as being specified by the manufacturer
of the immunoblotting reagents and equipment (Amersham).
The type of low fat milk powder is apparently not crucial
and Farmer's Pride low fat milk powder was bought from a
supermarket and stored in a dessicator. Initially a 5%
solution was prepared by weighing out 25 g of milk powder.
This was dissolved in 200 ml of PBS-T on a magnetic stirrer
and then made up to 500 ml in a volumetric flask. The
solution was then stored in a refrigerator until required.
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After a few runs had been performed, it was decided to
reduce the concentration to 2% dried milk in PBS-T. Seeing
that similar background levels were visually observed on
the luminescence film when compared to 5% dried milk
blocking solution, it was decided to use this lower
concentration in all subsequent protocols. The solution was
stored as outlined above. When a working protocol was being
used regularly, it was found that the dried milk dissolved
in solution began to coagulate after a 3 to 4 week period.
The solution thus had to be discarded and prepared fresh
monthly.
It was usual for several membranes to be treated together
when the protocol was being performed. Usually 6 to 9
membranes could be accommodated on the modified ELISA plate
when blotting the membranes (Section 5.2.1.7.2), and in the
plastic box when washing the membranes (Sections 5.2.1.7.4,
5.2.1.7.6 and 5.2.1.7.8). If 6 to 9 membranes were
processed together during an immunoblotting protocol, it
was found that 20 ml of 2% dried milk in PBS-T gave
sufficiently low background results. This will, however, be
discussed in more detail in section 5.2.1.7.3.
5.2.1.5 Choice of Secondary Antibody
In order to detect the antigen/antibody complex immobilized
on the membrane, a suitable visualization system had to be
employed. It was decided to add a second rabbit antibody to
the antigen/antibody complex on the membrane. Under
incubating conditions this would bind to the immobilized
complex. Binding between the two antibodies will take place
because both are rabbit antibodies and hence have similar
antigenic determinants and binding domains.
For immunoassay purposes this secondary antibody has the
added feature of itself bei.nq conjugated to an enzyme
(horseradish peroxidase), which in the presence of a
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suitable substrate (luminol), will catalyse the conversion
of luminol to the aminophthalate dianion and light of 425
nm will be emitted in the process. The emitted light
intensity is proportional to the amount of horseradish
peroxidase bound to the membrane which in turn is
proportional to the amount of secondary antibody bound to
primary antibody, and this is proportional to the amount of
antigen bound directly to the membrane. Thus the emitted
light intensity can be used to quantitate the antigen bound
to the membrane. When a luminescence film is imposed on the
membrane and luminol added to the complex, the light
emitted impinges on the film. The film can then be
developed and printed using standard photographic
procedures to allow the intensity of the emitted light to
be measured.
Such a technique of conjugating an antibody to an enzyme is
used extensively in immunocytochemistry for the
intracellular localization of antigens at the
ultrastructural level(170). The antibody/enzyme complex is
incorporated into a cell or cellular system and binds to
the selected antigen. When the substrate is added, light
emission or an absorption producing chromogenic reaction,
allows the localization of the antigen using electron
microscopy.
Several antibody-enzyme systems are commercially available
for the application required in this protocol. The
horseradish peroxidase (HRP) system is widely used in
immunoassay applications, especially immunoblotting and
ELISA. In this application, suitable substrates for the
enzyme must yield an insoluble coloured product on
reaction. The intensity of the colour is then correlated to
the concentration of analyte. The most popular of these
substrates are diaminobenzidine, 4-chloro-1-naphthol and 3-
amino-9-ethylcarbazole. A rabbit antibody (IgG) /HRP was
chosen by Leipold et al.(82) for the quantitation of
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photolesions in UV-DNA using an ELISA technique. It was
also specified by Wani et al.(162) for the characterization
of DNA damage induced by DV fluences as low as 2.5 J/m2 in
an ELISA application. HRP conjugated antibodies were also
used for immunoblotting detection of antibodies developed
against synaptosomal plasma membranes from rat brain(169).
Horseradish peroxidase is a low molecular weight (40 000 d)
glycoprotein enzyme which also has applications as a marker
in immunohistochemistry when coupled to immunoglobulin
G(171). Because of its small size it has superior
penetration properties of cells and cellular systems when
compared to other histochemical markers such as ferritin
and fluorescein (170) .
The antibody-enzyme system was supplied by Amersham as
"Anti-rabbit Ig, peroxidase-linked species-specific whole
antibody (from donkey)". The antibody was prepared by
immunizing donkeys with purified immunoglobulin fractions
from normal rabbit serum. This served to produce high
affinity rabbit antibodies. However, to remove cross
reacting antibodies towards human, rat and mouse
immunoglobulins, the pooled serum was adsorbed using an
affinity column packed with cross reacting human, rat and
mouse antigens. Finally, to select for specific binding to
rabbit immunoglobulins, the antibodies were purified using
a specific affinity column containing rabbit serum and the
required antibodies were eluted from the column using
selected mild conditions which minimized aggregation and
preserved immunologic activity of the antibodies. Mild
conditions are important because immuno~ogic functions may
well be lost under harsh acid/base denaturing conditions.
Horseradish peroxidase (type VI from Sigma Chemical
Company) was bound (by Amersham) to the purified
immunoglobulin molecules using an adaptation of the
periodate oxidation technique as proposed by Nakane and
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Kawaoi(170). Briefly, this involved the oxidation of HRP
with sodium periodate in order to form aldehyde groups on
the glycoprotein moeity of the enzyme. Addition of
fluorodinitrobenzene blocked free a- and €-amino groups and
hydroxide groups on the enzyme. This prevented self-
coupling and allowed the HRP-aldehyde to form Schiff bases
with any protein (e.g. rabbit immunoglobulin) having a- or
€-amino groups. Such a coupling reaction has been found to
be almost 100% efficient, since the conditions had been
selected to minimize loss of enzymic activity of the HRP
and immunologic activity of the antibody.
The antibody-enzyme system was supplied by Amersham in
phosphate buffered saline, pH 7.5 containing bovine serum
albumin (1% w/v) and an anti-microbial agent because the
HRP-antibody system is sUbject to bacterial contamination
if not used under sterile conditions. The product was
stored in a refrigerator and according to Amersham was
stable for 12 months under these conditions.
In section 5.2.1.7.7 the working dilutions and incubation
times chosen for the secondary antibody and for binding of
the secondary antibody to the membrane bound
antigen/antibody will be discussed in detail. In the
following section, the choice of equipment used in the
immunoassay will be discussed.
5.2.1.6 Choice of Equipment
As mentioned in Section 5.2.1.1, dot-blotting of the
antigen onto the Immobilon-N membrane was performed
manually using a micropipette set to deliver a specific
volume of antigen to the membrane surface. However, all
sUbsequent processing stages (interaction of the antigen
with crude serum or secondary antibody on the membrane
surface, as well as washing . of the membranes) occurred by
means of incubation of the membrane with the relevant
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reagent.
One of the problems in immunodetection of blots is
achieving an even coverage of the membranes with the
various incubating solutions. The use of excessive volumes
of expensive antibodies and detection solutions is also
avoided.
Methods which have been most commonly used for processing
(i.e. incubation and washing) of membranes include trays,
plastic bags and boxes. The membrane remains flat within
the box or tray and large volumes of reagents are used to
totally cover the membrane. Reagent volumes can be reduced
if plastic bags containing only a thin film of liquid are
used. This method was adopted by Plaza et al.(161), but led
to patchy results because of erratic reagent flow over the
membranes themselves. Processing using plastic bags also
has problems of leakage and contamination if radioactive
reagents are used (167). Other workers (172) used plastic tubes
to process thin strips of membrane by rolling the tubes in
detection reagent. The technique of using tubes has led to
the development by Thomas(167) of a rolling drum system.
Here, minimal volumes of reagents are used and all washing
steps are carried out without handling the membranes
themselves.
This se,emed to be the best technique available and a
shaking waterbath with a thermostat control was adapted to
utilize its shaking motion to provide the "rolling motion"
as used by Thomas. Such a technique was been succesfully
implemented by Wani et al. (162) for the quantitation of
pyrimidine dimers generated using sub-lethal doses of UV-
irradiation on human cells.
In order to avoid the use of plastic bags or trays, all
incubation procedures were carried out in 12 ml Polytop
(number 3) glass vials (shown in Figure 5.2.). It was
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Figure 5.2. Glass vial in which incubation of antibody, and
later secondary antibody, with the Immobilon-N
membrane was performed.
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important to ensure that the lid of each vial sealed well,
to prevent loss' of incubating solution. Several vials
(containing a single membrane each) were then placed in a
plastic lunchbox. The lunchbox was then sealed and placed
on the shaking waterbath for the required period of
incubation.
since this type of processing is dynamic, the membrane
moves constantly throughout the reagent solution. This
ensures that no localised depletion of reagent occurs,
making the incubation very thorough and efficient. This
results directly in increased binding of the immune complex
to the membrane and hence ensures maximum light emission
during detection. There is also no risk of uneven
detection, and scratching or tearing of the membrane cannot
take place during immunodetection.
This rolling drum technique was used successfully in the
immunoassay protocol which is to be described in the
following section.
5.2.1.7 Development and Use of a Working Protocol for
Thymine Dimer Detection in UV-Irradiated DNA
The previous section described the choice of reagents and
equipment used in the development of an immunoassay
protocol for the identification of thymine dimers in uv-
irradiated DNA. It also gave an indication of the reagent
concentrations used in preparing solutions. This section
now describes the specific nature of the protocol used in
detecting and quantitating thymine dimers in UV-irradiated
DNA.
5.2.1.7.1 Membrane cutting and Wetting
As mentioned in Section 5.2 ~1.1, an Immobilon-N transfer
membrane was chosen for the immunoblotting protocol because
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its charge modified surface preferentially binds nucleic
acids or nucleic acid components. It was supplied as 18 x
24 cm2 sheets which were cut to the required size. This was
best done using a ruler and pencil to mark 4 x 1 cm2
sheets. These were cut using scissors and subsequently
handled using a pair of fine tweezers. Such a precaution
was imperative to prevent fingerprints o~~cur ing any
antigen/antibody blots on the luminescence film. After
cutting, each membrane was labelled with a number or letter
in the top left hand corner using a pencil. This served to
identify each membrane during the processing -and analysis
stages.
Usually 9 membranes were transferred to a plastic box (10
x 8 x 6 cm3 ) and pre-wetted. For this approximately 20 ml
of 100% methanol was added to the box using a 20 ml beaker,
and the membranes immersed for a maximum of 5 seconds. Pre-
wetting could also have been achieved by immersing the
membranes in 70% ethanol or 50% isopropanol. The membranes
wet immediately in 100% methanol and changed colour from an
opaque white to a uniform translucent grey. The methanol
was decanted, and approximately 20 ml of Milli-Q water was
added to the membranes in the plastic box using a 20 ml
beaker. Immersion in water for 1 to 2 minutes served to
flush away excess alcohol and it was important to submerge
the membranes completely ( they had a tendency to float) in
order to effect complete alcohol to water exchange. The
Milli-Q ~ater was decanted from the box and approximately
20 ml of transfer buffer (PBS) was added using a 20 ml
beaker. The membranes were allowed to equilibrate for 15 to
30 minutes in the PBS solution prior to blotting. If the
membranes dried out at any stage of the immunoblotting
protocol, -i t was important for the wetting protocol to be
followed through again from the beginning.
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5.2.1.7.2 Blotting of the UV-DNA Antigen
As mentioned in section 5.1.1, Western Blotting generally
refers to the electrophoretic separation of proteins or
nucleic acid components on agarose gels, and the subsequent
transfer of the component to an immobilizing matrix. In
this work, the UV-DNA was transferred manually from a
sample vial to the membrane surface using a micropipette.
This is known as immunoblotting.
In this work, the membranes themselves could not be
transferred from the PBS solution to an open benchtop prior
to the blotting of the antigen because once blotted, the
membranes adhered to the benchtop and fast transfer to the
blocking solution was not possible. It was also important
to see where the clear solution containing the UV-DNA was
spotted, in order to prevent blotting of antigen more than
once on the same location of the membrane. For these
reasons, several methods of blotting were tried before a
final one was adopted.
Initially the membranes were transferred to a piece of
precut perspex which allowed 6 to 9 membranes to be laid
out on top of the perspex and hence blotted together.
Underneath the perspex a piece of card with the outline of
equally spaced circles was placed. This allowed equally
spaced blots to be blotted. When the antigen was blotted
and the membranes allowed to dry, the membranes themselves
became very dry (without the blots drying). This was
unsatisfactory because it led to patchiness of the blot
when visualised on the luminescence film. Thus a new
technique had to be developed.
ELISA plates offer an alternative means of blotting. The
plate have a 12 x 8 well configuration (see Figure 5.3a.).
Four adjacent wells were overlaid with a single membrane,
which .was positioned over the wells with tweezers. Because
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Figure 5.3a. An ELISA plate (96 well configuration).
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Figure 5.3b. An ELISA plate overlaid with pre-cut
Immobilon-N membranes and blotted with the uv-
DNA antigen. ..
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the membranes were now exposed to air on both surfaces, the
blots should have been able to dry more efficiently in
comparison with drying on a perspex plate. The ELISA plate
also helped in locating where antigen had been spotted (see
Figure 5.3b). Although the ELISA plate was an improvement
over blotting on perspex, the blots still took too long to
dry (approximately 30 minutes). More efficient air flow
across the membranes was required, and this was achieved by
removing the base of each flat bottomed well and placing
the ELISA plate across the top of an open plastic box.
Using this crude t e chnique, each membrane was positioned .
across 4 adjacent open wells of an ELISA plate, and the
blotting performed whi le the ELISA plate was positioned
over the open plastic box. The blots dried within 15
minutes which was insufficient time for the membranes
themselves to dry. If this technique had not worked, it
would have been necessary to attach a vacuum system to the
ELISA plate and forcibly dry the membranes by suction. This
would, of course, have been an extremely harsh means of
drying the blots and could have interfered with the
delicate antigen/antibody interactions on the membrane
surface.
The pre-wetted membranes were thus individually transferred
from the PBS buffer using tweezers. To facilitate easy
evaporation of the PBS buffer from the membrane, each
membrane was shaken manually, holding the membrane with
tweezers. with shaking, the membranes were dry within 30
seconds after transferral. The membranes were then placed
on the modified ELISA plate. The letter or number of each
membrane, located on the top left hand corner of the
membrane, faced upward on the ELISA plate. The ELISA plate
was then placed over an open plastic box ready for blotting
of the DV-DNA antigen.
As was outlined in Section 4,.2.1.3, the DV-DNA antigen was
heat denatured before being complexed to MBSA and Freunds
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Incomplete Adjuvant. This important procedure ensured
strand separation of the individual strands of the DNA
antigen and thus facilitated maximum exposure of the
immunogen (or antigen) to the rabbit antibody producing
cells. Briefly, the denaturation involved heating the UV-
DNA solution (contained in a Durham tube) at 100°C on a PEG
bath for 10 minutes. The sample was then rapidly
transferred to a beaker containing crushed ice for a
further 10 minutes. The latter treatment ensured strand
separation of the double helical DNA after the strands had
been initially separated by heating.
The immunogen used for rabbit immunizations consisted of a
complex mixture of DNA, MBSA, Freunds Adjuvant, some
acetophenone (to ensure photosensitized production of
thymine dimers only) and a small amount (less than 3%) of
associated histone protein dissolved, or partly dissolved,
in PBS. since all these components were injected into the
rabbit, antibodies were produced against all of them,
including the thymine dimer. For the quantitation only the
antigen generated against thymine dimer was relevant, so it
was important to exclude the addition of MBSA and Freunds
Adjuvant to the denatured UV-DNA that was used in the
immunoblotting protocol. The acetophenone was largely
evaporated during denaturation and the histone protein was
at a sUfficiently low concentration to be ignored.
Excluding the addition of MBSA and Freunds Adjuvant thus
reduced the possibility of antibody generated against MBSA
and ,Fr e und s Adjuvant responding to the UV-DNA antigen. As
will be shown in section 6.5, the antibodies produced by
the rabbits against thymine dimer in DNA in this study,
were only 40% specific for thymine dimer.
An important criterion in dot blotting protocols is the
volume of denatured UV-DNA antigen that is blotted manually
onto the membrane surface using a micropipette. The volume
that is chosen, must dry on the membrane surface faster
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than the membrane itself dries. If an excess of antigen is
blotted, factors such as site restriction and
stereochemical constraints might be important when the
antigen containing membrane is incubated with antibody
solutions and the antibody might not be able to interact
with the full complement of antigen presented on the
membrane surface.
A literature search revealed that the majority of
-immunoblot protocols us e d commercial blotting apparatus
(e.g. a 24 well Hybri-slot manifold, as used by Wani et
al. (162)) which dried the blots under a low vacuum. This
technique delivers a constant volume of antigen to the
membrane surface, as well as ensures a constant shape (e.g.
0.5 x 4 mm2) of the blot. This latter feature is important
at the detection stage if luminescence film containing the
the antigen/ antibody complexes is to be quantitated by
densitometric analysis of the blots. Here the intensity or
darkness of the blot on the luminescence film is
proportional to the amount of antigen present on the
membrane (see section 6.3.2).
In this work, a commercial blotting apparatus was
available, but prohibitively expensive. Hence, a Volac 10-
50 ~l micropipette was used to deliver a constant volume of
antigen to the membrane surface. Initially 4 x 10 ~l
aliquots of the heat denatured UV-DNA antigen were
delivered to 4 individual sites in the membrane surface
located over the wells of the modified ELISA plate.
However, this volume of antigen was too large and the
individual antigen blots spread into one another on the
membrane. Hawkes et al.(169) blotted samples as large as 20
~l, and also suggested the use of a Hamilton syringe to
deliver volumes as small as 100 nl of antigen to the
membrane surface. If such a small volume was chosen, the
antigen sample would have to be very concentrated to detect
the blot on the luminescence film. Because the UV-DNA
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antigen used in this work was 1 mgjml or less in
concentration, a volume substantially larger than 100 nl
was used. Hence a volume of 5 ,1..£1 was chosen, and this
volume of antigen was delivered to the membrane surface
using a 2-10 ,1..£1 positive displacement Gilson micropipette.
A protocol was tested using this volume of delivered
antigen. The blots were easily visualized on the
luminescence film, and hence this volume of antigen was
chosen for the immunoblotting protocol.
It was important to keep the micropipette in an upright
position whilst pipetting so that an even coverage of the
membrane was achieved. It was also important not to scratch
the surface of the membrane with the micropipette tip so
that scratch marks did not appear on the luminescence film.
Usually between 12 to 18 membranes were tre ated during a
single protocol, and thus the membranes were transferred
from the PBS solution to each of 2 ELISA plates (6 to 9
membranes per plate). After blotting the membranes, the
blots were allowed to dry by evaporation. By holding the
ELISA plate (containing the blotted membranes) to the
light, it was easy to identify when a blot had dried. When
all blots (usually 3 to 4) on a single membrane had dried,
the membrane was transferred with tweezers to the blocking
solution contained in a plastic box. This was continued
until all membranes from the same ELISA plate had dried,
and eventually each of the two plastic boxes contained
between 6 and 9 membranes each in the blocking solution (2%
dried milk in 0.1% PBS-T).
At this stage, Millipore suggested an additional step in
the protocol which allows for the fixing of the antigen to
the membrane by means of baking or UV-crosslinking. It must
however be kept in mind that the capacity and retention of
nucleic acids on a membrane surface may be affected by the
method used to treat the membrane sUbsequent to blotting
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with the antigen. Fixing the blots by means of baking at
80°C in an oven for 1 to 2 hours was recommended by
Millipore and this has been shown to increase the retention
of nucleic acids on the membrane by 10 to 30%. An
alternative technique which could also be employed involved
the exposure of dried membranes to a UV source (312 nm
transilluminator) for 3 to 5 minutes, after the which the
membranes were re-wet in 100% methanol.
seeing that oven baking the membranes increased an already
lengthy protocol (24 to 26 hours) by an additional 2 hours,
the latter UV crosslinking fixing step was adopted in the
developmental stages of the immunoblotting protocol. This
was performed by exposing the membranes individually to an
HBO light source (as described in section 2.8.1.1) with an
attached 313 nm filter for three minutes. It was found that
the membranes became extremely dry and white after UV-
crosslinking. In addition, it was not a satisfactory
technique to expose the antigen to a further UV dose, since
a small amount of thymine . dimer could well have been
generated during this time. This was especially important
when a comparison of the immunoblotting technique versus
the HPLC technique was performed using the same UV-
irradiated DNA sample for analysis (see section 6.3). When
the final immunoblotting protocol for the detection of
thymine dimer in DNA was established, the technique of UV-
DNA crosslinking was not used to fix the antigen to the
membrane.
5.2.1.7.3 Membrane Blocking with 2.0% Dried Milk in 0.1%
Tween-20 in PBS
As mentioned in Section 5.2.1.4, the blocking solution was
2.0%(w/v) dried milk powder in O.l%(v/v) Tween-20 in PBS.
The blocking solution was stored in the refrigerator, and
when required, the solutio~ was allowed to come to room
temperature. A 20 ml aliquot, as suggested by Thomas(167),
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was transferred to each plastic box using a beaker.
The boxes (containing 6 to 9 membranes each and the 2%
dried milk solution) were sealed using lids, and each box
placed on the shaking waterbath. During all processing
stages (washing and incubation) the boxes were shaken
horizontally at approximately 60 cycles per minute. The
membranes were shaken for one hour during the blocking
stage, as suggested by Amersham. This step served to block
all sites on the membrane (where antigen had not been
bound) with the dried milk solution.
5.2.1.7.4 Membrane Washing
When the blocking was complete, the boxes were removed from
the shaking waterbath and the dried milk solution decanted,
leaving the membranes in the box. A 10 ml aliquot of wash
solution (0.1% PBS-T) was added to each box using a 10 ml
beaker. Any membranes which adhered to the edges of the box
were manouvered to the base of the box, and the boxes
shaken vigorously by hand for 1 minute on a benchtop. This
vigorous wash dislodged any excess blocking solution from
the membrane surface or from the interior of the box. The
wash solution was decanted, and the vigorous washing
routine repeated. After decanting this second wash
solution, another 10 ml aliquot of wash solution was added
to each box, the boxes were sealed, transferred to the
shaking waterbath and washed for 15 minutes.
When this 15 minute wash was complete, the lids of the
boxes were removed, and the wash solution decanted. Any
membranes adhering to the edges of the box were again
manoeuvered to the base of the box and a fresh 10 ml
aliquot of wash solution was added to each box using a 10
ml beaker. The membranes were washed for two successive 5
minute washing routines o~ the shaking waterbath, with
fresh .wash solution added after the first 5 minute wash.
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Hawkes et al. (169) does not suggest a washing step after
blocking. Instead, the blots were incubated in crude serum
before being washed and then blocked a second time. since
a single blocking step produced a satisfactorily low
background in this work, a second blocking stage was
omitted in this work.
The details of washing routines were not specified by the
workers using an immunoblot technique for the quantitation
of modif ied DNA constituents (84,161,162). Hence the washing
routine as specified by Amersham was used.
To summarize the immunoblotting protocol thus far:
Immobilon-N membranes were cut and pre-wet in 100%
methanol, water and PBS. Individual membranes were
transferred to a modified ELISA plate. The membranes were
blotted with 5 ~l aliquots of denatured DV-DNA applied to
the surface of the membrane using a micropipette. The
membranes were blocked with a 2% dried milk in 0.1% PBS-T
solution for 1 hour on a shaking waterbath. The membranes
were then washed by means of:
a) two brief, but vigorous 1 minute washings,
b) one 15 minute wash, and
c) two five minute washes.
After an extensive wash routine which removed excess
blocking solution from the membrane surface, the membrane
had only antigen bound at 3 to 4 locations along its
surface. Hence all other sites on the membrane were blocked
with blocking solution only. This blocking regime ensured
that antibody present in the crude serum would only bind to
antigen, since specific antigenic determinants (largely
thymine dimers) of the antigen would respond to specific
binding sites of the antibody.
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5.2.1.7.5 Incubation with Dilutions of Crude Rabbit Serum
Rabbit blood was obtained while bleeding the rabbit from
the marginal ear vein (see section 4.2.2.4). The blood was
spun down with a centrifuge, thus separating the crude
serum (containing the antibodies) from the red blood cells
which were discarded. Several immunoblotting runs were
performed using the crude serum and because the
antigen/antibody was easily visualised on the luminescence
film during detection, the protocol was performed on the
crude serum without using purified IgG . . An 'a f f i n i t y
chromatography technique was used in this work to purify
the serum (see sections 4.2.3~4 to 4.3.2.10). Only IgG, and
not IgM, was separated from the serum proteins in this
routine. An alternative technique of ammonium sulphate
precipitation of the antibody was also attempted (see
sections 4.2.3.1 to 4.2.3.3). This technique was successful
in purifying antibody in the crude serum, but because of
the associated problems of only being able to purify less
than 500 ~l of serum obtained from a bleed of the rabbit
(Section 6.1.1) crude serum was used for all immunoblotting
protocols.
As outlined in section 4.2.2.4, 1.5 ml aliquots of serum
was stored in Eppendorfs in the freezer. Before the serum
was used it was removed from the freezer and allowed to
reach room temperature.
For this work, quantitation of the antibody against the
antigen was performed using immunoblotting with enhanced
chemiluminescence in order that antibody production as a
function of time could be determined. This would give an
indication when to bleed the rabbit, in order that the
maximum amount of antibody could be obtained for use in any
subsequent analysis stages of the immunoassay protocol. To
this end, the crude serum was diluted (see later) and the
protocol performed using the same antigen concentration and
187
a range of antibody dilutions. The more antibody present in
the serum, the further the serum could be diluted, until
the antibody was at such a low concentration that it could
not bind to the antigen to give detectable blots on the
luminescence film. Thus the more a serum was diluted, the
higher the concentration of antibody present in the serum.
As explained by Fonong et al.(166), the highest dilution of
antibody that yields a visible blot on the luminescence
film defines the end point or titre of that serum. In this
manner, a relationship between antibody production as a
function of time was obtained.
Rabbits were bled at weekly intervals for 4 weeks, followed
by blood being drawn twice at 10 day intervals. It is
likely that antibody production increases as a function of
time, and t o determine the highest antibody titre for an
overall immunization schedule (4 injections and 6 bleeds),
the antibody titre of the serum obtained from bleed 6 was
determined.
The serum was diluted by serial dilution. First, 100 ~l of
serum was removed using a Volac 20-200 ~l micropipette and
transferred to a clean and dry 12 ml glass vial (Number 3
from Polytop). Then 4900 ~ l of the wash solution/diluent
(PBS-T) was added using a Volac 100-1000 ~l micropipette to
give a total volume of 5000 ~l or 5 ml. It was important
that any diluent adhering to the inner walls of the pipette
tip be allowed to run to the exit of the tip, so that the
entire volume could be dispensed. The vial was sealed and
shaken for a few seconds by hand to disperse the serum in
the diluent. Thus a 1:50 dilution of the crude serum was
,-;- :-r ~
prepared. The vial was labelled with the dilution and date
to facilitate identification.
To prevent contamination between successive dilutions, a
new pipette tip was used to withdraw 2500 ~l of the 1:50
dilution. The solution held in the pipette tip was then
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transferred to a clean and dry 12 ml glass vial. A new
pipette tip was then used to add 2500 p,l of the PBS-T
diluent to the second glass vial. The vial was sealed and
shaken as before. Serial dilution of the 1:50 dilution thus
yielded a 1:100 dilution of the second sample.
using this serial dilut ion technique, the following
dilutions were prepared:
Remove 100 p,l "s e r um + 4900 J..LI PBS-T . . · · · · · · 1:50
Remove 2500 J..Ll of above + 2500 J..LI PBS-T · · · · 1:100
Remove 2500 J..LI of above + 2500 J..LI PBS-T · · · · · · 1:200
Remove 2500 J..LI of above + 2500 J..LI PBS-T · · · · · · 1:400
Remove 2500 J..LI of above + 2500 J..LI PBS-T 1:800
Remove 3333 J..LI of above + 1667 J..LI PBS-T · · · 1:1200
Remove 2500 J..Ll of above + 2500 J..LI PST-T · · · 1:2400
Remove 3333 J..LI of above + 1667 J..LI PBS-T · · · · · 1:3600
Remove 3333 J..LI of above + 1667 J..Ll PBS-T · · · 1:5400
Remove 3333 J..Ll of above + 1667 J..LI PBS-T · · · 1:8100
Remove 3333 J..LI of above + 1667 J..LI PBS-T .. . · 1:12150
Remove 3333 J..Ll of above + 1667 J..Ll PBS-T · 1:15187
Remove 3333 J..LI of above + 1667 J..LI PBS-T · · · 1:18984
Once the dilution schedule was complete, the final vial
contained 5000 J..LI of diluted serum. In addition, some vials
contained 2500 J..LI of diluted serum, while others contained
1667 #-£1 of diluted serum. usLnq a fresh pipette tip each
time, a volume of diluted serum was withdrawn from each
vial so that the final volume contained in each vial was
1667 p,l.
Although. the list is not exhaustive in terms of all the
dilutions that were performed, it does provide an
indication of the procedures required in order to determine
the antibody titre of a single serum sample.
As mentioned earlier (S~ction 5.2.1.7.2), 12 to 18
membranes were treated in a single protocol. Seeing that 2
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rabbits received the same immunogen via a subcutaneous or
intramuscular injection route, it was usual to determine
the antibody titre of a particular serum sample (e.g. 5th
bleed) for the subcutaneous rabbit and the intramuscular
rabbit simaltaneously. Thus 6 to 9 membranes were spotted
with the antigen (e.g. 0.5 mg/ml denatured and UV-
irradiated DNA) and then subjected to 6 to 9 dilutions of
the subcutaneous serum antibodies, while the other 6 to 9
membranes were spotted with the same antigen and sUbjected
to 6 to 9 dilutions of the intramuscular serum.
To perform the antibody incubation of the membranes, a
single membrane (4 x -1 cm2 ) was removed from the wash
solution and transferred to a glass vial containing 1667 ~l
of a specific antibody dilution. The dimensions of each
membrane were carefully chosen so that the membrane could
be accommodated within the glass vial. Each membrane was
labelled 1,2,3 or A, B, C, etc. and the surface of the
membrane containing this number and the blotted antigen,
was transferred to the vial in' such a manner that the
antigen containing surface faced the outside of the vial.
This ensured that the antigen bound membrane surface was
always in contact with the diluted serum while lying
horizontally throughout the incubation period. Numbering or
lettering of the membrane was also important so that a
particular membrane could be correlated to a specific
antibody dilution. To this end, a comprehensive list was
compiled of membrane number, antigen concentration spotted
and the corresponding antibody dilutions used in a
particular protocol. This list prove invaluable when
analysing the luminescence film for the cut-off antibody
dilution.
Once the membranes were transferred using tweezers to their
respective glass vials, the vials were transferred to the
same clean and dry p Las t i,c boxes used for blocking and
washing. The two boxes were sealed with lids and then
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transferred to the shaking waterbath .
Initially the membranes were incubated in the antibody
dilutions for an hour, according to Amersham's
instructions. However this period of incubation was far too
short as no blots were detected on the luminescence film.
The protocol was thus tailored to incubate the membranes
overnight for a 14 to 16 hour period. This incubation time
allowed the antibody to bind exclusively with the antigen
on the membrane surface, and the blot was successfully
detected on the luminescence film. Hawkes et al.(169)
suggested a 2 to 4 hour incubation period for dilute
solutions. However an overnight incubation was shown to be
as much as ten times more sensitive in immunoblotting
protocols carried out here. Hence an overnight incubation
period was used in all subsequent protocols.
5.2.1.7.6 Membrane Washing
Once incubation with the crude serum dilutions was
complete, the blots were again washed to remove an excess
of unbound antibody from the membrane surface. This was
performed by removing the plastic boxes from the shaking
waterbath and removing the membranes from the vials. All
membranes incubated with the dilution from the same serum
(e.g. subcutaneous, bleed 5) were transferred to another
plastic box containing 10 ml of wash solution, PBS-T. The
membranes that were incubated in the intramuscular diluted
seru~ were transferred to a second plastic box containing
10 ml of wash solution. As outlined in the previous washing
routine (Section 5.2.1.7.4), the membranes were sUbject to
2 vigorous washes, a single 15 minute wash and two 5 minute
washes.
At the completion of the wash routine, each blot on a
membrane consisted of UV-DNA antigen and antibody directed
against the antigen. Of course, antibodies were produced
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against MBSA and Freunds Adjuvant, and because these
antibodies would share similar, but not the same, antibody
binding sites, they will also have bound randomly to the
DV-DNA antigen.
5.2.1.7.7 Incubation with a Secondary Rabbit Antibody
Conjugated to Horseradish Peroxidase
In order to quantitate the "a nt i ge n / a nt i body complex, the
final stage in the immunoblotting protocol required that a
second antibody conjugated to an enzyme be · bound to the
antigen/antibody complex. As discussed in section 5.2.1.5.,
this antibody enzyme system was supplied by Amersham as
" Anti-rabbit Ig, horseradish peroxidase linked whole AB
(from donkey)". The peroxidase enzyme was chosen because of
its wide application in immunology; it can catalyse
reactions where light is emitted (as in this work), or it
can catalyse the production of a chromogenic reaction
product, especially in ELISA applications (Leipold et
al. (82)). Hawkes et al. (169) also specified HRP-conjugated
antibodies for the detection of monoclonal antibodies and
a range of soluble proteins, nucleic acids, "ba c t e r i a and
viruses.
The antibody/enzyme conjugate was stored in a refrigerator
and was allowed to come to room temperature before use.
Initially a 5 ~l aliquot of the stock conjugate was blotted
onto t.he membrane surface using a 2 to 10 ~l Gilson
micropipette and the membrane allowed to dry. When the
blots were quantitated using enhanced chemiluminescence, no
gradations of blot intensity as a function of antibody
dilutions could be discerned. Hence the protocol was
adapted to allow for incubation of the membranes in diluted
conjugate solutions.
It was important to determi~e the optimum dilution of the
secondary antibody/enzyme system. This would ensure maximum
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binding of the conjugate to the immune complex localized on
the membrane, while simultaneously reducing binding of the
conjugate to the membrane itself. This optimization thus
facilitated quantitation if the immune complex against a
clear background on the luminescence film.
Here, a series of secondary antibody/enzyme dilutions were
prepared in 12 ml glass vials (Number 3 from Polytop). A
1: 100 dilution was prepared by delivering 25 J..£l of the
conjugate to each of 18 giass vials using a 20 to 200 J..£l
Volac micropipette. Each solution was made up to 2500 J..£l by
addition of 2475 J..£l of diluent (PBS-T). The vials were
sealed and the solution shaken to disperse the conjugate.
An entire immunoblotting protocol was performed using this
dilution of conjugate. A 1:500 dilution of conjugate was
prepared by delivering 5 J..£l of the antibody/enzyme to each
of 18 glass vials. The solution was made up to 2500 J..£l by
addition of 2495 J..£l of PBS-T. The vials were sealed and an
immunoblotting protocol · performed. A final secondary
antibody dilution was prepared by delivering 2.5 J..£l of the.
conjugate to each of 18 clean and dry glass vials using a
2 to 10 J..£l Gilson micropipette. This gave a 1:1000 dilution
which was made up to 2500 J..£l in each case by addition of
2497.5 J..£l of PBS-T. The entire immunoblotting protocol was
performed using the same antigen and primary antibody
dilutions , with the 1: 500 and 1: 1000 dilutions of the
secondary antibody.
Once the luminescence films were developed and printed, the
blots on the film were observed to see which secondary
antibody dilution gave the darkest blot on the film against
the lightest background. For this work, the conjugate
diluted 1:500 was chosen and used in all subsequent
immunoblotting protocols. Thus eighteen 1:500 dilutions of
the secondary antibody/enzyme solution were prepared in
glass vials as outlined above for each protocol carried
out.
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To summarize, at this stage of the immunoblotting protocol,
the membranes were blotted with antigen, washed in PBS-T,
incubated in crude serum dilutions and washed again in PBS-
T. Using tweezers, the membranes were individually removed
from the plastic box where they had been washed, and each
transferred to a glass vial containing a diluted secondary
antibody solution. Unlike incubation of the membranes in
the crude serum dilutions where each membrane was incubated
in a different serum dilution, all secondary antibody
dilutions were identical and hence any membrane could be
transferred to any diluted conjugate solution.
The protocol as specified by Amersham allowed for a one
hour incubation period. However once a protocol had been
performed using this incubation period, it was decided to
extend the incubation time to six hours. Because this
longer incubation period allowed more secondary
antibody/ enzyme complex to bind to the antigen/ antibody
complex, the blot was more easily identifiable on the
luminescence film. Hence 6 hours was chosen as the
incubation period for secondary antibody/enzyme for all
subsequent immunoblotting protocols.
Incubation with secondary antibody was performed by
transferring the membranes with tweezers to individual
glass vials and ensuring that the antigen/antibody bound
surface faced the outside of the vial. The vials were
sealed and if more than 9 membranes were being processed at
a time, the vials were placed in 2 plastic boxes. The boxes
were sealed and then transferred to the shaking waterbath
set at approximately 60 cycles per minute for a 6 hour
period.
5.2.1.7.8 Membrane Washing
Once the incubation in secon?ary antibody was complete, the
final washing of the membranes took place. The boxes were
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removed from the shaking waterbath, the vials removed from
the boxes and the membranes transferred from the vials to
clean plastic boxes to each of which had been added 10 ml
of wash solution using a 10 ml beaker. Using the procedure
outlined for all other washing routines, the membranes were
vigorously washed thrice. This was followed by a single 20
minute wash on the shaking waterbath and four subsequent 5
minutes washes also performed on the shaking waterbath.
The immunoblotting protocol which was described above has
allowed antigen, antibody and a secondary antibody .
conjugated to HRP to form a single immune complex
immobilized on a membrane surface. The following section is
a summary of the immunoblotting protocol which was finally
adopted.
5.2.1.8 Summary of the Immunoblotting Protocol for
Thymine Dimer Detection in UV-Irradiated DNA
1. Membranes were cut into 4 x 1 cm2 strips and
each strip labelled in the top left hand corner.
2. Membranes were pre-wet in
a) 100% methanol for 2 seconds,
b) Milli-Q water for 1 to 2 minutes, and
c) PBS for 15 to 30 minutes.
3. Membranes were transferred to a modified ELISA
plate, allowed to dry, and then blotted with 5 J,LI
aliquots of denatured UV-irradiated DNA.
4. The membranes were blocked in 2% dried milk in 0.1%
Tween-20 in PBS for one hour on a s h a k i ng waterbath.
5. The membranes were washed using 0.1% Tween-20 in
PBS as follows:
a) two brief, but vigorous washes,
b) one 15 minute wash, and
c) two 5 minute washes.
6. The membranes were . incubated overnight in crude
serum dilutions on the shaking waterbath.
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7. The membranes were washed using 0.1% Tween-20 in
PBS as follows:
a) two brief, but vigorous washes,
b) one 15 minute wash, and
c) two 5 minute washes.
8. The membranes were incubated for 6 hours in a
1:500 dilution of secondary antibody conjugated to
horseradish peroxidase.
9. The membranes were washed using 0.1% Tween-20 in
PBS as follows:
a) three brief, but vigorous washes,
b) one 20 minute wash, and
c) four 5 minute washes.
The relevant detection protocol (enhanced
chemiluminescence, in this work) could be carried out as
soon as the immunoblotting protocol was complete. If the
detection protocol was not to be carried out immediately,
the membranes were stored in PBS buffer in plastic boxes in
the refrigerator.
The following section (5.2.2) describes the
chemiluminescent protocol that was chosen for detecting and
quantitating thymine dimer in DV-irradiated DNA. First, the
phenomenon of chemiluminescence will be dicussed. Then, the
choice of equipment used to perform the protocol will be
discussed. Finally, a description will be given of the
development and data collection stages of the
chemiluminescent protocol.
5.2.2 VISUALIZATION AND QUANTITATION OF IMMUNE
COMPLEXES USING ENHANCED CHEMILUMINESCENCE
The previous section (5.2.1) described the immunoblotting
protocol that was developed in this work for the
quantitation of thymine dim~rs in DV-irradiated DNA. This
technique involved blotting the DV-DNA antigen onto
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Immobilon-N charge modified membranes. Then the membranes
were incubated in dilutions of crude serum (containing
antibodies generated against the antigen). This allowed the
antibody to bind to the antigen. The final step in the
protocol involved incubation of the membrane in a dilution
of the secondary antibody (specific for the first
antibody). This secondary antibody was conjugated to the
enzyme horseradish peroxidase, and it also bound to the
immobilized antigen/antibody complexes. ' Thus immune
complexes consisting of antigen, antibody and secondary
antibody conjugated to HRP were immobilized on the
membrane.
This section now describes the teChnique of enhanced
chemiluminescence that was employed for the detection and
quantitation of thymine dimer antigen immobilized on the
Immobilon-N membrane.
5.2.2.1 Description of Enhanced Chemiluminescence as a
Visualization Technique
Chemiluminescence may simply be described as the chemical
production of light. This chemiluminescent process is said
to occur whenever a molecule emits a photon of energy, as
a result of an exothermic reaction in which one of the
intermediate or end products is left in an electronically
excited state. The chemiluminescent reaction occurs without
the abs9rption of light and it has been found that
approximately 200 kJ of energy is necessary to emit a
photon (173). In addition most chemiluminescent reactions
have been found to be of the oxidative type where only the
singlet state of the reactant species (luminol) is
involved.
If the chemiluminescent process occurs in a biological
system, then the process is called bioluminescence. This




Aristotle as the glow of dead fish and fungi. Several other
bioluminescent phenomena are well known, amongst them the
light of glow worms and the light of some bacterial
species. In contrast to bioluminescence, the
chemiluminescent properties of luminol (a cyclic
diacylhydrazide) and lucigenin were only discovered in 1928
and 1935 respectively, and their use in analytical and
clinical chemistry noted decades later.
The use of chemiluminescence in chemical and clinical
applications has led to investigations of the reactions and
mechanisms involved. For luminol, the most widely used
chemiluminescent compound in chemical assays, the light
emitting reaction can be seen in Figure 5.4. White and
Bursey(174) have demonstrated that the aminophthalate
dianion is the light emitting species in the reaction. In
general, electron donating sUbstituents increase the
efficiency of the chemiluminescent emission. To this end,
di- and tri-substituted luminol compounds have been shown
to be 13 and 30% respectively more efficient light emitters
than luminol.
The mechanism of organic chemiluminescence in
involves three key stages:
a} Preliminary reactions to provide
intermediate.
b} An excitation step in which the chemical energy of
the key intermediate is converted into electronic
excitation energy.
c} Emission of light from the excited product formed
during the course of the reaction.
The precise mechanism of formation of excited spec~es from
ground state molecules in solution at room temperature is
unknown. The only clue to resolving the mechanism is that
oxygen is involved in most~ if not all, chemiluminescent
reactions. It has been proposed that oxygen is in its















Figure 5.4. Schematic diagram representing a
chemiluminescent reaction involving the
oxidation of luminol to produce light of
wavelength 425 nm to 430 nm.
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triplet ground state, hence oxygen may exist as triplet
state complexes. Loss of nitrogen from the oxygen adduct
(or the gain of energy by some other process) could lead to
a vibrationally excited triplet state of the emitter
species. The excited triplet species could then inter-
system cross to its excited singlet state, after which
chemiluminescence is effected by the emission of a photon
of light of between 425 to 430 nm from the excited species
(see Figure 5.5.).
The efficiency of this light emission process varies
according to the reactant species involved. To this end,
the quantum yield of a chemiluminescent reaction is defined
as the number of photons of energy emitted during the
reaction, versus the number of molecules involved in the
specific luminescence reaction. For most chemiluminescent
systems this quantum yield is seldom greater than 0.01,
while bioluminescent reactions have quantum yields
approaching unity. The quantum yield for luminol ranges
from 0.01 to 0.05 (175), while measurements in dimethyl
sulphoxide have yielded an answer of 0.05 - the highest
quantum yield for chemiluminescent compounds (174) . These
figures suggest that the bioluminescence process is a more
efficient energy releasing process than chemiluminescence.
Despite the low quantum yields for chemiluminescent
systems, compounds which are chemiluminescent by nature
have been used in several analytical and clinical
applications(176). Auses et al. (177) used a luminol-
ferricyanide-hydrogen peroxide system to determine the
glucose levels in human serum. Gorus et al.(178) determined
uric acid concentrations using the enzyme uricase, to which
the addition of a luminol-potassium ferricyanide-hydrogen
peroxide system allowed chemiluminescent detection and
quantitation of uric acid. Other substrates also produce
light upon reaction with hydrogen peroxide. One such
example is Tepo [bis(2,4,6-~richlorophenyl)oxalate] which










Figure 5.5. Diagram representing the mechanism of organic
chemi 1umines cence (174) •
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to assay for NADH and the enzyme lactate dehydrogenase.
In addition, several chemiluminescent systems have been
used to monitor immunological reactions. The majority of
these utilize luminol or luminol derivatives such as
isoluminol (6-amino-2,3-dihydrophthalazine-1,4-dione) and
0- and m-aminobenzhydrazides in the immunoassay.
Amongst other applications, immunological assays have
allowed small numbers of micro-organisms to be rapidly
identified and quantitated using antibodies .l i nk e d to the
enzyme, horseradish peroxidase. In the presence of
pyrogallol and hydrogen peroxide, light emission catalysed
by this enzyme allowed as few as 30 bacterial cells to be
detected (180) . Schroeder et al. (181) have used an
immunochemiluminometric assay for the quantitation of
hepatitis B surface antigen. Chemiluminescence has also
been used as the means of quantitation of extremely low
levels (femtogram amounts) of the peroxidase enzyme when a
luciferin derivative was used as the substrate. This
approach has been applied to the estimation of peroxidase-
coupled antibodies bound to mouse lymphocytes(182).
These luminescent enzyme immunoassays have the advantages
of cheap and stable reagents, the assays are rapid, and
when used in a clinical laboratory, the assays can be
automated. In addition, the radiation hazards associated
with r adLoImmunoaaaaye are obviated and chemiluminescent
measurements are easy to make and require no complicated
apparatus. However, the most important advantage for the
work presented here, is the sensitivity of the detection
system. Detection limits for the luminescent assay of ATP
and NADH are reported to be 10-10 mole and 10-16 mole
respectively(178). Luminescent assays are, in addition, more
sensitive than the conventional colorimetric assays (ELISA)
that can be used. This sensitivity feature has been
exploited in the quantitation of very low levels of analyte
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or sample.
since chemiluminescent assays appear to provide the
sensitivity required in this work, it was decided to apply
a chemiluminescent substrate to the thymine dimer
containing immune complex localized on the Immobilon-N
membrane. Commercial manufacturers claimed that the
chemiluminescent assay could detect picograms of antigen
localized on blots. seeing that these levels fell below the
2.5 x 10-6 M concentration of dimer detectable by HPLC, the
chemiluminescence quantitation technique appeared to
provide a viable means of quantitation of thymine dimer.
To improve an already sensitive technique, Whitehead et
al.(184) in 1984, developed a procedure of enhanced
chemiluminescence for the sensitive determination of
peroxidase-labelled conjugates in immunoassays. Their work
proposed that the simultaneous use of synthetic firefly d-
luciferin and luminol, or a luminol analogue, in the
presence of an oxidant, allowed for an 80-fold enhancement ,
of signal-to-background ratio in an immunoassay protocol.
Using this synergistic approach, total light emission from
the luciferin and luminol analogue together, significantly
exceeded that from either compound when used alone (Figure
5.6.). This technique has successfully been implemented for
the immunoassay of serum a-fetoprotein, IgE and rubella
virus antibody.
This pioneering research has led to the development of
enhanced chemiluminescence (ECL) , that is, the sustained
emission of light, provided by the inclusion of chemical
enhancers in the HRP catalysed oxidation of luminol. with
the addition of suitable enhancers, this technique gives
about 10 to 100 times more light than oxidation of luminol
alone. These enhancers do not increase the quantum yield of
the reaction, but do regul~te the reaction between HRP,
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Figure 5.6. Graph illustrating the qualitative difference
















Figure 5.7. Diagram representing the principles of dot
blotting used in conjunction with enhanced
chemiluminescence.
204
to depress the light emission in the absence of HRP thus
contributing to an improved signal-to-background ratio. The
light generated in enhanced chemiluminescence is emitted
within 30 seconds, in comparison with colorimetric assays
which can take 30 minutes for development. These enhanced
light emissions are sUfficiently intense to impinge on high
speed Polariod instant film exposed to the luminescing
compound. This observation was noted by Thorpe et al.(185)
in 1984 who reported the use of high speed instant
photographic film for the quantitation of serum ferritin in
an enhanced luminescent immunoassay.
Previously, photographic monitoring of luminescent
immunoassays was not possible because the low light
intensities generated were not easily detected, even with
highly sensitive film. In contrast, light emission from the
luciferin enhanced chemiluminescent reaction of luminol
with HRP conjugates, was sUfficiently high to allow the
photographic film to be used as a detector. In addition,
the light emission has been shown to be constant over a
period of minutes(185) and the luminescent reaction can be
initiated before exposure of the membrane to the film
itself. Photographic detection also has the advantages of
requiring no external power source, the technique is rapid,
and a permanent hard copy of the results is obtained.
In this work, (refer to Figure 5.7.), a luminol-hydrogen
peroxide detection system was added to the immobilized
immune complex on the Immobilon-N membrane. The enzyme,
HRP, (conjugated to the secondary antibody) catalysed the
conversion of luminol to the aminophthalate dianion. In the
process, light of 425 to 430 nm was emitted. The intensity
of the emitted blue light is proportional to the amount of
HRP bound to the membrane which in turn is proportional to
the amount of secondary antibody bound to primary antibody
and this proportional to the amount of antigen bound
directly to the membrane. Thus the emitted light intensity
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can be used to quantitate the antigen bound to the
membrane. When an X- r a y or luminescence film (e.g.
Hyperfilm-ECL) is superimposed on the membrane and luminol-
hydrogen peroxide added to the complex, the light impinges
on the film which can then be developed and printed to
allow the intensity of the emitted light (and hence bound




The enhanced chemiluminescent (ECL) detection system that
was chosen was supplied by Amersham as an "ECL Western
Blotting detection system" (Catalogue Number RPN 2106). The
detection system was supplied as two 250 ml solutions
stored in white and black polythene screw-top containers.
These solutions were maintained at 2 to 8°C in the
refrigerator.
As mentioned in the previous section, several luminescent
substrates are commercially available, with luminol being
the most widely used compound. In order to ensure that the
chemiluminescent reaction proceeds optimally, an oxidant
must be added to the system. Most common is the use of
hydrogen peroxide, although hypochlorite, iodine and
permanganate can a l s o be employed(176). Catalysts that are
used in this luminescent reaction include Fe (CN6 ) 3- and
cu2+ , with the most efficient catalyst being heme. It is
usual for the reaction to proceed in an oxidizing
environment around pH 11.
The Amersham ECL detection solution 1 contained the
substrate for the reaction supplied as a per-acid salt in
a buffer solution at pH 9.5. Detection solution 2 contained
the oxidizable chemiluminescent compound, luminol, which
served to generate the light signal. In addition an. ,
enpancer was supplied, but not specified, in this second
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detection solution. This ensured that the chemiluminescent
reaction generated a sustained enhanced light output. The
solutions were provided at their working strength and were
sufficient for the detection of 4000 cm2 of membrane. This
ECL detection system was suitable for detection of sub-
picogram amounts of sample and to this end, was 10 times
more sensitive than colorimetric (ELISA) assays.
As well as the detection solutions necessary for
chemiluminescent immunodetection, other equipment is also
required. A suitable X-ray film to capture- the emitted
light is necessary and was supplied by Amersham (Catalogue
Number RPN 2103) as Hyperfilm-ECL. This is a high
performance double sided luminescence film developed for
the detection of light emitted in the course of ECL. It was
important to store the film properly, away from X-rays,
gamma-rays or other penetrating radiation. It was also
recommended that the film be stored at 4°C. Thus it was
stored in the refrigerator away from any chemicals or
noxious fumes.
The film was only opened in the dark or under safelight
illumination, and only prior to being used for assay
purposes. When it was required, a single 18 x 24 cm2 sheet
was removed under a safelight and the sheet cut into
approximately 8 x 4 cm2 strips to cover the membranes during
detection. This will, however be described in Section
5.2.3.2 . .No recommendations as to the stability of the film
were given by the manUfacturers, but it was found that
after a 6 month period, the film no longer yielded a clear
background when developed and printed without the light
from chemiluminescent immune complexes impinging on it. The
film was thus discarded and a new box acquired.
The ECL-Hyperfilm was specifically chosen because of its
characteristics in det.ect.i.nq light emission during
chemiluminescent assays. If the immune complexes were being
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detected by a radioimmunoassay, then a multipurpose
autoradiography film, a high resolution film for
autoradiography or a single coated film for the direct
autoradiography of tritium and 1251 labelled compounds would
have been chosen.
In order that all stray light be excluded from the film
while in contact with the Immobilon-N membrane, the film
and membrane were housed in a Hypercassette during
detection. The Hypercassette was supplied by Amersham
(Catalogue Number RPN 1642) and was 18 x 24 cm2 in area. The
interior of the cassette was black and non-reflective for
stray light absorption. The cassette was constructed from
hard aluminium alloy which allowed use at room temperature
or -80°C.
Hypercassettes are suitable for the quantitation of
radiolabelled compounds using photographic detection, or
for chemiluminescent applications. In order that the
cassette remained in good working order, it was important
to wipe the cassette out with paper towel after each use.
The use of strong acid or alkali was not recommended
because of the degradative properties of these chemicals.
When the cassette was being used in this work, the
membranes were overlaid with detection solution for 1
minute and then sealed in cling film before being
transferred to the cassette. In the dark, a strip of
luminescence film was placed over the light emitting
membranes, and the cassette closed during exposure of the
light to the film. The film was then developed and printed
using X-ray photographic chemicals. The entire ECL
detection protocol will be explained in sections 5.2.2.3.1
and 5.2.2.3.2.
Additional equipment required for this ECL protocol
included blunt tip fine forceps for handling the membranes
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and luminescence film, a timer with fluorescent dials that
could be seen in the dark, and clingfilm to wrap the
membranes during chemiluminescent detection. The supplier
of the detection solution (Amersham) suggested the use of
Saranwrap for the latter purpose. However the clingwrap
available in this laboratory was adequate and was used
throughout the developmental and data collection stages of
the chemiluminescent protocol. The plastic boxes that were
used during immunoblotting were also used during this
protocol; dur ing the detection stages and dur ing
photographic development and printing.
standard X-ray developer and fixer were used to process the
luminescence film. A Phenisol developer (5 litre) and Hypam
fixer (5 litre) supplied by Ilford were used. These 5 litre
solutions were stored in the dark and had to be diluted
before use. The dilutions as suggested by Ilford were
performed by transferring 100 ml of developer to a clean
and dry 500 ml amber bottle using a 100 ml measuring
cylinder. Using th~ same cyl~nder, 4 x 100 ml aliquots of
Milli-Q water were added to the amber bottle. This gave a
1+4 dilution. The bottle was sealed and shaken to dissolve
the developer.
In the same manner, a 50 ml measuring cylinder was used to
transfer 50 ml of fixer to a clean and dry amber bottle.
Then, 450 ml of Milli-Q water was added using the 100 ml
cylinder. This gave a 1+9 dilution of the fixer. The bottle
was sealed and shaken to dissolve the fixer. Both the
diluted developer and fixer were stored in the refrigerator
and allowed to come to room temperature before use. Seeing
that the developer contained hydroquinone which is easily
oxidized, the diluted developer had a limited shelf Li f'e ,
When it was freshly prepared, it was a very pale lemon
colour. When the colour changed to a deep orange/brick red,
the developer had expired a~d was not fit for use. It was
thus discarded a~d prepared fresh. The fixer did not have
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any oxidative properties and hence could be used for longer
periods.
When these solutions were required, 200 ml of each was
poured into individual plastic boxes (10 x 8 x 6 cm3 ) into
which the luminescence film was immersed. The film was
first immersed in the developer, followed by immersion in
the fixer. The photographic detection of immobilized immune
complexes will be discussed in section 5.2.2.3.2.
5.2.2.3 Development and Use of a Working Protocol
The previous section · has described the reagents and
equipment used in the development of a chemiluminescent
protocol for the quantitation of thymine dimer in UV-
irradiated DNA. This section now describes the usage of
these chemicals and equipment, while the subsequent sect ion
discusses the photographic protocol that was adopted for
the development and printing of luminescent film, in order
that the immune complexes were vizualized on the film.
5.2.2.3.1 Development and Use of a Working Chemiluminescent
Protocol
The protocol that was adopted for immunoblotting (Section
5.2.1.8) was specifically tailored to allow for optimum
signal strength of the immune complex visualized on the
luminescence film. In the same manner, the ECL protocol has
also been developed to allow optimization of the immune
signal during detection. In this way, the entire
immunoassay has been tailored so as to allow detection and
quantitation of very low concentrations of thymine dimer
generated in low concentrations of UV-irradiated DNA.
At this stage of the assay, the Immobilon-N membranes
contained bound immune co~plexes localized at several
positions along their surfaces. In addition, all extraneous
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serum components and proteins were largely prevented from
binding to the membrane surface at locations where the
immune complexes were not immobilized .
During the chemiluminescent protocol the use of gloves was
strongly recommended to prevent hand contact on the film or
detection reagents.
The membranes were removed from the PBS solution in the
plastic box to a second clean and dry plastic box. It was
important to place the membranes with their
antigen/antibody surfaces facing upwards in order that the
detection solution (containing luminol and hydrogen
peroxide) came into contact with the immobilized immune
complexes. Since 12 to 18 membranes were immunoblotted
together (6 to 9 for each subcutaneous and intramuscular
injection route), these membranes were transferred to 2
plastic boxes, each one containing the membranes sUbject to
dilutions of the same serum. Since the light was stable for
only a few minutes, it was important to work as quickly as
possible. The membranes were positioned adjacent "t o one
another in the box, in alphabetic or numeric order. Seeing
th~t membrane A was sUbject to a 1:50 dilution of serum
(for example) and membrane B subject to a 1:100 dilution
(for example), the order of membranes was important so that
a gradation of immune complex intensity could be visualized
in the luminescence film.
The Amersham detection solutions 1 and 2 were allowed to
come to room temperature and an aliquot of each was
withdrawn using a Volac 100-1000 #-£1 micropipette. The
volume of each solution used for detection was dependant on
the area of membrane -being detected. The final volume
required was 0.125 ml/cm2 (as specified by Amersham), and
for 9 membranes each having an area of 4 cm2 , the total
volume of solution required .was 36 cm2 x 0.125 ml/cm2 = 4.5
ml. Thus 2.25 ml of each detection solution was withdrawn
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and transferred to individual clean 5 ml beakers.
since it was important to work quickly during the
chemiluminescent protocol, all other solutions and
equipment were also prepared prior to detection. A piece of
clingfilm (approximately 10 x 10 cm2 ) was cut and positioned
on a piece of paper towel, ensuring that the clingfilm was
positioned flat on the towel without any folds or creases.
The luminescence film which had been pre-cut was allowed to
come to room temperature and the black plastic sleeve
containing the film was transferred to a · light sealed
drawer for easy access during photographic development and
printing. The amber bottles containing the 1+4 dilution of
the developer and the 1+9 dilution of the fixer were also
brought to room temperature. Approximately 200 ml of each
was decanted into individual plastic boxes.
At this stage all solutions were prepared and the equipment
positioned for easy access. The detection solutions (2.25
ml of each in individual beakers) were added together,
swirled around and then poured over the membranes which had
been positioned in the plastic box. It was important that
the entire membrane surface was covered to ensure that all
immune complexes came into contact with the solution. As
soon as the solution was poured over the membranes, the
timer was started and the membranes incubated for precisely
1 minute (as specified by Amersham). When the time had
expi.xed i a single membrane (e.g. membrane A) was removed
from the plastic box using tweezers and excess detection
solution drained off, by touching the underside of the
membrane against the paper towel. The membrane was then
positioned on the piece of pre-cut clingfilm. The
transferral procedure was repeated for all membranes that
were exposed to detection reagent and the membranes placed
adjacent to one another on the clingfilm with their
antigen/antibody sides faci~g upwards. The transferral of
all membranes did not take longer than 60 to 90 seconds.
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The clingfilm was then folded over the membranes themselves
and the edges of this clingfilm pocket were sealed and any
air bubbles and creases smoothed out. This latter step was
important as any artefacts on the clingfilm (e.g. creases)
were detected as interfering lines on the luminescence
film. At this stage the chemiluminescent reaction had been
generating light for 2 to 3 minutes, but because this light
fell just within the visible spectrum (425 to 430 nm), it
was not detected with the naked eye while the dark room
lights were on.
The following section describes how this chemiluminescent
light emission was captured on the luminescence film as
well as the techniques used to develop and print the film,
in order that the immune complexes be visualized.
5.2.2.3 . 2 Development and Use of a Working Protocol for
Photographic Development and Printing of the
Luminescence Film
The chemiluminescent protocol that was described in the
previous section (5.2.2.3.1) was performed with dark room
lights on. Because the protocol that is to be described
makes use of a light sensitive luminescence film, the
lights were switched off at this stage. However, it was
permissible for a red safe light to be switched on
throughout this protocol.
At this stage, the clingfilm pocket of membranes was
transferred to the open Hypercassette. The pre-cut
luminescence film was removed from the light sealed drawer,
and a single 8 x 4 · cm2 strip was placed over the
chemiluminescent light emitting membranes. Because the
lights had just been switched off, it was often difficult
to determine where the film should be positioned so as to
cover the entire membrane surface. It was best then to wait
a few seconds so as to become accustomed to the dark before
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placing the film.
In the development stages of the protocol, it was not known
how long the film should be exposed to the the light
emitting membranes in order to quantitate light emission.
Quantitation of light emission has been performed using
photomultipliers(176) as well as luminometers measuring a
photocurrent (184). The only clues as to the length of
exposure of the film to the developer was given by Thorpe
et al.(185) who were the first researchers to monitor EeL
immunoasays photographically. They suggested that the film
only needed a 30 to 60 second exposure time to the
membranes. However, Amersham alluded to an increase in the
intensity of chemiluminescent light emission over
approximately 10 minutes, after which the intensity began
to decrease steadily (see Figure 5.6.).
If only a single exposure of the film to the membranes was
to be made, then the remaining (stable) chemiluminescence
would not be made use of and would thus be wasted. It was
therefore decided to sequentially expose a series of films
to the membranes. This technique would then confirm whether
a particular immune complex incubated with a specific
primary antibody was detectable on the film or not.
The film was initially exposed to the membranes for 3
minutes. This was performed by positioning the film over
the membranes and then pressing down on the film with the
knuckles to ensure maximum contact between the film and the
membranes. The Hypercassette was then closed and the time
noted. It was important not to move the cassette during
exposure otherwise blurry photographs would have been
printed. As soon as the first exposure period was complete,
the Hypercassette was opened and the film removed using
tweezers. A fresh piece of unexposed film was immediately
placed over the membranes, . the cassette closed and this
second piece of film allowed to expose for 4 minutes. When
214
this exposure period was complete, the exposed film was
removed and a third piece of unexposed film placed over the
membranes and exposed for 5 minutes. The exposure periods
were chosen as 3,4 and 5 minutes respectively in order that
any decrease in chemiluminescent light intensity would be
compensated for by an increase in exposure period. Hence
the intensity of the immune complex visualized on the
luminescence film should have been roughly the same for
each film so as to allow for comparisons to be made between
the blots on the 3 pieces of film.
As soon as the first piece of exposed film was removed from
the Hypercassette using tweezers, it was immersed in the
1+4 dilution of the developer. Since these photographic
chemicals were specific for developing X-ray film, the
exposure periods of the film to the chemicals had to be
adapted so as not to over- or underdevelop the film. Ilford
suggested a 3 to 8 minute exposure period of the film to
the developer. However, when this was tried the film became
too dark which prevented detection of the immune complexes.
Then a few runs of the entire protocol were performed using
1, 2 and 4 minute developing times. Although the shorter
periods were an improvement, the film was still being
subject to the developer for too long.
As an alternative technique, it was decided not to set a
time for exposure of the film to the developer. The film
was thus immersed in the developer solution using tweezers,
and the box containing the developer and film was
positioned close to the red safe light. For the more
concentrated UV-irradiated DNA used as antigen, the film
was removed from the devel~per when black immune complexes
were seen on the film while it was in the developer. For
the less concentrated UV-irradiated DNA (less than 0.01
mg/ml DNA) sample used as the antigen, the film was removed
when it had become sUfficiently "grey". Usually, it took
between 15 and 30 seconds for this to occur.
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As soon as the film was removed from the developer using
tweezers, it was immersed in the 1+9 dilution of the fixer.
Ilford suggested a 3 to 5 minute exposure period, but to
speed up the protocol, 1,2 and 4 minute exposure periods
were experimented with. Because a 1 minute exposure period
was not visually different from a 4 minute exposure time,
this former time was chosen and used in all subsequent
work.
Once the film had been fixed, it was removed from the fixer
using tweezers and washed under a gentle stream of water to
remove excess developer and fixer. The film was dried us ing
a hairdryer set at the lowest heat setting.
There was sufficient time for the first piece of exposed
film to be developed and printed before the second piece
was removed from the Hypercassette and developed and
printed. This second piece was then immersed in the
developer for 15 to 30 seconds and transferred to the fixer
where it was immersed for 1 minute. It was washed under a
stream of water and allowed to dry before the entire
developing and printing procedure was repeated for the
third piece of film. If a second series of membranes were
immunoblotted at the same time, then the entire
chemiluminescent protocol as explained in section 5.2.2.3.1
and above, was repeated.
This entire protocol usually took no more than 15 minutes
to perform. If this chemiluminescent technique was being
used on a regular basis in a clinical or analytical
laboratory , it provides a means of analysis of several
samples over a short space of time.
Only when the developing and printing protocol was
,?omplete, and when the pre-cut unexposed f i.Lm had been
returned to its drawer, coul~ the lights be switched on and
the film analysed and interpreted.
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However, before the chemiluminescent protocol was
performed, it was important to ensure that all the
chemicals were working and not past their expiry date. The
detection system was checked by pipetting 0.5 ml of each
detection solution into a 5 ml beaker. with the lights
switched off, 3 ~l of HRP-antibody conjugate was added to
the detection solution using a Gilson 2-10 ~l micropipette.
The solution was swirled around and blue light seen. In
most cases the blue light could be seen for 10 minutes or
longer, but this was not an indication of the stability of
the light in this work, because diluted, and not stock HRP-
antibody conjugate was used in the protocol described in
this work. It merely confirmed that the chemiluminescent
protocol was working. This procedure was performed whenever
immune complexes could not be visualized on the
luminescence film. The detection system did, however,
produce blue light whenever it was tested and was stable
for at least 12 months if stored in the refrigerator.
The luminescence film was also checked to see that it
yielded a clear background when developed and printed. A
pre-cut piece of film was immersed in the developer and
fixer for the required periods of time before being washed
and dried. The background was clear when tested during the
first 4 to 6 months of use. After that time, the film
became too dark when developed and printed and was thus
discarded and a new pack of film was bought. The developer
also had . a limited shelf life. When new film was bought,
the developer was also discarded and bought fresh.
In order to develop a rapid means of quantitation of the
emitted light, an attempt was made to use a Macam
Spectroradiometer (SR 9010-PC) attached to a Samsung
Personal Computer. This instrument allows emitted light
(DV, visible and chemiluminescent) to be ~aptured using a
diffuser and light guide, an~ then electronically converted
to a light output reading by means of a monochromator. The
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chemiluminescent protocol was performed on a series of
immunoblotted membranes, and once the detection solution
was added to the membranes, the probe was positioned over
a light emitting membrane. No reading was however
registered by the radiometer when the spectrum was scanned
from 400 to 450 nm over a 15 minute time period. seeing
that it was very difficult to detect the emitted light in
the dark, using the naked eye, it was not surprising that
the emissions were not detected using the radiometer. If
this technique had been successful, the emitted light could
have been quantitated and correlated to light emissions
from known thymine dimer concentrations when the
chemiluminescent protocol was performed. In this way,
thymine dimers generated at these known low DNA
concentrations could have been calculated. Since the light
could not be detected, this technique was not developed any
further.
As will be explained in section 6.3.2, the luminescent
films containing immune complexes of varying intensities,
were also quantitated using a GS 300 Transmittance/
Reflectance Scanning Densitometer attached to a Varian 4270
Chart Recorder. This instrument allowed the density of the
immune complex on the luminescence film to be determined
against the individual background reading for that film.
This technique was used for quantitating those complexes at
or near the cut-off dilutions of the antibody for a
specific DNA concentration. These results will be discussed
in section 6.3.2.
5.2.2.4 Summary of the Chemiluminescence Protocol for
Thymine Dimer "Oua nt i t a t i on in UV-Irradiated DNA
1. The detection solutions were brought to room
temperature and equal volumes pipetted into individual
beakers to give a final volume of 0.125 ml/cm2 of
membrane.
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2. The membranes were drained of excess PBS buffer and
placed in a fresh container. The detection reagent was
added directly to the antigen/antibody surface of the
membranes.
3. The membranes were incubated for exactly 1
minute.
4. Excess detection reagent was drained off and the
membranes wrapped in clingfilm. Any creases or air
pockets were smoothed out.
5. The membranes were placed (antigen/antibody s ide
up) in the Hypercassette. It was important to work as
quickly as possible, minimizing the delay between
incubation with detection reagent and exposure to the
film.
6. The lights were switched off and a sheet of pre-cut
luminescence film was placed over the light
emitting membranes. The cassette was closed and the
film exposed for 3 minutes.
7. The film was removed and a fresh piece of film
positioned over the mem~ranes for 4 minutes.
8. While the second piece of film was being exposed,
the first piece was immersed in developer for 15 to 30
seconds, and then fixer for 1 minute.
9. This luminescence film was washed under a gentle
stream of water and dried using a hairdryer.
10. The second, and any subsequent pieces of exposed
film, were also immersed in developer and fixer.
11. The films were analysed for the presence of immune
complexes at specific antibody dilutions.
Chapter 5 has thus described the development and use of a
working immunoblotting protocol with chemiluminescent
detection for the quantitation of cis-syn thymine dimer in
DV-irradiated DNA. In Chapter 6, attention is now turned to
results and discussion of the purification techniques used
in this work (ammonium sUlp~ate precipitation of antibody
and affinity chromatography), as well as the abovementioned
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immunoblotting protocol with EeL detection and
quantitation. As an extension of this work, DNA of 0.025
mgjml was irradiated and analysed by immunoblotting with
ECL. The cut-off antibody dilutions were correlated to
thymine dimer yields (using a calibration graph). These
results were then used to support a mechanism as proposed
by Thomas(54) for the acetophenone photosensitized
dimerization of thymine in DNA. Here, a comparison was made
between experimental (determined by immunoblotting) and





The main aim of the work reported in this thesis was the
development of an immunoassay technique for the
quantitation of thymine dimer in UV-irradiated DNA. This
would be a more sensitive technique for thymine dimer
quantitation than the HPLC techniques currently being used
in these laboratories and would allow the extension of
thymine dimer quantitation from in vitro (free thymine or
calf thymus DNA) a queous systems to quantitation in in vivo
cellular systems. The experimental techniques employed in
the development of an immunoassay protocol were described
in Chapters 4 and 5. Briefly, DNA-acetophenone-PBS
solutions of varying concentrations were prepared and
irradiated with ultraviolet light of wavelengths greater
than 290 nm to cause photosensitized production of the cis-
syn thymine dimer. Injection of this UV-irradiated DNA
antigen into laboratory rabbits allowed antibodies against
the thymine dimer to be generated by the rabbits' immune
system. The antibodies were collected by bleeding the ear
vein of the rabbits. Purification of the crude serum was
performed by the classical ammonium sulphate protein
precipitation technique as well as by the more
sophisticated technique of affinity chromatography. The
immunoassay technique of immunoblotting was developed using
crude serum (containing thymine dimer antibodies) and
quantitation of the thymine dimer was performed using
enhanced chemiluminescence detection of the
antigen/antibody complexes.
This chapter deals with an evaluation of the purification
techniques employed in this work, as well as presenting
results obtained from the immunoblotting analysis of crude
serum samples. Included here will be a discussion of the
sensitivity of this immunoblotting technique in comparison
with the HPLC system currently being used. Thereafter the
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applicability of immunoblotting for quantitating thymine
dimer lesions at DNA concentrations undetectable by HPLC
will be discussed. To this end, the construction of a
calibration graph (cut-off antibody dilutions versus
thymine dimer concentrations) will be discussed.
Additionally the mechanism of acetophenone photosensitized
dimerization of thymine as proposed by Thomas(54) for 0.1
mg/ml to 1.0 mg/ml DNA samples was tested at 0.025 mg/ml
DNA by irradiating DNA and analysing the dimer yields by
. immunoblotting. Support for the proposed mechanism at this
low (0.025 mg/ml) DNA concentration was made· by comparing
simulated (obtained by using the computer programme, CAKE)
and experimental (determined by immunoblotting) data.
6.1 PURIFICATION OF THE CRUDE SERUM
In this work two techniques (ammonium sulphate
precipitation and affinity chromatography) were employed
for the purification of proteinaceous antibodies. These UV-
DNA antibodies were generated by rabbit immunocompetent
cells and secreted into the rabbit blood stream. Blood was
obtained from the marginal ear vein of the rabbit, and the
serum (containing the antibodies) separated from the red
blood cells by centrifugation. Aliquots of this crude serum
were frozen in Eppendorf vials to prolong their lifespan
and prevent microbial degradation. The vials were thawed
whenever the s 'erum was required for immunoblotting analysis
or purif.ication.
Protein purification is intrinsically a delicate procedure
to undertake because of the fragile conformations of
proteins which are crucial in controlling cellular
metabolism. The degree of purification and percentage
recovery required for a specific 'p r ot e i n dictates the
technique(s) which is to be used. Precipitation methods
employing ammonium and sod~um sUlphate, ethanol, dioxane
and polyethylene glycol for purification are inherently
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crude, but do provide a starting point for gross
purification. Chromatographic methods making use of
sophisticated technology and instrumentation provide a more
selective and expensive means of separating proteins from
each other. In this research, both precipitation and
chromatography were employed in purifying crude serum
containing thymine dimer antibodies.
6.1.1 A COMPARISON OF AMMONIUM SULPHATE PRECIPITATION
AND AFFINITY CHROMATOGRAPHY AS PURIFICATION
TECHNIQUES
The purification of proteins by precipitation required that
a saturated solution of ammonium suLphat;e be prepared.
Ammonia solution was used to adjust the pH of the ammonium
sulphate solution to 6.5. Crude serum was stirred using a
magnetic stirrer and the saturated ammonium sulphate
supernatant added to reach 50% saturation at which antibody
precipitation occurs. The solution was adjusted to pH 7.8
(0. 5 M NaOH) , after which it was stirred on a magnetic
stirrer for 2 to 3 hours while the protein precipitated.
Centrifugation (2 x 15 minutes, 12000 rpm) separated the
protein from the supernatant which contained serum
proteins, amongst other biomolecules. The protein was re-
suspended in PBS buffer and the entire procedure repeated
to remove extraneous material from the precipitated
fraction. The purified components were finally dialysed
against large volumes of 50 mM phosphate buffer to remove
excesses of ammonium sulphate salt.
In essence, this technique provides a satisfactory, yet
gross means of purifying all antibody classes (IgG, IgM,
IgA and IgE) from contaminating serum constituents and has
been used for such purposes since it was initially devised
by Kendall(186) for protein (gamma globulin) purification in
1937. Phillips and Kalthoff(135) , who prepared monoclonal
antibodies for specific binding to pyrimidine dimers in
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RNA, precipitated the antibodies from ascites fluid with
50% saturated ammonium sulphate. This technique was also
applied by Eggset et al. (187) prior to aff inity absorbing
DV-DNA antibodies onto a DNA-Sepharose column.
However, the drawbacks of ammonium sulphate precipitation
in the work presented here lie not in the application of
the technique, but in the small volumes of serum (500 ~l or
less) available for purification after a bleed of the
rabbit. Although much of the developmental work for this
protocol used the i/v T serum (approximately 50 ml
available in total for purification and immunoblotting
work), antibody purification using such small volumes of
serum is a delicate procedure which cannot be accomplished
with a high degree of success if quantitative work is
required.
A further drawback of this technique lies in the fact that
a pH of 7.8 must be established for protein precipitation
of immunoglobulins, non-immu~e serum globulins and albumin
to occur. However, alternative methods(140) suggest a pH of
7 • 4 be established in order for precipitation to occur.
Although this pH difference is only 0.4, the fact that
there is a difference suggests the range of proteins (whose
pI falls between 7.4 and 7.8) which will precipitate using
this ammonium sulphate technique. Thus if the purification
of a single antibody class (e.g. IgG) from other antibody
classes or contaminating serum proteins is required, then
ammonium sulphate precipitation does provide a drawback in
terms of its resolving powers. However, if crude
purification is all that is required (i.e. ammonium
sulphate _ precipitation of antibodies prior to
chromatographic separation) , then ammonium sulphate
precipitation does initially serve an important function.
As an alternative to the crude purification technique
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discussed above, a chromatographic technique for antibody
purification was developed to separate immunoglobulins from
contaminating serum components. The techniques of ion-
exchange chromatography, hydroxylapatite chromatography and
hydrophobic interaction chromatography have all been used
elsewhere(142) in immunological applications for
purification of antibodies. However, these separations
(relying on differences in charge, shape and hydrophobic
character of the antibody molecules) are extremely
specific, usually producing highly pure antibodies for use
as antigens or ligands in analytical or clinical .
applications. Such applications were not required in this
work and hence the technique of affinity chromatography was
employed to demonstrate chromatographic separation of
immunoglobulins.
Affinity chromatography relies on the specific interaction
of proteins or glycoproteins with ligands which are
immobilized on an insoluble matrix. For the application at
hand, Protein A (a cell wall protein expressed by the
bacterial species Staphylococcus aureus) interacted with
the antibody molecules . Extensive work by Swedish
researchers in the 1970' s elucidated that only the IgG
antibody molecule (comprising 75 to 80% of the total
antibody population) interacts with Protein A, hence
effecting separation of this antibody class from other
antibodies (IgM, IgA and IgE) and serum proteins.
An affinity chromatography cartridge (containing the
Protein A ligand immobilized onto a cellulose matrix) was
attached to a Waters Delta Prep 4000 preparative HPLC
system with a Waters Tunable 486 UV absorbance detector and
Waters 745 Data Module. Seeing that neither the preparative
HPLC system or the affinity cartridge had been used in
these laboratories, development of a protocol for antibody
purification went hand-in-h?nd with becoming familiar with
the workings of the HPLC.
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A 0.05 M Tris/HCl, 0.1 M NaCl, pH 8 buffer solution was
used to load a diluted serum sample onto the Memsep 1000
affinity chromatography cartridge. Thereafter a 0.1 M
glycine/HCl solution,pH 2.5 desorbed the IgG component from
the cartridge, the fraction was collected and confirmed to
be IgG.
Results of the chromatographic separation of IgG using
affinity chromatography were illustrated in sections
4.2.3.8.2 to 4.2.3.8.4, where optimum separation was
achieved using a 100 J.Ll rheodyne loop volume and the
following gradients generated by the HPLC solvent delivery
system:
Tris/HCl pH 8.0 - 1.5 ml/min - 0 to 2 minutes and
glycine/HCl pH 2.5 - 1.5 ml/min - 2 to 20 minutes.
The results obtained on injection of commercial rabbit IgG
onto the Memsep cartridge were discussed in section
4.2.3.9.
In immunological applications, the percentage recovery of
antibody using a particular purification technique is most
easily carried out by radiolabelling the antibody,
purifying the serum sample and performing scintillation
counting on the resultant fraction. Seeing that
radioimmunoassays were not utilized in this work an
alternative technique was established. A solution of
commercial rabbit IgG (0.96 mg/ml in PBS) was prepared and
injected onto the preparative HPLC. The maximum absorbance
of the IgG fraction on the Waters 486 Tunable absorbance
detector was used to convert the experimentally determined
absorbance to a concentration reading. The Beer-Lambert
Law, A = €Cl (with € = 1.43 (mg/ml)-l cm- 1 as determined in
section 4.2.3.1 and 1 = 1 cm) gave a concentration of 0.909
mg/ml for the sample which had passed through the Memsep
cartridge. This corresponded to a 94% recovery of the
commercial rabbit IgG. If a~ extinction coefficient of 1.50
(mg/ml)-l cm- 1 is used(135), then the recovery is 90%
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efficient.
In this work it was not necessary or relevant to quantitate
absolute antibody production in the various serum samples
obtained after bleeding the rabbits. Seeing that factors
beyond the control of the researcher (genetic pre-
disposition of the animal to the immunogen, age and
immunological status of the animal) influence antibody
production, quantitation of these serum samples would have
served no purpose in this work. As will be shown in Section
6.3, correlation of cut-off antibody dilutions (obtained by
immunoblotting) to thymine dimer concentrations was made
without knowing or calculating the specific thymine dimer
antibody concentrations in any serum samples.
In an article entitled "Liquid Chromatography of
Immunoglobulins", Regnier(142) comments that the majority of
antibody purification regimes employ mUlti-step processes
using one or more separation techniques to bring about
efficient purification and/or separation. In this context,
ammonium sulphate precipitation is usually followed by or
incorporated with ion-exchange chromatography to produce
antibodies which contain less than 10% protein by mass.
Another example is given of an antibody preparation that
was pre-fractionated onto a Protein A column and was
resolved into its three idiotypic components using a
hydroxylapatite column(148). It seemed pertinent to apply
this log~c to the purification techniques that were used
individually in these laboratories, i.e. to follow protein
precipitation with HPLC. An i/v T serum sample was subject
to a single ammonium sulphate precipitation, the protein
re-suspended in PBS buffer and a diluted sample thereof
injected onto the Memsep cartridge. Although quantitation
of antibodies was not important in this work, areas
integrated under the peaks by the Waters 745 Data Module
give an indication as to the percentage IgG in any
particular serum sample. Depending on the sample used, the
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IgG consisted of approximately 30% of the crude sample
(i. e . without ammonium sulphate precipitation) inj ected
onto the Memsep cartridge. When the ammonium sulphate
precipitated antibody was passed through the Memsep, the
area percentage increased to approximately 95%. If a 4 fold
purification of the antibody using ammonium sulphate
precipitation is assumed(138), then coupling these two
techniques results in an approximate 12 fold purification
of the IgG component. This figure is in the range of that
given for DEAE ion-exchange chromatography, where the
antibody classes and subclasses may be separated from one
another. (Mahler and Cordes(138) note that crystallization
of a protein results in a 250 fold purification - far
superior to the purifications achieved using
chromatography, but much more difficult to perform.) As was
noted above, affinity chromatographic purification of
proteins yielded a percentage recovery of greater than 90%.
If maximum recovery of an antibody class from a particular
serum sample is important for the research at hand, then
affinity chromatography is superior to the 80% recovery of
antibodies that can be achieved using ammonium sulphate
precipitation (138) .
In contrast to the high recoveries and successful
applications of the affinity chromatography techniques
mentioned above, a few features of affinity chromatography
must be discussed in terms of the disadvantages they might
provide in purification regimes. Included here is the
inability of this technique to separate antibody subclasses
from one another, changes in antibody conformation during
desorption with the glycine/HCl buffer and the removal of
nucleases using this technique. These are discussed in the
following section (6.1.2).
6.1.2 LIMITATIONS OF AFFINITY CHROMATOGRAPHY
section 4. 2 . 3 • 8 discussed the development and use of an
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affinity chromatography protocol to separate the IgG
antibody component from contaminating serum proteins and
other immunoglobulin classes. The technique was chosen from
a range of chromatographic applications since it
demonstrated the purification of antibody molecules from
whole serum without separating the immunoglobulin classes
from one another. At the same time the technique allowed
separation of the various serum proteins from the antibody
of interest (IgG) and eluted the IgA, IgM and IgE
antibodies with the serum proteins. Although the technique
proved successful in this work because a high degree of
resolution was not required, affinity chromatography does
have drawbacks. These will now be highlighted and discussed
sequentially.
As was stated above, in the work presented here it was not
necessary to separate the antibody classes from one
another. But if resolution of these classes is integral to
the research being undertaken, then an alternative
technique to affinity chro~atography must be chosen to
effect separation of the antibody classes from one another.
A range of techniques are currently available to serve this
purpose. separation can be achieved using electrophoresis
where the differences in size and charge of the various
antibody classes are used to bring about resolution.
Nussenweig et al.(188) fractionated mouse antiserum by zone
electrophoresis but achieved only partial separation of IgG1
and IgG2 antibodies because of the small diferences in
electrophoretic mobility of these two types of antibody.
However, electrophoresis has in many instances now been
replaced by ion-exchange chromatography as a separation
technique. Anion exchange chromatography using a Waters
PROTEIN-PAK DEAE-5PW column was used successfully for the
separation of IgG, IgM, IgA, transferrin and albumin(157)
(hence separation of the a~tibody from the contaminating
serum proteins was achieved). This operation requires the
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careful simultaneous control of ionic strength and pH
gradients using Tris and NaCl buffers at alkaline pHs (7 to
8.5) to bring about efficient separation. This technique
has been used to purify monoclonal antibodies of a variety
of idiotypes from both ascites and tissue culture fluid.
Ion-exchange chromatography also provides a means of
resolving immunoglobulin sub-classes, as was demonstrated
for the separation of mouse IgG3 and IgG2b from IgG1 and
IgG
2a
( 14 5 ) .
The abovementioned techniques exploit subtle differences in .
size, charge and electrophoretic mobility of the antibody
molecules, and hence effect differing degrees of resolution
of the antibody population according to the specific
technique. Hence, prior to the researcher chosing a method
for chromatographic separation of antibodies, it is
important to establish the degree of purity required. If
the application demands resolution of the various crude
antibody components on an idiotypic basis, then ion-
exchange chromatography or the more sophisticated
techniques of hydroxylapatite or hydrophobic interaction
chromatography must be used. If, however, the application
demands only the separation of antibody from contaminating
serum protein, then affinity chromatography provides a
cheap option which can find use in both analytical or semi-
preparative operations depending on the size of the Memsep
cartridge chosen and the flow rates of the buffers used.
If the IgG fraction is to be collected in a semi-
preparative or preparative application and used for
structural analysis of the IgG, then affinity
chromatography is deleterious in that it brings about
structural and conformational changes to the antibody
molecule: as was outlined in section 4.2.3.7.1, a 0.05 M
Tris/HCl, 0.1 M NaCl, pH 8 buffer solution was used to load
the IgG onto the Memsep cartridge, while 0.1 M glycine/HCl,
pH 2.5 interfered with the binding of the IgG/Protein A
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complex and thereby released the IgG for detection. It is
the acid environment (pH 2.5) which induces changes to the
IgG, and these are manifest as changes to the three
dimensional structure of the antibody. In particular, a
general expansion of the molecule is brought about due to
an increase in the angle between the two Fa b arms(189).
Another drawback as to the applicability of affinity
chromatography is given by Munns and Liszewski(190) who note
that the technique does not always eliminate nuclease
activity from the antibody preparation. The removal of
nucleases is important in preventing degradation of the
material under investigation. It is therefore recommended
that additional steps be taken (in conjunction with
affinity chromatography) to ensure nuclease removal or
inactivation. This may be accomplished by combining ion-
exchange and affinity chromatography techniques although a
20 to 40% loss of antibody population usually accompanies
nuclease removal. Alternative procedures which may be
employed include the use of charcoal and alum for nuclease
removal.
This section (6.1) has discussed the techniques of ammonium
sulphate precipitation and affinity chromatography in terms
of their applications and limitations in the purification
of antibodies. Apart from demonstrating that purification
of antibodies can be achieved using the Memsep cartridge
and Delta Prep 4000 HPLC (both of which were newly acquired
in this laboratory), it had been thought that pure antibody
preparations were necessary in order to carry out the
immunoblotting protocol. To this end, Section 6.2.
discusses aspects of the immunoblotting with ECL detection
chosen to provide a more sensitive means of thymine dimer
quantitation than HPLC currently used in these
laboratories.
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6.2 IMMUNOBLOTTING ANALYSIS OF IRRADIATED DNA WITH
ENHANCED CHEMILUMINESCENT QUANTITATION OF
ANTIGEN/ANTIBODY COMPLEXES
The research presented here outlines the development of an
immunoassay protocol for the in vitro detection of thymine
dimers in DV-irradiated DNA. The technique of
immunoblotting was chosen over the radioimmunoassay and
immunofluorescence immunoass'ays because of ' t h e ability of
immunoblotting to reveal lesions induced by low fluences of
DV radiation « 10 J /m2 ) . Immunoblotting also has the
advantage of requiring unsophisticated instrumentation in
comparison with that required by radioimmunoassay and
immunofluorescence.
An adapt ion of the immunoblotting protocol presented here
was first described by E.M. Southern(83) in 1975 to allow
for proteins and nucleic acids (e.g. DV-irradiated DNA) to
be immobilized on a membrane matrix. In this work,
subsequent processing of the immobilized DV-irradiated DNA
antigen involved blocking unreacted areas of the membrane
surface with 2% dried milk in PBS-Tween solution, followed
by incubation of the membrane with diluted serum samples
(containing antibodies generated against thymine dimers of
the DV-irradiated DNA). The membrane was finally incubated
with a second antibody (specific for the primary antibody)
bound to the enzyme hors~radish peroxidase. At the end of
the 24 ~our protocol, each immobilized blot consisted of
antigen, primary antibody and secondary antibody conjugated
to the enzyme and bound together as a complex by a series
of specific antigen/antibody interactions.
In this work the technique of enhanced chemiluminescence
was chosen to quantitate thymine lesions generated in the
UV-irradiated DNA. Chemiluminescence has the advantages of
cheap and stable reagents, ~apid assay times and superior
sensitivities over ELISAs and radioimmunoassays that could
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have been chosen as quantitation techniques. Enhanced
sensitivity of the assay is gained by the addition of
chemical enhancers to the chemiluminescent detection
solutions. These enhancers provide a 80 to 100 fold
enhancement of sensitivity(184).
In the protocol employed here, the antigen/antibody
complexes immobilized on the Immobilon-N membrane were
overlaid with ECL detection solutions (luminol-H202-
enhancer) which permitted the peroxidase enzyme to catalyse
the production of light (425 to 430 nm) generated during
the course of conversion of luminol to the aminophthalate
dianion. The light was captured on luminescence film which
was developed and printed using standard photographic
chemicals. The emitted light intensity was correlated to
antigen bound to the membrane surface and hence allowed
thymine dimer quantitation of the immobilized UV-irradiated
DNA.
This section (6.2) descr ibes the results of the
immunoblotting protocol that were obtained during the
development stages of the protocol. Then the discussion
will consider antibody production in terms of the injection
routes chosen for the immunization of rabbits. Thereafter
the applicability of both immunoblotting and enhanced
chemiluminescence will be discussed from the perspective of
the problems experienced during the running of the
protocols.
6.2.1 RESULTS OF IMMUNOBLOTTING ANALYSIS TO DETERMINE
OPTIMUM CONDITIONS UNDER WHICH TO BLEED THE
RABBIT
Immunizations of the DV-DNA antigens were performed once a
week over a four week period (see section 4.2.2.3). Rabbits
were bled prior to injecti?n as well as. 10 and 20 days
after the final injection to obtain the serum containing
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the thymine dimer antibodies. The immunoblotting protocol
was performed on each sample of serum obtained from a
single rabbit bleed. Seeing that two rabbits received the
same immunogen via different injection routes (intravenous,
intramuscular and subcutaneous), one immunization schedule
(4 inj ections and 6 bleeds per rabbit) necessitated the
performance of 12 individual protocols with ECL detection
in order to determine the optimum conditions under which
the rabbits should be bled to obtain maximum antibody
titres.
Quantitation was performed by examining the cut-off
antibody dilution of a particular serum sample, i.e. that
antibody dilution where the immune complex was no longer
visible on the luminescence film. Results are presented as
cut-off antibody dilutions (y-axis) versus days of
immunization/bleeding (x-axis). The performance of these
protocols not only served to develop the techniques of
immunoblotting and ECL but also allowed one to determine
when the rabbit should be bled so as to obtain maximum
antibody concentration. The higher the antibody titre, the
more antibody available.
Results are presented in tabular form in Tables 6.1., 6.2.
and 6.3. while they are represented graphically in Figures
6.1., 6.2. and 6.3. Figure 6.4. illustrates a typical
luminescence film containing antigen/antibody complexes
viewed after development and printing of the films.
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Days Subcutaneous Intravenous







* A terminal bleed was required at 24 days because of
the problems which arose with the intravenous
injection route of the UV-DNA antigen (see section
4.2.2.3) .
Table 6.1. Cut-off antibody dilutions of the thymine dimer
containing serum generated in response to the
subcutaneous and intravenous injection of
1.0 mg/ml DNA.
Days Subcutaneous Intramuscular




21 1:3600 1:3600 or 1:5400*
31 1:7200 1:5400
41 1:8000 1:9000
r -* Hybond versus Immobilon-N membranes (see Section
6.2.3.).
Table 6.2. Cut-off antibody dilutions of the thymine dimer
containing serum generated in response to the











Table 6.3. Cut-off antibody dilutions of the thymine dimer
containing serum generated in response to the
sUbcutaneous and intramuscular injection ot
0.5 mgjml DNA.
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• intravenous * subcutaneous
Figure 6.1. Cut-off antibody dilutions of the thymine
containing serum generated in response to the
subcutaneous and intravenous injection of
1.0 mg/ml DNA.
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Figure 6.2. Cut-off antibody dilutions of the thymine dimer
containing serum generated in response to the
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Figure 6.3. Cut-off antibody dilutions of the thymine dimer
containing serum generated in response to the

















Figure 6.4 . Typical luminescence film illustrating a
gradation in antigen/antibody blot intensity in
relation to incr~asing serum dilutions.
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Because antibody production is a biological process over
which little control can be exercised by the researcher, it
is not possible to draw conclusions as to the extent of
antibody production in response to the DV-irradiated DNA.
The higher antibody titre in a particular serum sample, the
more it can be diluted for use in the immunoblotting
protocol, and the higher the cut-off dilution which is
achieved in the assay. In the results presented here, the
highest antibody titre at day 41 implies that serum taken
around this time is optimum for analysis. It must be noted,
however, that the same 'subcutaneous' rabbit received
immunizations of 1.0, 1.0 and 0.5 mg/ml DV-DNA in three
succesive immunization schedules. In the same manner, the
'intramuscular' rabbit received doses of 1.0 and 0.5 mg/ml
DV-DNA in a series of two immunizations. Hence the 1:800
dilution of serum for the second immunization schedule is
specific only for that serum. Thus a 1: 800 dilution of
serum in the third immunization schedule cannot be
correlated to the former 1:800 dilution because the assay
does not provide a means of determining absolute antibody
concentrations in the various sera samples.
From an immunological point of view, it is advantageous for
bleeds to be performed months after immunization of the
antigen, in order to monitor the long term course of
acquired immunity of the animal. However, such a procedure
served no purpose in this work and because only three
rabbits were available for immunization, it was important
to begin subsequent, immunizations only weeks after the
final bleed of the previous schedule was complete.
6.2.2 EFFECT OF INJECTION ROUTE ON ANTIBODY PRODUCTION
Although few conclusions can be inferred as to the extent
of antibody production during the course of immunizations,
it is generally believed that -the efficiency of stimulation
of the immune response is related to the site of
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innoculation (131). In this work, three inj ection routes
(intravenous, intramuscular and subcutaneous) were used,
with success shown in the latter two cases. The main
reasons for the differences in efficiency (quoted as
intravenous < intramuscular < subcutaneous by Hurn and
Chantler(131) are the speed with which the antigen is lost
from the site of injection and the likelihood of it passing
through the lymph nodes or other centres of immunologic
activity. However, these factors are extensively affected
by the use of oily adjuvants which can stimulate a local
cellular reaction thereby releasing antigen over a period
of several weeks or even months.
Because Freunds Incomplete Adjuvant was used to stimulate
antibody production in rabbits in this work, the
subcutaneous and intramuscular injection routes were chosen
so as not to cause loss of condition of the rabbits. Hurn
and Chantler(131) note that subcutaneous or intradermal
injection invariably leads to ulceration, but provided the
sites are well chosen no problems are experienced.
Injection of the immunogen by sucbcutaneous and
intramuscular means in this work was compatible with the
rabbits and no problems were experienced during the course
of either the three or two immunization schedules. Problems
related primarily to the generation of the condition of
fatal fat embolism (see section 4.2.2.3) were experienced
with injection of Freunds Adjuvant using intravenous
injection.
'Th e following sections (6.2.3 and 6.2.4) highlight aspects
of the immunoblotting and ECL assays that were considered
in this work in order to provide a viable means of





Immunoblotting has been used successfully in this work to
detect thymine dimers in UV-irradiated DNA. In addition,
immunoblotting allowed the quantitation of thymine dimers
at dimer concentrations undetectable by HPLC (see section
6.4) and thus provides a more sensitive means of dimer
detection than HPLC. Immunoblotting also has the advantage
of not requiring pre-treatment of the DNA antigen prior to
analysis. Furthermore, a single 400 ~l irradiated aliquot
of DNA allowed several more analyses to be performed using ·
immunoblotting, as only 5 ~l of sample was required for
immunoassay analysis Ln comparison with the 30 ~l of
hydrolysate injected onto the Ultracarb 5 ODS 30 column
during HPLC analysis.
The work presented in this thesis discusses the development
of an immunoblotting protocol for thymine dimer
quantitation. The technique is however only as good as the
chemicals and reagents used in its application. To
illustrate this point, an immunoblotting protocol with ECL
detection was performed using two different membranes for
immobilization of the antigen/antibody complexes. In the
first case, the charge modified Immobilon-N membrane
(chosen for this work) was used. A nylon based Hybond
membrane was also used in the same assay with all other
chemicals and reagents the same. Results indicate that a
1:5400 dilution of serum (obtained after immunization of a
1 mg/ml DNA antigen injected intramuscularly) was not
detectable using Hybond, but with the Immobilon-N membrane
the 1: 5400 dilution was clearly visible. An observation
such as this is indicative of the extent ' to which the
sensitivity of the assay is dependant on the reagents and
equipment used during experimentation.
Thus, in the work presented here, reagent concentrations
and incubation times were optimized to provide the
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strongest signal of the immune complex against the clearest
background (section 5.2.1.7). One factor which could not be
controlled with a large degree of success was the way in
which the membrane itself dried while the blotted UV-DNA
was drying. This protocol is discussed in section
5 . 2 . 1 . 7 . 2. As was noted, the membranes were pre-wet in
methanol, water and PBS prior to transferral to an adapted
ELISA plate positioned over an open plastic box. Each
membrane was shaken by hand to remove excess solvent prior
to being blotted and it was found that the membrane dried
erratically in comparison with the rate at which the UV-DNA
dried on its surface. In a few cases the membrane became
very white prior to the antigen drying (indicative of the
membrane drying out). Although the situation was much
improved by moving a stream of air across the membrane
surface there was no absolute control over the rate of
drying, especially for the more concentrated and viscous
DNA samples which took longer to dry. The best way of
overcoming the problem was to move a stream of air across
the membranes and transfer a membrane to the dried milk
solution as soon as the antigen blots were dry. As will be
outlined in section 6.2.4, this feature did affect
visualization of the antigen/antibody complex on the
luminescence film.
6.2.4 APPLICABILITY OF ENHANCED CHEMILUMINESCENT
QUANTITATION OF IMMUNE COMPLEXES
ECL was used in this work to detect and quantitate
antigen/antibody complexes immobilized on a membrane
surface and thus together with immunoblotting, these
techniques allowed the successful quantitation of thymine
dimer lesions generated in UV-irradiated DNA at
concentrations as low as 2.5 x 10-10 M (Section 6.4).
The sensitivity achieved in . the immunoassay protocol with
chemiluminescent detection used here is comparable with
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that used by researchers elsewhere. The detection limits
for the chemiluminescent assay of ATP and NADH are reported
to be 10-10 mole and 10-16 mole repectively(178). Application
of chemiluminescence in immunology has allowed rabbit
IgG(19l) and hepatitis B surface antigen(192) to be monitored
in a solid phase immuno~ssay with chemiluminescent
detection. However, these latter two assays had the
disadvantage of non-specific binding of serum components
(e.g. haemoglobin, cytochrome) which can affect the
sensitivity of the assay(18l).
To obviate the problems associated with binding of non-
specific components, Schroeder, Hines et al.(18l) monitored
hepatitis B surface antigen using a solid phase immunoassay
where the antigenf antibody components were bound to the
surface of conventional PVC microtitre (ELISA) plates. The
protocol allowed for wash steps which eliminated
interference from serum components during assay. A
luminometer added peroxide to initiate chemiluminescence
and provided an automated output of light generated at 10
second intervals. The technique allowed for 0.1
picomolflitre of antigen to be detected.
If the protocol followed by Schroeder, Hines et al. is
compared with that used in this work, then, in essence, the
same principles have been applied to the quantitation of
thymine dimer. Several wash steps were included in the
immunoblotting portion of the protocol to reduce the amount
of non-specific binding occurring at unreacted portions of
the membrane. However the means of quantitation between the
method of Schroeder et al.(18l) and the work presented here
was different. Visual analysis of the immune complexes was
used in this research to identify a darkened spot on the
luminescence film against the background interference. As
will be shown in Section 6.3, where a calibration graph of
cut-off antibody dilutions v~rsus dimer concentrations was
constructed, use of a luminometer attached to a chart
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recorder allowed, in some cases, more sensitive detection
of the cut-off dilutions. It thus appears desirable to use
a luminometer to confirm cut-off dilutions which may be at
the limit of sensitivity of the chemiluminescent detection
system.
Despite precautions being taken to minimize background
interference (use of a blocking solution and several wash
routines), non-specific binding to the membrane was not an
easy factor to control. Apart from non-specific binding,
background interference can possibly be attributed to the
way in which the membranes were washed, as well as the age
of the luminescence film. In the former case, between 6 and
9 membranes were washed together in a plastic box using
PBS-Tween as the wash solution. The box was placed on a
shaking waterbath and the membranes washed by the PBS-Tween
solution flowing over them in a backwards and forwards
motion. It is possible that this routine could result in
some membranes not coming into contact with wash solution,
especially if two or more membranes adhered to one another
during washing. Thus removal of serum components (causing
the high background interference) would not be effected,
resulting in very little discrepancy between a darkened
immune complex and background interference on the
luminescence film. As a suggestion for workers in this
field, an improvement could be made by reducing the number
of membranes per box, or enclosing each membrane in a glass
Polytop vial containing wash solution as was done for
membrane incubation with the primary and secondary
antibodies. However, such a step is extremely tedious and
time consuming, considering that 12 to 18 membranes were
treated in a single protocol and each membrane was washed
approximately 12 times during the protocol.
The protocols which yielded the strongest immune complex
signal against the clearest background were those which
utilized fresh luminescence film stored in a refrigerator.
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As was outlined in section 5.2.2.3.2, the luminescence film
decayed over a 4 to 6 month period especially if it was
maintained at room temperature. Initially the entire film
became darkened prior to developing and printing and
thereafter no discernable immune complexes were detected on
the film. It was thus imperative to check the background
signal of the luminescence film and buy fresh film whenever
necessary.
A further consideration in viewing the antigen/ antibody
complexes on the luminescence film is whether the outer
ring of the complex or the inside of the complex be viewed
to determine if the complex is present at a specific
antibody dilution. At -the lower DNA concentrations « 0.025
mg/ml DNA) the antigen blots did not appear to dry and bind
to the membrane in the circular shape that the antigen was
delivered to the membrane surface. Instead, lower surface
tension (in the less concentrated DNA samples) appeared to
cause the antigen blot to spread out, resulting in uneven
drying of the blot on the_ membrane. The problem was
compounded if the membrane itself dried erratically so that
a non-symmetric blot usually with a darkened rim and of
varying intensity was observed on the luminescence film,
making detection and quantitation extremely trying. with a
fair degree of success, this problem was averted by viewing
the most symmetrical blot over a range of 2 or 3 blots
produced using identical conditions and incubation times.
The result was confirmed using the scanning densitometer
(Section 6.4) to confirm or negate a signal against
background interference.
Thus the sensitivities afforded by both immunoblotting and
EeL together allow the quantitation of thymine dimer in uv-
irradiated DNA at concentrations as low as 2.5 x 10-10 M. It
therefore appears possible that the immunoassay technique
described in this thesis ~ill provide the sensitivity
called for in the planned extension (in this laboratory) of
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kinetic and mechanistic studies of thymine dimer
quantitation to in vivo cellular systems. In this context,
pyrimidine dimers generated at sub-lethal DV fluences have
been detected by Wani, D'Ambrosio and Alvi(162) who
demonstrated the quantitation of these dimers in human
cells by immuno-slot blotting analysis. Fibroblasts were
irradiated with a germicidal lamp (254 nm), the DNA
extracted (phenol, chloroform) and the DNA used in an
immuno-slot blot assay as proposed by Nehls et al. (84) •
(Immuno-slot blot assays utilize a sophisticated piece of
equipment to deliver the required volume of antigen to the
membrane surface through a slot which ensures a constant
shape of antigen on the surface.) Results indicate that
irradiation with light of a 0.5 J/m2 fluence allowed 20 ng
of irradiated DNA to be detected and hence adds support to
the applicability of this immunoblotting technique for the
quantitation of low concentrations of DNA found in cellular
systems. In these laboratories, quantitation of dimers in
cellular systems was initiated by irradiation of E. coli
bacteria in the presence of acetophenone(51). Although
problems were experienced in absorption of acetophenone by
the bacteria, this irradiation substrate is suitable for
the work presented here, the applications of which are
described in section 6.8.
In order to detect low concentrations of thymine dimer, it
is imperative to establish a calibration graph of cut-off
antibody dilutions versus thymine dimer concentrations.
Thus, the following section (6.3) discusses aspects of a
calibration graph that was constructed to allow the
quantitation of dimer yields at levels undetectable by the
HPLC currently employed in these laboratories.
6.3 CONSTRUCTION OF A CALIBRATION GRAPH FOR THYMINE DIMER
QUANTITATION
This research has been directed towards the development of
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an immunoassay technique for the quantitation of the most
important UV-photoproduct, the cis-syn thymine dimer. As
was discussed in Chapter 5, the immunoassay protocol of
immunoblotting was developed in conjunction with enhanced
chemiluminescence to allow the detection and quantitation
of thymine dimer, this technique was then used successfully
in determining antibody titres in rabbit serum during and
after a series of injections of the UV-irradiated DNA
antigen into laboratory animals (Section 6.2). However, if
this immunoblotting protocol is to be used in detecting
thymine dimer in cellular systems in vivo, then the
technique must be SUfficiently sensitive to detect
extremely low levels (~g/ml) of thymine dimer. with this in
mind, a calibration graph of antibody cut-off dilutions
versus known dimer concentrations was constructed so that
the dimer concentration of an unknown antigen sample (i.e.
UV-irradiated DNA) could be obtained by determining the
observed cut-off dilution and relating it (through the
calibration graph) to dimer concentrations.
currently in these laboratories dimer concentrations in UV-
irradiated DNA are measured by HPLC. Thus the HPLC was used
to measure dimer concentrations required to construct the
calibration graph of cut-off antibody dilutions versus
dimer concentrations.
In order to do this, a range of DNA-acetophenone-PBS
solutions of varying concentrations were prepared as
outlined in Section 2.8.2.5 and irradiated using the HBO
500W/2 short arc mercury lamp (Section 2.8.1.2). The DNA
solutions were irradiated to reach maximum or near maximum
dimer yields . (1.0 mg/ml DNA for 10 hours and 0.5 mg/ml for
6 hours). A second O. 5 mg/ml DNA sample was irradiated
immediately after the first one. This second UV-irradiated
DNA sample was di~uted as follows: after transferral to a
Durham t.ube , a 200 ~l a Li.quot; of the 0.5 mg/ml UV-
irradiated DNA was transferred to a clean and dry Durham
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tube. Addition of 200 ~l of PBS to the second Durham tube
diluted the DNA sample to 0.25 mgjml in a 400 ~l volume.
using the remaining 200 ~l aliquot of the 0.5 mgjml DV-DNA
solution as the "stock", the following dilutions were
performed:
Remove 80 ~l 0.5 mgjml UV-DNA + 320 ~l PBS 0.1 mgjml
Remove 40 ~l 0.5 mgjml UV-DNA + 360 ~l PBS 0.05 mgjml
Remove 20 ~l 0.5 mgjml UV-DNA + 380 ~l PBS 0.025 mgjml
Remove 10 ~l 0.5 mgjml DV-DNA + 390 ~l PBS 0.0125 mgjml
Although lower DNA concentra~ions were prepared (and will
be discussed later in this section), the abovementioned
concentrations of 1.0 mgjml to 0.0125 mgjml were used as a
starting point in constructing the calibration graph. It is
important to note that all volumes correspond to the
original 400 ~l of sample that was irradiated. Each 400 ~l
sample of a different DNA concentration was then split: 200
~l for analysis by HPLC and 200 ~l for analysis by
immunoblotting. Such a step was necessary to ensure that
the light intensity (and hence energy) impinging on the DNA
was identical for each aliquot to be analysed by the two
different techniques.
6.3.1 HPLC ANALYSIS
The calibration graph of dimer concentration versus
integrated peak area constructed in Section 3 . 2 . 3 was
specific for the chromatographic parameters (column,
eluant, flow rate, injection volume) employed. Hence, for
this calibration graph to be useful, the same parameters
were used in determining dimer yields of the 1.0 mgjml to
0.0125 mgjml DNA 200 ~l samples. Despite the fact that only
200 ~l of each sample was available for HPLC analysis (as
opposed to 400 ~l elsewhere in this work), this did not
prove to be a problem du~ing acid hydrolysis of the
samples. The volumes of reagents outlined in Section 3.1.1
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were halved, whereas the acid hydrolysis reaction and
centrifugation were still used at 1 hand 15 min
respectively. In this manner, 30 ~l of each hydrolysate was
injected into the HPLC onto an Ultracarb 5 aDS 30 C18
reverse phase column and Milli-Q water (pH 6.0) mobile
phase at a 0.7 mljmin flow rate. MUltiple injections of a
particular DNA sample were performed on the HPLC. Dimer
peak areas were integrated at 220 nm and the calibration
graph (Section 3.2.3) used to calculate dimer yields. Table
6.4 illustrates the DNA concentrations analysed as well as
the resulting dimer concentrations. These results are
represented graphically in Figure 6.5. This graph confirms
the linearity between DNA concentration and thymine dimer
concentration in DV-irradiated DNA observed by others in
these laboratories (50,54) •
[DNA] I mg/ml . * I M Range of [Dimer]t/ M[Dlmer]
1.0 3.722 x 10-5 (3.443 to 4.088)
x 10-5
0.5 1.926 x 10-5 (1.894 to 1.956)
x 10-5
0.25 8.840 x 10-6 (8.500 to 9.940)
x 10-6
0.1 4.621 x 10-6 (4.090 to 5.030)
x 10-6
0.05 2.013 x 10-6 (1.660 to 2.360)
x 10-6
0.025 - -
*. Average dimer yield
t. Range of dimer yields obtained by mUltiple analysis
of the DV-DNA s~mple.
Table 6.4. Cis-syn thymine dimer yield as a function of DNA
concentration, [Acp] = 2 x 10-2 M, 1 mgjml DNA =
10 hours iradiation and 0.5 mgjml to 0.025 mg/ml
= 6 hours irradiation.
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Figure 6.5. Cis-syn thymine dimer yields as a function of
DNA concentration, [Acp] = 2 x 10-2 M, 1.0 mg/ml
DNA = 10 hours irradiation and 0.5 mg/ml to
0.025 mg/ml DNA = 6 hours irradiation.
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For the 0.5 mg/ml and 1.0 mg/ml DNA samples, a 0.05 AUFS
(Absorbance units Full Scale) value on the y-axis of the
chromatogram was used. For the other DNA concentrations
(0.025 mgjml and lower) 0.02 and 0.01 AUFS were employed
for the y-axis. These two last mentioned scales show
significant signal-to-noise ratios during analysis. Thus
while it was difficult to analyse low concentrations of
dimer (because the sensitivity threshold of the instrument
was being reached), the situation was worsened because of
a drifting baseline with significant signal-to-noise ratio.
This made analysis extremely difficult. Figure 6 .6.
illustrates the peak integration area for 1 mgjml DNA, as
opposed to the peak used by the computer to integrate the
dimer area for the 0.05 mgjml DNA. In the latter case, the
peak is not significantly different from the baseline
noise. To minimize this instability as far as possible, the
instrument was stabilized for approximately 1 hour between
injections of DNA hydrolysate.
When the 0.05 mgjml DNA sample was analysed by HPLC, the
dimer peak did not give its characteristic UV spectrum.
However, after the "Spectrum Analysis" file of the HPLC
programme (loaded onto the attached NEC APCll computer) was
used, the dimer was identified according to its retention
time and UV spectrum. The "Integration" file then allowed
a peak area to be calculated at the particular retention
time. These observations can be seen in Figure 6.7. for the
analysis of 0.05 mg/ml DNA. Using the same technique, the
0.025 mg/ml DNA sample was analysed by HPLC, but a UV
spectrum was not identified using the "Spectrum Analysis"
file. So the thymine dimer generated in this sample of DNA
was not detectable by HPLC. Thus cis-syn thymine dimer of
approximately 2 x 10-6 M, generated after 6 hours UV
irradiation of a 0.05 mgjml DNA sample was detected by the
Waters 990 photodiode array petector.
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Figure 6.7. HPLC chromatogram showing separation of a
0.05 mg/ml DNA hydrolysate illustrating
specifically the cis-syn dimer peak
undetectable by the Waters 990 photodiode array
detector.
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It was not important to determine the absolute detection
limit of the instrument, as the main crux of the thesis
involves the determination of dimer yields (by
immunoblotting) at DNA concentrations below the HPLC
detection limit. (As mentioned elsewhere previous workers
in this laboratory(54) could only examine acetophenone
photosensitized irradiations of DNA at concentrations
greater than 0.1 mg/ml DNA.)
The next section discusses the immunoblotting protocol
(antigen and antibody dilution preparation) used in this
work to determine dimer concentrations in UV-irradiated DNA
at levels undetectable by the HPLC. The use of scanning
densitometry will be outlined as a confirmatory technique
to detect antigen/antibody complexes on the luminescence
film after ECL.
6.3.2 IMMUNOBLOTTING WITH ENHANCED CHEMILUMINESCENCE
QUANTITATION
For HPLC purposes the UV-irradiated DNA was acid hydrolysed
to break down the DNA to its component parts prior to
analysis. For immunoblotting purposes, this same UV-
irradiated DNA was the antigen in the protocol developed in
Chapter 5. As was outlined in that chapter, the DNA was
denatured (in addition to being irradiated) before being
complexed to methylated bovine serum albumin and Freunds
Incomplete Adjuvant, and then injected into rabbits.
However, when the UV-DNA was used as the antigen in the
immunoblotting protocol, it was merely denatured before
being bound to the Immobilon-N membrane. Such a step helped
prevent antibodies generated against MBSA and Freunds
Incomplete Adjuvant responding to the immmobilized antigen.
Antigen preparation in the immunoblotting protocol involved
denaturation of the 200 . ~ l aliquots of varying DNA
concentrations by heating for 10 minutes at 100°C, followed
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by cooling on ice for 10 minutes. All solutions required
for immunoblotting analysis were prepared fresh. Because
the construction of the calibration curve necessitated the
use of much serum sample, the i/v T (intravenous terminal)
serum was used (approximately 50 ml of serum was obtained
after cardiac puncture, in comparison with 0.5 ml to 1.0 ml
serum obtained during a routine bleed of the rabbit) and
diluted for this purpose. For detection new X-ray
luminescence film as well as developer and fixer were
acquired and stored in a refrigerator (4 °C) to prolong
their lifespan.
The ECL detection solutions supplied by Amersham were
tested to ensure that blue light of 425 to 430 nm was
generated. This was performed by adding 500 J1.1 of each
detection solution to the same 5 ml glass beaker. with the
lights switched off, 3 J1.l of stock secondary antibody
conjugate was added to the detection solutions and the
contents of the beaker swirled by hand. The presence of the
blue light confirmed the detection solutions to be
generating and catalysing the light emission signal.
The i/v T serum which was frozen was brought to room
temperature. Fresh serial dilutions of this serum were
prepared as outlined in Section 5.2.1.7.5 in clean and dry
Polytop 12 ml glass vials. Using the 200 J1.1 sample of the
1 mg/ml irradiated and denatured DV-DNA as the antigen, the
immunoblotting protocol was performed as summarized in
section 5.2.1.8. Primary antibody dilutions of 1: 400 to
1:12150 were used as a starting point, and only two 5 J1.1
aliquots of antigen were spotted onto the Immobilon-N
membrane to conserve sample. (If the sample had run out,
more would have had to be irradiated and once again
analysed by HPLC.) The ECL detection protocol (summarized
in section 5.2.2.4) was performed on the antigen/antibody
complexes immobilized on t~e membranes. Results indicated
that the cut-off dilution of the antibody sample for the
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1.0 mg/ml DNA antigen was not reached with a 1:12150
dilution of the serum.
Hence, further dilutions of the i/v T serum (1:20000,
1:30000, 1:45000 and 1:67000) were prepared and the
immunoblotting protocol was performed using these dilutions
and the 1 mg/ml DV-DNA antigen. ECL detection and analysis
indicated that the antigen/antibody complex was still
present on the X-ray film. Further dilutions of 1:80000,
1:90000, 1:100000 and 1:110000 were used in the same
immunoblotting protocol. Visual analysis of the X-ray f ilm "
indicated the 1:80000 and 1:90000 and possibly the 1:100000
dilution were present as an antigen/antibody complex on the
film. Because these results were integral to the thes is,
the protocol was repeated with the 1: 80000 to 1: 110000
dilutions of serum to obtain mUltiple X-ray films of the
potential 1:100000 cut-off dilution of antibody using a 1
mg/ml antigen. In addition, the same protocol was performed
using PBS as the antigen to check that it was the solute
(uv-irradiated DNA) and not the solvent (PBS) causing a
darkened spot on the X-ray film. No darkening of the film
was observed visually using the PBS as antigen. Those X-ray
films containing the "possibly visible" antigen/antibody
complexes were examined using scanning densitometry. A GS
300 Transmittance/Reflectance scanning densitometer
(Hoeffer Scientific Instruments, San Fransisco) attached to
a Varian 4270 Chart Recorder/Integrator (both on loan from
the Department of Biology at the University of Natal,
Durban) was used to scan the X-ray film over the darkened
areas. Although problems were experienced in scanning
against a relatively dark background of the X-ray film,
Figure 6.8 illustrates the 1:80000 and 1:1000000 dilutions
to be present against the background noise, the height of
the signal "be i ng proportional to the intensity of the spot
and hence proportional to the concentration of antigen
bound to the membrane. The 1~110000 showed no difference in




Figure 6.8. Chart recorder signals of 1:80000 and 1:100000
dilutions of crude serum used in an
irnrnunoblotting protocol to determine the cut-
off dilution of the 1.0 mg/ml DNA antigen.
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tentatively assigned to the cut-off dilution for the 1
mg/ml DNA sample. It is important to add though, that any
value between 1:100000 and 1:110000 could possibly be the
correct one, but time did not permit the preparation of a
series of dilutions between these values, nor the
performance of the lengthy protocols required.
In the same manner that has been described above,
individual 0.5 mg/ml, 0.1 mgiml, 0.05 mg/ml 0.025 mg/ml and
0.0125 mg/ml DNA samples were irradiated and used as the
antigen in the immunoblotting protocol with ECL detection
o f the immune complexes. Table 6.5. shows the DNA
concentrations and cut-off dilutions that were detected by
visual inspection of the X-ray film. It also illustrates
the cut-off dilutions that were determined using scanning
densitometry. A few of these dilutions have been extended
using this alternative detection technique. The data is
represented graphically in Figure 6.9.
[DNA] [Dimer] I M Cut-off Cut-off
I mg/ml dilution dilution
(visual) (densi-
tometry)
0.50 1.926 x 10-5 1:45000 1:45000
0.10 4.621 x 10-6 1:19000 1:19000
0.05 2.013 x 10-6 1:10000 1:10000
0.025 1.006 x 10-6 1:5400 1:8100
0.0125 5.030 x 10-7 1:3600 1:5400
Table 6.5. DNA and dimer concentrations used in the
immunoblotting assay together with the cut-off
dilutions determined using visual analysis and
scanning densitometry of the X-ray films.
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Figure 6.9. Calibration 'graph of cis-syn thymine dimer
concentrations versus cut-off antibody
dilutions for DNA concentrations of 0.5 mg/ml
to 0.0125 mg/ml.
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A further invest igation to determine the lowest detection
limit of the immunoblotting protocol was carried out. In
this case, a single 0.5 mg/ml DNA sample was irradiated for
6 hours and diluted. The assays yielded the cut-off
dilut ' ons as shown in Table 6.6. at these lower DNA
concentrations.
rDNA] I mg/ml I rDimer] I M* I cut-off Dilution
6.250 x 10-3 2.516 X 10-7 1:10000
3.125 x 10-3 1.258 X 10-7 1:5400
7.812 x 10-4 3.145 X 10-8 1:3000
1.953 x 10-4 7.863 X 10-9 1:400
3.125 x 10-5 1.258 X 10-9 1:50
6.250 x 10-7 2.516 X 10-10 1:1
* obtained by dilution of a 0.5 mg/ml UV-irradiated
DNA sample.
Table 6.6. DNA and dimer concentrations used in the
immunoblotting protocol together with the cut-
off antibody dilutions determined using scanning
densitometry of the X-ray films.
As was outlined earlier in this section, the X-ray films of
the lower DNA concentration as antigen were also examined
under a GS 300 Transmittance/Reflectance scanning
densitometer to confirm or negate a "possibly visible"
antigen/antibody complex on the X-ray film. The dimer
concentrations versus cut-off dilutions are represented
graphically in Figure 6.10.
If the cut-off dilutions determined by immunoblotting for
the entire DNA concentration range (1.0 mg/ml to 6.25 x 10-7
mg/ml) are examined, a distinct anomaly becomes evident. A
DNA concentration of 5 x 10-2 mg/ml has a cut-off dilution
of 1:10000, while this same cut-off dilution is obtained
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Figure 6.10. Calibration graph of cis-syn thymine dimer
concentrations versus cut-off antibody
dilutions for DNA concentrations of
6.25 X 10-3 mg/ml to 6.25 X 10-7 mg/ml.
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for the 6.25 x 10-3 mg/ml DNA antigen. In the same vein, the
1.25 x 10-2 mg/ml DNA concentration has a cut-off of 1:5400,
while it is also the cut-off for the 3.125 x 10-3 mg/ml DNA
concentration. Figure 6.11. illustrates the dimer
concentration plotted against the cut-off dilutions for the
entire range of DNA concentrations used. It was thought
that this calibration graph would yield a straight line of
dimer concentration versus cut-off dilution since the lower
the dimer concentration, the fewer the antibody molecules
which would bind to the dimer, hence more dilute serum
samples (containing proportionally fewer antibody
molecules) would be needed to produce this cut-off dilution
observed as a lightening of the antigen/antibody complex on
the X-ray film after ECL detection. Clearly, an unexpected
feature of the immunoblotting protocol is coming to light.
6.3.3 EXPLANATION OF THE ANOMALY IN THE CALIBRATION
GRAPH
As was outlined above (Section 6.3.2), a non-linear
calibration graph was obtained (see Figure 6.11) to relate
dimer concentrations (determined by HPLC) and cut-off
antibody dilutions of antigen/antibody complexes
(determined by immunoblotting with ECL detection). The non-
linearity of the calibration graph can possibly be
explained in terms of a "masking effect" on the Immobilon-N
membrane itself. At the higher DNA concentration (e. g.
0.025 mg/ml) the DNA which is acting as the antigen in this
protocol, is saturating .t he membrane. Hence, a layering of
antigen is occurring on the membrane surface limiting
access of antibody and secondary antibody molecules to
every thymine dimer molecule during the immunoblotting
protocol. Because a series . o f reagents are added
succesively to the membrane, a bulky antigen/antibody
complex (formed after incubating the antigen containing
membrane with diluted serum) . could restrict access to other
antigen/antibody complexes during addition of the secondary
262



















Figure 6.11. Calibration graph of cis-syn thymine dimer
concentrations versus cut-off antibody
dilutions for DNA concentrations of
5 x 10-1 mg/ml to 6.2 5 X 10-1 mg/ml.
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antibody conjugate (which is itself bulky) . Thus
steric hindrance and the phenomenon of "site restriction"
can explain the non-linearity of the calibration graph.
In terms of the explanation given above, at the lower
antigen concentrations (6.25 x 10-3 mg/ml to 6.25 x 10-7
mg/ml DNA) that portion of the membrane that was blotted
with antigen is not saturated with the antigen. Hence no,
or little, layering of the UV-irradiated DNA on the
membrane is occurring. Thus each antigen molecule comes
into contact with primary and secondary antibodies,
resulting in darker antigen/antibody complexes on the
luminescence film. This extends the range of cut-off
dilutions (which were observed in section 6.3.2) and hence
affords "increased sensitivity" at these lower DNA
concentrations.
In molecular biology applications, ethidium bromide is used
to confirm the presence of DNA (or its constituents) in
solution or immobilized on membranes (as in this work) by.
intercalating with the DNA. However, its applications are
qualitative in nature and the compound must be used in the
dark. Thus, although it could theoretically be used to
stain the DNA immobilized on the membrane, it would not
reveal whether a certain concentration of DNA was
saturating the membrane. However, a means of obviating site
restriction of the antigen would be to decrease the volume
of UV-irradiated DNA blotted onto the membrane surface.
section 5.2.1.7.2 explained the choice of a 5 ~l antigen
volume. This could be reduced to 1 or 2 ~l, but this
modification was not attempted in this work because of time
constraints. This does, ' however, provide a suggestion for
future workers.
The following section (6.3.4) discusses the choice of
calibration graph needed . t o convert cut-off antibody
dilutions to thymine dimer yields.
6.3.4
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ESTABLISHMENT OF THE CUT-OFF ANTIBODY DILUTION
VERSUS THYMINE DIMER CALIBRATION GRAPH
To help clarify the discussion which is to follow, Table
6.7. illustrates the dimer concentrations used and the
resulting cut-off dilutions determined by immunoblotting
for the entire range of DNA concentrations employed.
rDimerl / M I Cut-off Dilution
1.926 x 10-5 1:45000
8.840 x 10-6 1:30000
4.621 x 10-6 1:19000
2.103 x 10-6 1:10000
1.006 x 10-6 1:8100
5.030 x 10-7 1:5400
2.516 x 10-7 1:10000
1.252 x 10-7 1:5400
3.145 x 10-8 1:3000
7.863 x 10-9 1:400
1.258 x 10-9 1:50
2.516 x 10-1 0 1:1
Table 6.7. Experimentally determined cis-syn thymine dimer
yields and cut-off dilutions for DNA
concentrations of 5.0 x 10-1 mg/ml to 6.25 x 10-7
mgjml.
Regression analysis (using the computer programme
Statgraphics) was performed on selected and all calibration
points. B~th sim~le and mUltiple linear regression options
were used. Simple regression fits the best straight line
(given by y = mx + c) through the points. Unlike simple
regression, mUltiple regres~ion fits the best straight line
through the origin (i.e. y = mx). Both procedures use least
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squares to estimate the regression model.
Four regression analyses were performed:
1. Regression analysis of the lower region of the
calibration graph using the simple linear mode of analysis.
2. Regression analysis of the lower region of the
calibration graph using mUltiple regression.
3 . Regression analysis of the entire calibration graph
using a simple linear mode of analysis.
4. Regression analysis of the entire calibration graph
using mUltiple regression.
The slope, intercept and correlation coefficients for these
regression analyses are given in Table 6.8.
Slope I Intercept I Correlation
dilution M-I Dilution Coefficient
1 3.878 x 1010 438.7 0.9850
2 4.107 x 101 0 0 -
3 2.503 X 109 3974 0.9927
4 2.659 x 109 0 -
Table 6.8. Slope, intercept and correlation co-efficient
data for the four regression analyses performed
on the calibration data points.
As will be seen in section 6.5, substantial antibody
production has occurred against non-thymine dimer antigens
and this fact must be accounted for by the choice of
calibration graph. To this end, the graph which most
adequately fits the observation is given in Figure 6.12.,
where a y-intercept of 3974 has been calculated by the
Statgraphics regression analysis programme (Table 6.8.). In
this context, it must be noted that analysis 2 and ana~ysis
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Figu~e 6.12. Calibration graph used to relate cut-off
antibody dilutions to thymine dimer yields.
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and therefore do not adequately reflect these observations.
Analysis 1 allows non-dimer antibody production of only one
tenth that observed in analysis 3 and thus is also
excluded.
Thus despite the apparent non-linearity of the calibration
graph, one can fit a straight line to this data with a
slope of 2.503 x 109 dilution M-I and intercept of 3974. The
correlation coefficient of these points was calculated by
the programme to be 0.9927. The intercept of 3974 possibly
takes account of the antibody production against MBSA and
Freunds Adjuvant. It seems logical that it accounts for
antibody directed against these components and not the
associated DNA components (phosphate-deoxyribose backbone,
purine and pyrimidine bases and histone protein) because a
constant volume and concentration of MBSA and Freunds
Adjuvant were injected into the rabbits during each of the
immunization schedules. In contrast, DNA of varying
concentrations (1.0 and 0.5 mg/ml) were injected into the
rabbits during successive immunization schedules.
since some antibody production is directed against non-
dimer antigen, the relationship between dimer concentration
and antibody dilutions can be expressed as
kD=--
A-a
where D is the thymine dimer, k is the slope of the
calibration graph relating dimer concentrations to cut-off
antibody dilutions (A) and a is that portion of the
antibody production directed against non-dimer antigen. The
above relationship is based upon the linearity between cut-
off antibody dilutions and thymine . dimer yields as was
established earlier in this section.
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Thus
log k (A-a,) + log D = log k
and
log (kA-ka) + log D = c
where c represents a constant. Replacing kA with y and ka
with Ye' then
log (y-Yo) + log D = c












where dD represents the error in determining dimer yields
D
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and gy represents the error in estimation.
y
More specifically the latter estimates the ability of a
naked eye to detect the presence or absence of an immune
complex on the luminescence film. If this value can be
estimated, then the error in determining the dimer yields
can be calculated.
Visual analysis is used to calculate pH measurements when
comparing a given reaction colour against a colour pH
scale. Assuming it is possible to visually observe a 0.1 pH
difference, then the range of values which can be observed
is 0.2. Seeing that visual analysis is also used ' this
work, this value (0.2) was inserted into the final
equation.
Using the cut-off dilutions outlined in Table 6. 7 ., the
following table provides the relevant errors in calculating
the thymine dimer yields based on the cut-off antibody
dilutions.
cut-off dD dD I M
dilution D
1:45000 -0.2194 4.225 x 10-6
1:30000 -0.2305 2.037 x 10-6
1:19000 -0.2529 1.168 x 10-6
1:8100 -0.3319 6.681 x 10-7
1:5400 -0.3926 3.949 x 10-7
1:10000 -0.3319 8.351 x 10-8
1:5400 -0.7573 9.527 x 10-8
Table 6.9. Table illustrating the error of estimation of
dimer yields based on the error in determining
cut-off antibody dilutions.
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Although dimer concentrations below 1.258 x 10-7 M were
analysed in this work (correlating to an error of 9.527 x
10-8 M), the cut-off dilution of 3974 attributed to non-
dimer antibody production does not allow an error to be
determined for the 1: 3000, 1: 400, 1: 50 and 1: 1 antibody
dilutions.
The following section (6.4) discusses the sensitivity of
the immunoblotting protocol as used for the quantitation of
thymine dimers in UV-irradiated DNA. Thereafter the
discussion will extend to the investigation of the .
specificity of the antibody produced by the rabbits in
response to the UV-irradiated DNA antigen.
6. 4 SENSITIVITY OF IMMUNOBLOTTING ANALYSIS FOR THYMINE
DIMER QUANTITATION
In immunoassays, the question of sensitivity of any
particular assay can be monitored in two ways. The first
assesses the lowest UV fluence required to bring about
detectable dimer quantitation. The other approach examines
the mass or concentration of thymine dimer detectable by
the assay. Researchers in the field have commonly adopted
the former approach in determining the sensitivity limits
of their assays. Amongst them are Seaman et al.(74) who used
a radioimmunoassay to measure induction and removal rates
of thymine dimer in DNA extracted from bacterial and
mammalian cells. The sensitivity limit of detection allowed
dimers induced by UV fluences of 5 Jjm2 (254 nm irradiation)
to be detected. Later workers increased the sensitivity of
radioimmunoassay by using plasmid DNA labelled in vitro by
nick translation with [32 P]-deoxyribonucleotide
triphosphates as a competitive tracer. Using this method
Mitchell and Clarkson (193) detected photoproducts in
cellular DNA at UV doses of 2.5 Jjm2.
More recently, the ELISA assay (Leipold et al.(82) and Wani
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et al.(124) ) was used to measure pyrimidine dimers in DNA,
extending the limit of sensitivity of dimers to 1 to 2 J/m2.
However, Wani et al.(162) (1987) detected dimers induced by
even lower sub-lethal (0.5 J/m2) DV doses using immunoslot
blot analysis. Recently an ELISA was used to characterize
a monoclonal antibody (TDM-2) which recognised dimers
induced by DV fluences of 0.5 J/m2(194).
In this work, however, a DV source of fixed intensity was
employed for the irradiation of in vitro calf thymus DNA.
It is possible that Pyrex filters could have been employed
to reduce the DV intensity, but the choice of filter would
have been crucial so as not to interfere with the
photosensitized irradiations being performed. It was thus
easier to approach the question of sensitivity by
considering the lowest dimer concentration detectable by
immunoblotting with EeL quantitation.
Indirectly, the sensitivity of the protocol employed in
this work has already been calculated. Referring to Table
6.6. (Section 6.3.2), the lowest possible dimer
concentration detected using immunoblotting is 2.5 x 10-10
M observed after 6 hours irradiation of a sample of DNA of
concentration 6.25 x 10-7 mg/ml. Previous members of this
research group (54) (working in the o. 1 mgjml DNA
concentration range), detected about 2 x 10-6 M thymine
dimer with 2 x 10-2 M acetophenone (as in this work) and a
1 mm Pyrex filter (unlike the 10 mm Pyrex filter used here)
after approximately a half hour irradiation.
As mentioned in Section 6.3, the sensitivity threshold of
the Waters 990 photodiode array detector for dimer
detection lay between 0.05 mgjml DNA (where the dimer was
detected at 2.10 x 10-6 M) to 0.025 mg/ml DNA (where the
dimer was not detected) after 6 hours irradiation of the
DNA sample. If an absolute ,s e ns i t i v i t y threshold of dimer
detection at 0.05 mgjml DNA after 6 hours irradiation is
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assumed, together with the immunoblotting limit of 6.25 x
10-7 mg/ml DNA, then immunoblotting is approximately 8000
times more sensitive than the HPLC used in these
laboratories. If an absolute sensitivity threshold of dimer
detection in 0.025 mgjml DNA is assumed after 6 hours
irradiation, then immunoblotting is about 4000 times more
sensitive than the detection threshold of the UV photodiode
array detector used in this work.
The following section (6.5) considers the specificity of
the antibody generated by the rabbit immune system.
6.5 SPECIFICITY OF THE ANTIBODY GENERATED BY THE RABBIT
IMMUNE SYSTEM
Researchers who have generated anti-DNA antibodies in
laboratory animals have usually undertaken a detailed
examination of the antigenic specificity of the antibody
produced. Results indicate that the antigenic determinant
of antibodies generated against UV-irradiated DNA is the
cyclobutane pyrimidine dimer as suggested by shortwave
photoreversal (71), enzymatic photoreactivation of the UV
photoproducts(72,73,196) and correlation of the antigenic
activity with expected or chromatographically measured
repair kinetics of dimers(74,195).
The majority of the sera tested in the abovementioned
example$ showed specificity for the thymine dimer, a few
showed specificity for the cytosine-cytosine
dimer(71,124,193,196) while the majority were not tested for
their specificity to cytosine-thymine dimers or 6-4
photoproducts. At the beginning of the 1980's only the
serum produced in the experiments of Strickland and
Boyle(198) showed specificity for thymine cyclobutyl dimers
and showed no response when tested against cytosine-
thymine, cytosine-cytosine '. 6-4 photoproducts and other
non-dimer photoproducts. However, these researchers were
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experimenting with monoclonal antibodies (Section 1.2)
producing IgG molecules which recognized adjacent thymine
residues in single stranded DNA or synthetic
oligonucleotides with a high degree of discrimination.
In 1991 Mizuno et al.(168) developed a monoclonal antibody
(TDM-l) which bound to 313 nm UV-irradiated DNA in the
presence of acetophenone. A monoclonal antibody recognizing
6-4 photoproducts was developed by Matsunaga et al.(197).
Specificity of a particular anti-UV-DNA serum can be
enhanced by removing non-specific antiserum by pre-
adsorption with single stranded DNA. Seaman et al. (174)
report that pre-adsorption as mentioned above, removed non-
specific binding to single stranded DNA without reducing
specific (UV single stranded DNA) binding. However, two
other studies(195,198) report that anti-UV· single strand DNA
activity could not be separated from cross-reactivity with
undamaged single stranded DNA. These results suggest that
in the former case, two different antibody populations were
present in the antiserum; one specific for UV single
stranded DNA and the other specific for single stranded
DNA. In the latter case, a single antibody population with
high specificity for UV single stranded DNA and low
specificity for single stranded DNA was present.
The investigations noted above allude to the heterogenous
nature of the antigenic ' determinant and the antibodies
produced in response to them. In this work UV-DNA complexed
to MBSA and Freunds Incomplete Adjuvant was injected into
rabbits. Apart from responding to the thymine dimer, the
rabbit immune system would also have produced antibodies to
the MBSA protein, Freunds Adjuvant, a small concentration
of acetophenone and histone protein « 3%) associated with
the DNA as well as alien sequences of calf thymus DNA. As
was mentioned in section . 1 . 2 , antibody production to
thymine dimer occurs primarily in response to
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conformational changes induced by dimerization, rather than
the dimers themselves.
To investigate the specificity of the antibody containing
serum in this work, a series of immunoblotting protocols
were performed using various irradiated and/or denatured
DNA samples as the antigen in the protocol. In the routine
protocols that were performed in this work, irradiated and
denatured DNA was used as the antigen. Hence, the double
stranded calf thymus DNA was separated (by denaturation)
allowing maximum exposure of the thymine dimer to the
rabbit immunocompetent cells. As has already been
mentioned, a 1 mg/ml DNA (irradiated and denatured) gave a
1:1000000 cut-off dilution in the immunoblotting protocol.
The same protocol was performed using using 1 mg/ml DNA as
the antigen. However, the DNA that was used was not
irradiated but was denatured prior to use in the protocol.
This implied that the DNA strands were separated, allowing
antibody production against the DNA deoxyribose-phosphate
backbone, the purine and py~imidine bases and any histone
protein. Seeing that the same serum was used in each part
of the protocol, antibody production of MBSA and Freunds
Adjuvant was identical in each case.
Initial results indicated a cut-off dilution of between
1:55000 and 1:60000. Further investigations confirmed
1:56000 and 1:58000 dilutions being present as
antigen/antibody complexes for the e t c: 6 (subcutaneous
injection of antigen, sixth bleed) and i/m 6 sera used in
this assay. The cut-off dilution was thus taken to be
1:60000 which was confirmed using the scanning densitometer
as before.
Thus approximately 60% of the antibody generated by the
rabbits were directed against DNA constituents. By
implication approximately 49% of the antibody production
was directly produced against the thymine dimers or
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conformational changes induced by the dimerization process.
The following sections (6.6 to 6.8) turn to examine the
v~lidity of the previously developed kinetic mechanism for
the formation of thymine dimers in calf thymus DNA(54).In
previous work the lowest DNA concentration used to test the
mechanism was 0.1 mgjml DNA. Here lower DNA concentrations
were used to test the mechanism.
6.6 VALIDITY OF THE PREVIOUSLY DETERMINED MECHANISM AT
0.025 mg/ml DNA
This research is aimed at developing an immunoassay
technique to detect thymine dimer concentrations at levels
below the sensitivity threshold of the Waters 990
photodiode array detector currently used in this
laboratory. To this end, an immunoblotting protocol was
established and developed together with the technique of
enhanced chemiluminescence for the detection and
quantitation of thymine dimer lesions. The majority of the
development work for this immunoassay was performed at DNA
(and hence thymine dimer) concentrations detectable by
HPLC. When the technique was established, DNA
concentrations yielding dimer concentrations below the
sensitivity limits of the HPLC were tested to see whether
immunoblotting provides a more sensitive means of detection
over HPLC analysis. The results of this investigation are
manifest in the calibration graph data, the details of
which indicate that dimer concentrations as low as 2.5 x
10-10 M were detected.
Previous members of this research group (50,54) used HPLC
routines for quantitation purposes and used the HPLC
results together with chemical and actinometric data to
propose mechanisms for photosensitized dimerization for the
various thymine containing systems (aqueous thymine,
thymidine, thymidylyl-3',5'-thymidine, calf thymus DNA and
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plasmid DNA) under investigation. Thomas(54) examined the
kinetics of the acetophenone photosensitized irradiation of
calf thymus DNA at 0.1 mg/ml to 10.0 mg/ml DNA using both
2 x 10~ M and 4 x 10~ M acetophenone. The aim of the work
presented in the following sections is to examine the
validity of this previously developed kinetic mechanism for
the formation of thymine dimers in calf thymus DNA at
concentrations lower than those which could be examined
using HPLC techniques.
DNA of 0.025 mg/ml concentration was irradiated for varying
lengths of time. The irradiated DNA was used as the antigen
in immunoblotting analyses after which the cut-off
dilutions were correlated to thymine dimer concentrations
using a calibration graph (Section 6.3.4). These values
together with the mechanism proposed by Thomas~~, were used
in the programme CAKE to obtain simulated thymine dimer
yields. Support for the mechanism was found by comparing
experimental (determined by immunoblotting) and simulated
(determined by CAKE) dimer yields.
6.6.1 DNA IRRADIATION AND ANALYSIS BY IMMUNOBLOTTING
The DNA concentration which would give dimer yields
undetectable by HPLC was chosen for testing the kinetic
mechanism of photosensitized dimerization of thymine in
DNA. For this a DNA concentration of 0.025 mg/ml was
chosen. At this concentration the antigen/ antibody
complexes produced in the protocol would be dark and thus
hence easier to analyse.
A 0,025 mg/ml DNA solution was prepared as outlined in
section 2.8.2.5 and 400 ~l aliquots of the solution were
irradiated for varying lengths of time (0.5, 1.5, 2.5, 3.8
and 6 hours). The maximum irradiation time of 6 hours was
chosen to correlate with the 6 hour irradiation that the
0.5 mg/ml DNA sample (Section 6.3.1) was subjected to. In
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addition, the Blak-Ray J-221 Longwave photovoltaic DV
intensity meter (Section 2.8.1.1) was used to ensure no
significant discrepancy {( 3 I-£W cm- 2 over a 40 I-£W cm-2
average lamp intensity) between light intensities used for
the various irradiations. The DNA samples were denatured
(Section 4.2. 1. 3) before being used as the antigen in
immunoblotting protocols. Table 6.10. lists the irradiation
times of the 0.025 mg/ml DNA samples together with the
subsequent cut-off dilutions that were determined using
immunoblotting with ECL detection. The immunoblotting
protocol was repeated a number of times on each irradiated
DNA sample. Scanning densitometry was also employed to
confirm or negate a "possibly present" antigen/antibody
complex.






Table 6.10. Irradiation times and cut-off dilutions for
0.025 mg/ml DNA as analysed by immunoblotting
with ECL quantitation.
The above results (Table 6.10.) are represented graphically
in Figure 6.13. As can be seen, there is an increase in
dimer yield with increasing irradiation time, until
approximately 2.5 hours is reached. Thereafter a levelling
off in dimer concentration is evident in line with the fact
that maximum dimer yields are being reached at these
irradiation times. Saturation in dimer yields reflects a
limitation in substrate (c~ntiguous thymines in the DNA)
available for dimerization (i.e. undimerized), rather than
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Figure 6.13. Cut-off antibody dilutions as a function of
irradiation time, [DNA] = 0.025 mg/ml and
[ Acp] = 2 x 10 -2 M.
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a limitation in acetophenone available for photosensitized
reactions to proceed. The lower cut-off dilution after 3.8
hours represents a 6% decrease in maximum dimer yields
which falls within the range of experimental error for a
technique where visual observation of the results formed an
important part of the analysis.
The slope and intercept from the calibration graph were
used to convert the cut-off dilutions (as determined by
immunoblotting) to dimer concentrations. seeing that a
linear model (y = mx + c) was used, the following equation
is applicable:
[TT] = Cut-off dilution - Intercept
Slope
where [TT] refers to the thymine dimer concentration. Table
6.11. gives the calculated dimer yields determined at the
5 irradiation times using the above equation.
Time I h I [Dimer ] - - ,,.. I M I [ Dimer ] _; _ I M
0.5 1.125 X 10-7 5.265 X 10-8
1.5 1.279 X 10-7 1.135 X 10-7
2.5 1.744 X 10-7 1.455 X 10-7
3.8 1.640 X 10-7 1.644 X 10-7
6.0 1.744 X 10-7 1.721 X 10-7
Table 6.11. Experimental dimer yields (from immunoblotting)
and simulated dimer yields (outputted from
CAKE, see later) for the analysis of 0.025
mgjml DNA.
The next step is to obtain simulated thymine dimer yields




SIMULATION OF THYMINE DIMER YIELDS USING CAKE
CAKE is a computer programme designed for the Computer
Analysis of Kinetic Equations (199-201), allowing the solution
of a set of differential equations as specified by the
user. The equation is set in a Jacobian matrix which is
stored within the computer to ensure that a minimum number
of operations are performed to solve these non-linear
equations. Solution of equations is performed using the
Newton-Raphson process with a backward differential
formula. CAKE has been used with success in this
laboratory (54,110,111,202) and elsewhere (200) in a number of
different problems. In'particular, Thomas(54) used CAKE in
supporting a proposed mechanism for the ' acetophenone
photosensitized irradiation of calf thymus DNA. The
mechanism and associated rate constants (see below),
initial concentrations of all species and reaction times
were supplied to the programme. CAKE used this information
to calculate the final thymine dimer concentrations
expected. A good agreement between experimental and
simulated data was taken by Thomas(54) as support for the
validity of the proposed mechanism.
The mechanism as proposed by Thomas(54) is as follows:
gap ---) sap k 1 = 1.6 X 10-3 s-l
sap ---) tap k 2 = 6.0 x 1010 s-l
tap + gap ---) gap + gap k 3 = 1.7 x 108 dm3mol-1s-1
tap ---) gap k 4 = 5.0 X 102 s-l
tap + x ---) gap + x k s = 1.0 X 108 dm3mol-1s-1
tap + tt ---) ttt + gap kG = 4.0 X 109 dm3mol-1s-1
tap + tt ---) tt + gap k 7 = 1.3 X 108 dm3mol-1s-1
ttt ---) dim k 8 = 1.1 x 107 s-l
dim + tap ---) gap + dim k9 = 1.3 x 108 dm3mol-1s-1
ttt ---) tt k 10 = 2.0 x 109 s-l
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where gap is the ground state acetophenone, sap is the
singlet state acetophenone, tap is the triplet state
acetophenone, x is any non-contiguous thymine base, tt i s
a contiguous thymine pair, ttt is a triplet state thymine
pair and dim represents the thymine dimer
The rate constants refer to the following processes:
k 1 is the rate constant obtained from chemical actinometry
for the amount of light absorbed by a gap molecule, k 2 is
the intersystem rate constant for acetophenone crossing
from the singlet to triplet state, k 3 is the the rate
constant for acetopheneone self quenching, k 4 is the rate
constant for non-radiative decay of triplet acetophenone to
the singlet ground state, k s is the rate constant for
quenching of triplet acetophenone by any non-contiguous
thymine bases in the DNA, kG is the rate constant for
triplet energy transfer from triplet acetophenone to a
thymine moeity in a contiguous thymine pair, k 7 is the rate
constant for quenching of triplet acetophenone by ground
state contiguous thymine pairs, kg is the rate constant for
dimerization, kg is the rate constant for quenching of
triplet acetophenone by the thymine dimer photoproduct and
k 10 is the rate constant for decay of triplet thymine to the
ground state.
Some of these rate constants were available from
literature, whereas the rest were determined from
actinometry data or by steady state Stern-Volmer analysis.
The initial concentrations of reactant species were
specified as follows: gap = 2.0 x 10-2 , sap = 0.0, tap = 0.0
and ttt = 0.0. The irradiation times of 0.5, 1.5, 2.5, 3.8
and 6 hours were used and the programme run to obtain
simulated thymine dimer yields at these various irradiation
times. Seeing that experimental dimer yields were obtained
at these times using immun~blotting, a direct comparison
could be made between the experimental and simulated dimer
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yields.
However, the programme also required an initial
concentration of contiguous thymine pairs as well as a
value for any non-contiguous thymine bases. The former
concentration was taken as having the same value as the
dimer concentration calculated after 6 hours irradiation~~.
The non-contiguous base concentration was determined as a
mUltiplicative function of 14.65 of the maximum dimer
concentration(l14). Table 6.11., lists the simulated dimer
yields obtained. These are compared to the experimentally
obtained values in Figure 6.14.
If Figure 6.14. is examined, excellent agreement between
simulated and experimental dimer yields is achieved at 0.5
and 6.0 hours irradiations while at 3.8 hours irradiation
the correlation is fairly good. The only major
discrepancies are evident at 1.5 and 2.5 hour irradiations.
However, the simulated data line passes between the
experimental data points at these irradiation times.
Thus without altering the mechanism proposed for the
acetophenone photosensitized irradiation of calf thymus
DNA, good correlation between simulated dimer yields
(obtained from -t h e mechanism) and those obtained by
immunoblotting is evident. It is important to note that
this correlation is obtained with dimer yields calculated
from simple linear regression of the entire range of
calibration points. It therefore appears that the anomaly
of non-linearity evident in the calibration graph (Section
6.3.2 and 6.3.3) does not significantly affect these
results but does warrant further investigation. By
implication, although the volume of antigen delivered to
the membrane surface during immunoblotting did cause site
restriction when antibody and conjugated secondary antibody
were delivered to the memb~ane surface, this feature did
not affect the calibration graph and subsequent simulations
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Figure 6.14. Calculated dimer yields (from immunoblotting)
and simulated dimer yields (outputted from
CAKE) for the analysis of 0.025 mg/ml
irradiated DNA .
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performed using it. If sample conservation was important,
it would obviously have been advantageous to deliver a
smaller volume of antigen during immunoblotting. Hawkes et
al. (169) note that visible spots can be seen if O. 1 J.,LI antigen
is administered to a nitrocellulose membrane in an
immunoblotting assay. In contrast, it is not recommended
that a volume of greater than 5 J.,LI be administered manually
using a micropipette because of the problems of antigen
drying on the membrane surface at a slower rate than what
the membrane itself dries (Section 6.2.1).
6.7 APPLICATION OF THE MECHANISM AT 0.025 mg/ml DNA
The main aim of the work performed in these laboratories is
the elucidation of the kinetics and mechanism of the
photosensitized dimerization of pyrimidine bases in DNA in
cellular systems. A reductionist · approach was adopted
investigating first the photosensitized dimerization of
thymine, thymidine, TpT(110,11 1) , cytosine and uraci I (92) seeing
that more information was available in the literature for
these simpler systems. Thereafter, the investigation was
extended to thymine containing micellar systems(85) and
finally to the most complex UV absorbing system, DNA. In
this context, the kinetics and mechanism have been
elucidated to explain the acetophenone photosensitized
dimerization of calf thymus DNA(54) and the para-aminobenzoic
acid photosensitized dimerization of pUC19 plasmid DNA~~.
These systems were investigated in vitro as a major step to
understanding the in vivo processes. However, no kinetic
study of photosensitized dimerization in vivo has been
carried out, and it is thus unknown how significantly the
kinetics of an in vivo system would differ from an in vitro
one. An in vivo mechanism would have to consider the
various dimer repair processes occurring simultaneously
with dimer formation as well as the scattering and
absorption of radiation by various components of the cell,
including the outer cell wall and membrane and the nuclear
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membrane. Patrick and Gray(203) note that any differences
between the in vitro and in vivo photosensitized
irradiation of DNA would be primarily accounted for by the
shielding from radiation in the cellular system. In its
basic form, the mechanism should thus be the same, apart
from taking cognisance of the important repair pathways in
the in vivo case.
As a step towards confirming or elucidating a mechanism at
the cellular level, the technique of immunoblotting was
developed to quantitate lesion formation at levels « 0.05 ·
mg/ml DNA) undetectable by the HPLC in use in these
laboratories. Using a calibration graph, cut-off antibody
dilutions were converted to thymine dimer concentrations.
The kinetics and mechanism as proposed by Thomas(5~ for the
acetophenone photosensitized irradiation of calf thymus DNA
was tested using the experimentally determined thymine
dimer concentrations. without changing the mechanism, or
altering any of the kinetic parameters, good · correlation
between experimental and simulated dimer yields supported
the validity of the mechanism at 0.025 mg/ml DNA.
The fact that the data could be applied to the mechanism is
an important step forward in moving towards the elucidation
of the kinetics and mechanism of photosensitized
dimerization of DNA in vivo. What is more significant is
that it was applied to the mechanism at dimer
concentrations which previously were not detectable in
these laboratories using HPLC analysis. This of course
suggests that the same or similar mechanism is operating at
the DNA .c onc e nt r a t i on (0.025 mg/ml) four times lower than
the concentration at which at which the mechanism was
previously tested. In . these studies the acetophenone
concentration was kept constant at 2 x 10-2 M. A decrease in ,
DNA concentration implies a higher effective acetophenone
concentration available . for photodimerization at
wavelengths greater than 300 nm. However, saturation limits
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for sensitized dimerization must be accounted for primarily
because of nucleation phenomena sterically reducing thymine
residues available for dimerization~3). As a consequence it
is postulated that of the acetophenone which is
photoexcited, only a certain proportion may induce
dimerization, the remainder of which must decay to the
ground state via non-radiative decay or fluorescence as
proposed in the mechanism of Thomas. In extending these
studies the mechanism will need to be tested at
sequentially lower DNA concentrations.
Evidence for the same mechanism operating over a range of
DNA systems is provided by ~he work performed by Aliwell~~
in these laboratories. Using the triplet photosensitizer
para-aminobenzioc acid (PABA, found in many sunscreen
preparations as an active UV absorber), the
photodimerization of aqueous free thymine, thymidylyl-
3' ,5' -thymidine (TpT) and pUC19 plasmid DNA were
investigated. HPLC analysis was used to quantitate thymine
dimer yields and mechanistic and kinetic data determined.
In its bare form, the proposed mechanism accounted for the
excitation of PABA to triplet PABA, the transfer of this
energy to free thymine molecules or contiguous thymine
pairs (as in TpT and pUC19), the quenching of triplet PABA
by free thymine molecules, TpT or non-contiguous thymine
moeities in DNA and finally dimerization of contiguous
thymine pairs. The significant feature of this mechanism is
that it proposed to be operational within all these thymine
containing systems, each one representing a gradation from
the simplest (free thymine) to the most complex (DNA)
system. This gives support to the work presented here which
showed that the same mechanism was valid over a range of
DNA concentrations.
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6.8 SUGGESTIONS FOR FUTURE WORK
This thesis has described an immunoblotting protocol with
enhanced chemiluminescent detection for the quantitation of
cis-syn thymine dimers. The protocol was successful in
quantitating dimers at levels above the detection limit of .
the HPLC (currently used in these laboratories for dimer
quantitation). It was also used successfully in dimer
quantitation at levels undetectable by the HPLC and to this
end the immuno technique was between 4000 to 8000 more
sensitive than the chromatographic technique.
with the planned extension of this work to thymine dimer
detection at cellular levels, it is hoped that
immunoblotting with enhanced chemiluminescent quantitation
will provide the necessary sensitivity required.
In these laboratories quantitation of thymine dimers in
cellular systems was initiated by irradiation of E. coli
bacteria in the presence of acetophenone(51). Although
problems were experienced in absorption of acetophenone by
the bacteria, this irradiation substrate does find
application in the work presented here. The DNA of
irradiated E. coli can be extracted (lysosyme in Tris to
lyse the cell walls, followed by addition of Triton X-lOO
to sever the cell membrane, thereby releasing the DNA and
other cell components into solution) and purified (phenol-
chloroform for protein removal folowed by RNAse treatment
for removal of RNA components). The DNA can then be used as
the antigen in an immunoblotting protocol. It will also be
necessary to raise antibodies to the extracted DNA, taking
care to produce as uncontaminated a DNA sample as possible
during the extraction and purification procedures.
An important advantage of the immunoplotting technique is
the sensitivity it con~ers to the system under
investigation. Unlike the attempts made by Bolton(51) to
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irradiate litres of cultured E. Coli cells in the presence
of acetophenone, imrnunoblotting analysis of irradiated and
extracted DNA would require a much smaller volume or a
lower concentration of thymine dimer for analysis, so
smaller volumes of E. coli cells need to be irradiated. To
this end a calculation was performed to estimate the
quantity of cells that need to be irradiated for such a
purpose.
A single E. coli cell contains approximately 5 x 10-15 g of
DNA(204). Using the molecular structure of an
oligonucleotide containing all four nitrogenous bases
(Figure 1.2.), it was calculated that 58.934% of the
structure (by mass) consists of the phosphate-deoxyribose
backbone. Thus in the single E. coli cell, 41.066% (i.e.
2.0532 x 10-15 g) of the DNA is comprised of the nitrogenous
bases. If 25.4% of the bases are thymine (a mass percentage
is assumed, since no mention was made by Josse et al.(205)
as to a mass or molar percentage), then 5.2151 x 10-16 g of
thymine is present in a single cell. For dimerization to
occur, the thymine moeities must be adjacent to one
another. In this context, the nearest neighbour frequency
for thymine is quoted to be 0.076(205). Thus 3.9634 x 10-17
g of the DNA is present as dimerizable thymine residues.
Under acetophenone photosensitizing conditions,
approximately 95% of the thymine bases will dimerize to
give thymine dimers(26) , thus it is possible that 3.7652 x
10-17 g of the DNA will exist as thymine dimers after
irradiation. Taking the molar mass of the thymine dimer to
be 252 glmol, 1.4941 x 10-19 mol of dimer could be present.
The sensitivity of inununoblotting as determined in this
work is 2.5 x 10-10 M dimer (Section 6.5) detected in a 5 ~l
aliquot of irradiated DNA blotted onto the membrane surface
during an inununoblotting protocol. In this volume of DNA,
1.25 x 10-10 mol thymine di~er was thus detected. A single
protocol may require approximately 20 aliquots to be
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blotted. Thus 2.50 x 10-14 mol thymine dimer is the minimum
number of moles of thymine that needs to be extracted from
the cellular substrate. If a single cell contains 1.4941 x
10-1 9 mol thymine dimer (as calculated above), then a
minimum of approximately 167000 E. coli cells must be
irradiated and the DNA extracted.
It must be added that this figure is merely an estimate as
to the number of cells needed to run an immunoblotting
protocol. In this regard, the DNA content of the cell is
merely an approximation, as the chromosome number of the E.
coli may vary according to whether the cell is in a
replication cycle or not. If such an irradiation and
extraction was to be performed, it would also be necessary
to consider the efficiency of the extraction procedure
itself, as well as the purity of the DNA preparation.
However, in its bare form, this calculation does provide a
starting point in applying the immunoblotting protocol to
the detection of dimers in c~llular systems. When the work
proves successful in this application, it can then be
extended to other irradiation substrates (e.g. human skin
cells) and kinetic mechanisms (proposed to explain the
acetophenone photosensitized irradiation of calf thymus
DNA(54)) tested in all cases. If the mechanism is found to
apply (with or without modification) then the work
presented in these laboratories will provide important




This thesis presents an immunological approach for the
detection of cis-syn thymine dimers in DV-irradiated calf
thymus DNA. The DV-DNA antigen was injected into laboratory
rabbits and the serum (containing the DV-DNA antibodies)
obtained by bleeding the ear vein.
The crude serum was purified using the technique of
ammonium sulphate precipitation of proteins as well as by
the more sophisticated technique of affinity.
chromatography. The latter involved the selective binding
of the IgG component of the serum to Protein A and the
procedure was developed and optimized on a Waters Delta
Prep 4000 HPLC system.
The immunoassay technique of immunoblotting was chosen to
immobilize the antigen, antibody and a secondary antibody
(conjugated to the enzyme, horseradish peroxidase) on a
commercially available membrane system. The technique of
enhanced chemiluminescence was then chosen to detect and
quantitate the immune complexes. This involved the addition
of luminol to the membrane bound complexes, and resulted in
the horseradish peroxidase catalysing the conversion of
luminol and one of the products (light of 425 nm to 430 nm)
impinging on a luminescence film. The film was then
developed and printed using standard photographic
techniques.
Development of a protocol for the detection and
quantitation of thymine dimer involved the selection of
reagents and equipment from a wide commercial range, and
optimization of the reagent concentrations and incubation
times so as to yield the clearest signal on the
luminescence film. To this end, immunoblotting with ECL
detection allowed the quantitation of cis-syn dimer lesions
at 2.5 x 10-10 M - the technique being between 4000 to 8000
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times more sensitive than HPLC currently used in this
laboratory.
Characterization of the antibody population indicated that
40% of the antibody was directed against the thymine dimer,
with the remaining percentage being produced in response to
the deoxyribose-phosphate backbone, purine and pyrimidine
bases of the DNA and to a small percentage of acetophenone.
A calibration graph of dimer concentration versus cut-off
antibody dilutions was constructed. Non-linearity of the
graph was explained in terms of site restriction and
stereochemical constraints of the antibodies coming into
contact with the antigen on the membrane surface.
Using immunoblotting with ECL detection and quantitation,
the calibration graph was used to calculate thymine dimer
yields at 0.025 mg/ml DNA concentration at this
concentration thymine dimers are undetectable by HPLC
techniques. The previously determined kinetic mechanism for
the acetophenone photosensitized dimerization of calf
thymus DNA ([DNA] > 0.1 mg/ml) was used to model dimer
formation at this lower DNA concentration using the
computer programme CAKE. A good agreement between
experimental and simulated data was taken as support for
the applicability of this mechanism to the irradiated 0.025
mg/ml DNA solution.
The .i mp l i c a t i ons for the same kinetic mechanism operating
at a range of DNA concentrations (0.025 mg/ml to 10.0
mg/ml) are manifold. The same mechanism may well be
operational at DNA concentrations (~g/ml) present in
cellular systems and it is hoped that the work presented in
this thesis will provide a stepping stone in elucidating
cis-syn dimer (and other photoproducts) yields as well as
the kinetic mechanisms for tpeir formation in UV-irradiated
cellular systems. In this manner, the molecular basis
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start photosensitized irradiation of DNA
equations
gap - ) sap ) 1 . 6e - 3
sap - ) tap ) 6 . 0e l O
tap + gap - ) gap + gap ) 1 . 7e 8
tap - ) gap ) 5 . 0e 2
tap + x - ) gap + x ) 1 . Oe 8
tap + tt - ) ttt + gap ) 4 . 0e 9
tap + tt - ) tt + gap ) 1 . 3e 8
ttt - ) dim ) 1 . l e 7
dim + tap - ) gap + dim ) 1 . 3e 8










time final = 1.8e3
alter
time final = 5.4e3
alter
time final = 9.0e3
alter
time final = 1.38e4
alter
time final = 2.16e4
finish
where gap = ground state acetophenone
sap = singlet state acetophenone
tap = triplet state acetophenone
x = any non-contiguous thymine base
tt = contiguous thymine pair
ttt = triplet contiguous thymine pair
dim = dimer
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